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SURVIVAL AND INACTIVATION OF LISTERIA MONOCYTOGENES, SHIGA TOXIN-
PRODUCING ESCHERICHIA COLI, AND MULTIDRUG-RESISTANT AND SUSCEPTIBLE 
SALMONELLA SEROVARS EXPOSED TO HEAT AND ANTIMICROBIALS ON FOOD 
CONTACT AND FOOD SURFACES CONDITIONS 
Compared to planktonic cells, bacterial biofilms are more resistant to sanitizing agents, 
causing crucial challenges for their inactivation in various food environments. The first study of 
this dissertation investigated biofilm formation of seven pathogenic Escherichia coli serogroups 
(i.e., O157, O26, O45, O103, O111, O121, O145) and two or three phenotypes of Salmonella 
Newport and S. Typhimurium (i.e., susceptible, multidrug-resistant [MDR], and/or multidrug-
resistant  with acquired ampC gene [MDR-AmpC]). One-week mature biofilms were also 
exposed to water and to two commercially available quaternary ammonium compound-based 
(QAC) and acid-based (AB) sanitizers. Specifically, seven strain mixtures of the above-
mentioned pathogen groups were separately spot-inoculated onto the surface of stainless steel 
coupons for target inoculation of 2 log CFU/cm
2
. Coupons were then stored statically and 
partially submerged in non-sterilized meat (10% w/v) homogenate at 4, 15, and 25°C. Microbial 
counts on days 0, 1, 4, and 7 and survivors after exposure (submersion in 30 ml for 1 min) to 
water, QAC and AB of one-week mature biofilms were enumerated using selective and non-
selective media. At 4°C, pathogen counts on inoculation day ranged from 1.6±0.4 log CFU/cm
2 
to 2.4±0.6 and changed to 1.2±0.8 to 1.9±0.8 on day-7 with no appreciable differences among 
the pathogen groups. After treatment with QAC and AB on day-7, counts were reduced (P<0.05) 
to less than 0.7±0.6 and 1.2±0.5, respectively, with similar trends among the inoculated pathogen 
groups. Biofilm formation at higher temperatures was more enhanced. E. coli O157:H7, as an 
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example, increased (P<0.05) from 1.4±0.6 and 2.0±0.3 on day-0 to 4.8±0.6 and 6.5±0.2 on day-
7, at 15 and 25°C, respectively. As compared to 4°C, after sanitation, more survivors were 
observed for 15 and 25°C treatments with no appreciable differences among the seven pathogen 
groups. Overall, similar patterns of growth and susceptibility to QAC and AB sanitizers were 
observed for the seven pathogen groups.  
The second study of this dissertation compared the lactic acid resistance of individual strains 
of six serogroups of wild-type and rifampicin resistant non-O157 shiga toxin-producing 
Escherichia coli and susceptible, multidrug-resistant (MDR), and/or MDR with acquired ampC 
gene (MDR-AmpC) Salmonella Newport and Typhimurium against E. coli O157:H7 (5-strain 
mixture). After inoculation (6 log CFU/ml) of a sterile 10% (w/w) beef homogenate (28 ml 
homogenate, 0.3 ml inoculum), lactic acid (1.7 ml, 88%) was added for a target concentration of 
5%. Before acid addition (control), a 2 seconds after acid addition (time-0), and 2, 4, 6 and 8 min 
after addition of acid, aliquots were analyzed (two repetitions, three acid challenges per 
strain/mixture) for survivors. Inoculated counts (6.1±0.1 log CFU/ml) of wild-type E. coli 
O157:H7 mixture were reduced (P<0.05) to 1.1±0.2 by the end of the 8-min acid challenge, 
while the rifampicin-resistant E. coli O157:H7 mixture, inoculated at 5.9±0.2, reached the 
detection limit (<1.0 log CFU/ml) after 6 min of exposure. Of the wild-type non-O157 and of the 
rifampicin-resistant variant strains, irrespective of serogroup, 85.7% (30 out of 35 strains) and 
82.9% (29 out of 35) reached the detection limit within 0 to 6 min of exposure, respectively. Of 
the Salmonella strains, 87.9% (29 out of 33 isolates) reached the detection limit within 0 to 4 min 
of exposure, irrespective of serovar or antibiotic resistance phenotype. Results of non-log-linear 
microbial survivor curve analyses indicated that the non-O157 E. coli serogroups and multidrug-
resistant and susceptible Salmonella strains required less time for a 4D reduction compared to E. 
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coli O157:H7. Overall, the results of this acid challenge showed, for nearly all strains and time 
intervals, that individual strains of wild-type and rifampicin-resistant non-O157 E. coli and of S. 
Newport and Typhimurium were less (P<0.05) acid tolerant than the E. coli O157:H7. The vast 
majority of non-O157 E. coli strains showed similar (P≥0.05) acid tolerance and also the 
majority of drug resistant and susceptible Salmonella strains were similarly (P≥0.05) acid 
tolerant.  
The third study of this dissertation investigated decontamination of beef trimming inoculated 
with shiga toxin-producing Escherichia coli and Salmonella using lactic acid (LA). The efficacy 
of LA was compared against (i) six non-O157 Shiga toxin-producing E. coli (nSTEC) serogroups 
and (ii) antibiotic susceptible and multidrug resistant S. Newport and S. Typhimurium serovars. 
The antimicrobial effects against these pathogens were compared to those obtained against E. 
coli O157:H7. Four-strain mixture inocula of rifampicin-resistant E. coli O157:H7, O26, O45, 
O103, O111, O121 and O145, and antibiotic susceptible and multidrug resistant (MDR and/or 
MDR-AmpC) S. Newport and S. Typhimurium were evaluated on beef trimmings (100-g pieces). 
The inoculated (3 log CFU/cm
2
) trimmings were immersed (30 s) in solutions of LA (5%, 25 or 
55°C). Pathogen populations on untreated and treated samples were enumerated (two or three 
repetitions, three samples each), and data were analyzed as a complete randomized block design. 
Initial levels (3.1-3.3 log CFU/cm
2
) of E. coli O157:H7 and nSTEC serogroups were reduced 
(P<0.05) by 0.7 (E. coli O157:H7) and 0.4-0.9 (nSTEC) log CFU/cm
2 
in 25°C LA-treated 
samples, and 1.4 (E. coli O157:H7) and 1.0-1.3 (nSTEC) log CFU/cm
2 
in 55°C LA-treated 
samples. No differences (P≥0.05) were obtained between surviving counts of the six nSTEC 
serogroups and those of E. coli O157:H7. LA at 25°C and 55°C reduced (P<0.05) Salmonella 
counts (3.0-3.3 log CFU/ cm
2
) by 1.2-1.5 and 1.5-1.9 log CFU/cm
2
, respectively, while 
v 
 
corresponding E. coli O157:H7 reductions were 0.5 and 1.2 log CFU/cm
2
, respectively. 
Reductions of Salmonella counts were not influenced by serovar or antibiotic resistance 
phenotype, and were similar (P≥0.05) or higher (P<0.05) than reductions of E. coli O157:H7. 
The results indicated that LA decontamination of beef trimmings can be as effective against the 
six nSTEC serogroups and antibiotic susceptible and multidrug resistant S. Newport and S. 
Typhimurium as it is against E. coli O157:H7. 
The fourth study of this dissertation was conducted with the objective of evaluating survival 
and multiplication of L. monocytogenes inoculated on cooked chicken breasts which were stored 
aerobically at 7°C for 7 days. Reduction of pathogen cells by microwave, domestic oven, and 
stove top reheating was also evaluated. L. monocytogenes populations increased from 3.7±0.1 to 
7.8±0.2 log CFU/g after 7 days. Microwave oven reheating for 90 s, and stove-top and oven-
reheating to 70°C internal temperature reduced pathogen populations to <0.4-2.6, <0.4-4.8, and 
1.4-5.9 log CFU/g, respectively; numbers of survivors after reheating were higher (P<0.05) in 
products stored for increasing length of time up to 7 days. At shorter microwaving times and 
lower product internal temperatures (stove-top and oven-reheating), similar reduction trends 
were observed but with higher levels of survivors after treatment. Although reheating methods in 
this study reduced L. monocytogenes contamination by 2-5 log CFU/g, growth of the pathogen 
during previous storage allowed high numbers of survivors after reheating, especially after 2 
days of storage. This indicates that storage period, and type and intensity of reheating need to be 
considered for safe consumption of leftovers. 
The last study of this dissertation was designed to evaluate growth of L. monocytogenes 
inoculated on cooked chicken meat with different marinades and survival of the pathogen as 
affected by microwave oven reheating during aerobic storage at 7°C. Raw chicken breast meat 
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samples were treated with three commercially-formulated and three domestically-available 
marinades, and then cooked (74.4°C internal temperature), cooled to 4°C, and surface-inoculated 
with L. monocytogenes. During storage at 7°C, on days 0, 1, 2, 4, and 7, samples were reheated 
by microwave oven (1100 W) for 45 or 90 s and analyzed microbiologically. L. monocytogenes 
counts on non-marinated control samples increased (P<0.05) from 2.7±0.1 to 6.9±0.1 log CFU/g 
during storage. At day-7 of storage, pathogen levels on samples marinated with tomato juice 
were not different (P≥0.05; 6.9±0.1 log CFU/g) from those of the control, whereas for samples 
treated with the remaining marinades, pathogen counts were 0.7 to 2.0 log CFU/g lower (P<0.05) 
than those of control samples. Microwave reheating reduced L. monocytogenes by 1.9 to 4.1 (at 
45 s) and 2.1 to 5.0 (at 90 s) log CFU/g. With similar trends across different marinates, the high 
levels of L. monocytogenes survivors found after microwave reheating, especially after two days 
of storage, indicate that length of storage and reheating time need to be considered for safe 
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With advancements of molecular subtyping methods and available databases in North 
America, such as FoodNet and PulseNet, few cases of foodborne illnesses, hundreds of miles 
apart, can be associated with each other and the food source within days, preventing additional 
spread of illness. From a practical standpoint, contamination of food during commercial 
production, transportation, and processing is unavoidable; however, advancements in food 
microbiology in the last century have resulted in major public health improvements and 
reduction in economical losses due to spoilage microorganisms and foodborne illness episodes 
by pathogenic microorganisms (Davidson et al., 2005).  
Among more than 200 known diseases that could potentially be transmitted through food, 
few pathogens are of major concern in commercial food processing. Earlier estimates considered 
Campylobacter, Salmonella serovars, Escherichia coli O157:H7, Listeria monocytogenes as 
major agents responsible for foodborne illnesses with over 75 million cases and 300,000 
hospitalizations, and more than 5,000 deaths per year in the United States due to known (75%) 
and unknown (25%) pathogens (Mead et al., 1999). More recent epidemiological investigations, 
in 2011, estimated foodborne agents to cause 9.4 million illness episodes, about 56,000 
hospitalizations, and 1,351 deaths per year with Norovirus, Salmonella serovars, Clostridium 
perfringens and Campylobacter as leading causes of foodborne illness, Salmonella serovars, 
Norovirus, Campylobacter spp. and Toxoplasma gondii as leading causes of hospitalizations and  
Salmonella serovars, T. gondii, L. monocytogenes and Norovirus as leading causes of foodborne 
deaths in the U.S. (Scallan et al., 2011a; 2011b; Morris, 2011). 
2 
 
Among the many pathogens that can survive, multiply, and proliferate on meat products, 
members of Enterobacteriaceae are of major concern due to their ability to survive in a wide 
array of environmental conditions and their potential pathogenicity to humans (Jay, 2005). 
Among members of this family, E. coli O157:H7, other shiga toxin-producing E. coli, and 
Salmonella serovars are major concerns in primary processing of meat products. Due to the 
ubiquitous and halophilic nature as well as its ability to proliferate at refrigerated temperatures, 
L. monocytogenes is considered as a major concern for further processed, value-added, and 
ready-to-eat meat products (Juneja and Sofos, 2010). 
As one of the most researched pathogens, inactivation of Salmonella by various 
interventions has been the subject of research for more than 100 years (FDA 2009, 2010). More 
than 30 salmonellosis outbreaks in the United States and around the world have been associated 
with fresh meat as well as processed low-moisture food products in the last decade (FDA, 2009). 
In addition to Salmonella serovars, emergence of multiple drug resistant Salmonella strains in the 
food chain has been of a great concern and subject of recent investigations (Bosilevac et al., 
2009; Arthur et al., 2008). 
L. monocytogenes is widely distributed in the environment. Although rare in occurrence, as 
compared to other major foodborne diseases, listeriosis is a severe illness, being responsible for 
3.8 % of foodborne hospitalizations and 27.4% of foodborne disease deaths in the United States. 
The very young, elderly, pregnant women, and the immunocompromized are among the most 
susceptible groups. Due to the presence of L. monocytogenes in a wide array of environments, its 
halophilic nature, its potential to form biofilms, and its ability to survive and multiply at 
refrigeration temperatures, it has been of special interest in academic and industrial research in 
ready-to-eat food products (Sofos and Geornaras, 2010). 
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Most Escherichia coli strains are not capable of causing foodborne illness in humans. 
However, Enterohemorrhagic E. coli has the potential of secreting shiga toxins, and cause 
Hemolytic Uremic Syndrome (HUS) in infected human host (Wells et al., 2009; Elder et al., 
2000). The O157:H7 serotype as well as six non-O157 Shiga toxin-producing E. coli (O26, O45, 
O103, O111, O121, and O145 serotypes) are responsible for the majority of E. coli related 
foodborne illnesses in the United States (Juneja and Sofos, 2010). 
This dissertation examined control of significant foodborne pathogens in food processing. 
The first study of this dissertation investigated biofilm formation and inactivation by sanitizers of 
foodborne pathogenic E. coli and Salmonella serovars. The second and third studies were 
designed to investigate the lactic acid resistance of individual strains as well as mixtures of non-
O157 STEC strains and serogroups, and resistant and susceptible Salmonella serovars as 
compared to E. coli O157:H7 in a meat homogenate and beef trimmings. The objective of these 
investigations was to determine whether currently implemented lactic acid interventions in 
primary processing of red meat, known to be efficient against E. coli O157:H7, are also capable 
of reducing and/or eliminating non-O157 STEC, and antibiotic resistant and susceptible 
Salmonella serovars. The last two studies of this dissertation investigated reheating as an 
intervention and the antimicrobial properties of marinating ingredients against post-cooking 
inoculated L. monocytogenes to assure the safety of leftover cooked chicken meat during 






REVIEW OF LITERATURE 
Shiga toxin-producing Escherichia coli, and antibiotic resistant and susceptible Salmonella 
Typhimurium and Newport 
Among the pathogens that can survive, multiply, and proliferate on the surface of meat 
products, some members of Enterobacteriaceae are of major concern due to potential 
pathogenicity to humans (Jay, 2005). Escherichia coli O157:H7, other shiga toxin-producing E. 
coli, and Salmonella serovars are major concerns in primary processing of meat products (Wells 
et al., 2009).  
Most E. coli serotypes are not capable of causing severe foodborne illness in humans. 
However, enterohemorrhagic E. coli have the potential of secreting shiga toxins, and cause 
Hemolytic Uremic Syndrome (HUS) in infected human hosts (Wells et al., 2009; Elder et al., 
2000). After the multi-State Pacific Northwest outbreak of E. coli O157:H7 (Bell et al., 1994) 
this serotype became the first microbial agent to be declared as an adulterant in food products by 
the U.S. Food Safety Inspection Service (FSIS, 1999). Along with serotype O157:H7, six non-
O157 Shiga toxin producing E. coli (O26, O45, O103, O111, O121, and O145) serotypes are 
responsible for the majority of E. coli related foodborne illnesses in the United States (Johannes 
and Romer, 2010).  
E. coli naturally reside in the lower intestine of many warm-blooded animal species and can 
benefit the host through protecting the gastrointestinal area against pathogenic organisms as well 
as producing absorbable vitamin K (Jay, 2005). Most E. coli are not capable of causing health 
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complications in human through oral ingestion and are not involved in foodborne illness 
episodes, however some subgroups of this organism are capable of causing health complications 
in humans. Enterohemorrhagic E. coli (EHEC) strains, are capable of producing shiga toxins that 
are responsible for causing Hemolytic Uremic Syndrome (HUS). HUS is characterized by 
hemolytic anemia and acute renal failure and is primarily a concern in children, the elderly, and 
individuals with suppressed immune system (Ahn et al., 2009; Jahanner and Romer, 2010).  
After outbreaks of gastrointestinal illnesses in 1983 (Bell et al., 1994), E. coli O157:H7 was 
first recognized as a pathogenic agent capable of causing HUS. After major outbreaks, including 
a multistate Pacific Northwest outbreak of E. coli O157:H7 in 1992-1993 (Bell et al., 1994), and 
an outbreak of ground beef and beef trimming contaminated with E. coli O157:H7 in August 
1997 and July 2002, this pathogen became the first microbial agent to be declared as an 
adulterant in ground beef by the U.S. Food Safety Inspection Service (FSIS, 1999). Emergence 
of this pathogen has led to much advancement in food regulation and production systems 
including mandatory Hazards Analysis Critical Control Point (HACCP) based food safety 
management systems for meat processors (Sofos, 2009; Oliver et al., 2009). Most recent 
epidemiological investigations estimate every year in the United States E. coli O157:H7 is 
responsible for 3,268 illness episodes with 46.2% and 0.5% hospitalization and death rates, 
respectively (Scallan, et al., 2011). 
Along with E. coli O157:H7, in recent years other serotypes of EHEC have been involved in 
foodborne episodes. A recall of ground beef associated with E. coli O26 by a Pennsylvania 
company (USDA-FSIS, 2011), a recall of ground beef contaminated with E. coli O111 in Japan 
(USDA-FSIS, 2011), and an outbreak of beef sausage contaminated with E. coli O26 in 
Denmark (Ethelberg et al., 2009) are some of the most recent examples. E. coli O26, O45, O103, 
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O111, O121, and O145 serotypes are responsible for the majority of episodes of foodborne 
illness and HUS, associated with non-O157 shiga toxin-producing E. coli in the United States 
(Bethelheim, 2007; Mathusa et al.,2010; Grant et al., 2011). It is estimated that 1,579 illness 
episodes, with a 12.8% hospitalization rate and a 0.3% death rate are caused by non-O157 STEC 
every year (Scallan et al., 2011).  
As one of the most researched pathogens, inactivation of Salmonella by various 
interventions has been the subject of research for more than 100 years (FDA 2009, 2010). More 
than 30 salmonellosis outbreaks in the United States and around the world have been associated 
with fresh meat as well as processed low-moisture food products in the last decade (FDA, 2009). 
In addition to Salmonella serovars, emergence of multiple drug resistant Salmonella in the food 
chain has been of a great concern and of recent investigations (Bosilevac et al., 2009; Arthur et 
al., 2008). 
Due to prevalence of shiga toxin-producing E. coli and antibiotic susceptible and resistant 
Salmonella serovars (Barkocy-Gallagher et al., 2003; Bosilevac et al., 2009), these pathogens 
have been the subject of recent investigations (Sofos, 2009; Oliver et al., 2009). Recent studies 
indicate that MDR Salmonella is reduced at least as effectively as E. coli O157:H7 and 
susceptible Salmonella when treated with antimicrobial interventions currently in use in U.S. 
beef processing plants (Arthur et al., 2008). 
Foodborne episodes with STEC in meat 
Consumption of undercooked ground beef, roast beef, smoked meat products, sausages and 
nonintact steaks contaminated with O157 and non-O157 serotypes of E. coli has caused a large 
number of reported outbreaks and sporadic cases of human illness (Hussein, 2007). E. coli 
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related foodborne illness includes a range from mild diarrhea, abdominal pain, vomiting, and 
bloody diarrhea to hemorrhagic colitis (HC) and HUS (Nataro and Kaper, 1998). Although rare 
in occurrence, HUS can affect infected host, such as infants, children and the elderly, and is 
characterized by thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure 
(Hussein, 2007). From 1984 to 2007, 146 STEC outbreaks and sporadic cases of human illness 
have been traced to consumption of beef contaminated with O157 and non-O157 serotypes of E. 
coli, with 88% of the cases traced back to ground and nonintact beef (Hussein and Bollinger, 
2005a). 
Cattle as reservoir of STEC 
Although STEC serotypes have been isolated from a variety of animals (Beutin et al., 1993; 
1995), they have been associated primarily with ruminants (Hussein, 2007). E. coli-related 
human illnesses have been traced primarily to beef or other edible parts of cattle and food 
products contaminated with cattle manure (Wilson et al., 1992; Bielaszewska et al., 2000). STEC 
serotypes have been isolated from bulls, cows, heifers, steers, and calves (Cizek et al., 1999; 
Hussein et al., 2003; Ezawa et al., 2004) as well as feedlot cattle and cattle in grazing conditions 
(Padola et al., 2004). 
Prevalence of STEC in cattle 
Prevalence of STEC serotypes in feed yards and grazing conditions, and human related 
foodborne illness cases, have been shown to be higher in warmer months (Hussein, 2007). In 
general, it is estimated that 0.3 to 19.7% of feedlot cattle, 0.7 to 27.3% in irrigated pasture, and 
0.9 to 6.9% of cattle in rangeland forages carry STEC serotypes in their gastrointestinal area. At 
slaughtering facilities, prevalence of O157 STEC serotypes ranges from 0.2 to 27.8% (Hussein 
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and Bollinger, 2005a). In an one year study in three beef processing plants (Barkocy-Gallagher et 
al., 2003) it was shown that 60.6% and 56.6% of cattle hides, 5.9% and 19.4% of cattle manure 
samples, and 26.7% and 58.0% of carcasses were contaminated with O157 and non-O157 
STECS, respectively. 
Prevalence of STEC in beef 
It is estimated that 0.1 to 43.0% of carcasses in packing plants, 0.01 to 43.3% of sub-primal cuts 
in packing plants, 0.1 to 4.4% of meat cuts in supermarkets, an average of 2.4% meat products 
used in fast food chains, 0.1 to 54.2% of ground beef, and 0.1 to 4.4% of sausage samples in 
supermarkets can be contaminated with O157 STEC (Hussein and Bollinger, 2005b). Similarly, 
1.7 to 58.0% of sub-primal cuts in packing plants, 3.0 to 62.5% in supermarkets, an average of 
3.0% of meat products used in fast food chains, 2.4 to 30.0% of ground beef, 17.0 to 49.2% of 
sausage samples, and 1.7 to 58.0% of carcasses in packing plants were contaminated with non-
O157 STEC (Hussein and Bollinger, 2005b). 
Control of STEC in beef  
It is estimated that non-O157 STEC are more common in beef products than O157 STEC 
serotypes (Grant et al., 2011). Although some studies have indicated that non-O157 STEC are no 
more resistant than O157 STEC serotypes in response to common commercial processing 
procedures in beef processing, it appears that more investigation is needed for control of non-
O157 STEC serotypes on carcasses, meat cuts, and meat products (Johnson et al., 2006; 





In addition to planktonic cells, biofilm communities of pathogens are of significant importance  
to the food industry. Bacterial biofilms were first described in 1943 (Zobell, 1943) and currently 
are considered as a major challenge in sanitation and hygiene at food processing (Simoes et al., 
2010; Shi and Zhu, 2009; Chmielewski and Frank, 2003). Biofilms are a community of viable 
and noviable cells of a single or a collection of species anchored to a surface and covered with a 
layer of extracellular polymeric substances that makes biofilms potentially resistant to cleaning 
and sanitation practices in food processing areas (Shi and Zhu, 2009; Chmielewski and Frank, 
2003). Improper cleaning and sanitation of food contact surfaces has been a contributing factor 
to many foodborne illness episodes (Shi and Zhu, 2009; Chmielewski and Frank, 2003).    
Listeria monocytogenes and its inactivation by reheating interventions and marination 
Among more than 200 known diseases that could potentially be transmitted through food 
routes, few pathogens are of major concern in food processing. Previous estimates were 
considering Campylobacter, Salmonella serovars, E. coli O157:H7, L. monocytogenes as major 
agents responsible for foodborne illnesses with over 75 million illness and 300,000 
hospitalizations, and more than 5,000 deaths per year in the United States due to known (75%) 
and unknown (25%) pathogens (Mead et al., 1999). More recent epidemiological investigations 
in 2011 revealed similar trends for foodborne illness with 9.4 million episodes of food safety 
illness, about 56,000 hospitalizations, and 1,351 deaths per year, with Norovirus, Salmonella 
serovars, Clostridium perfringens and Campylobacter as leading causes of foodborne illness, 
Salmonella serovars, Norovirus, Campylobacter  and Toxoplasma gondii are leading causes of 
hospitalizations, and  Salmonella serovars, T. gondii, L. monocytogenes and Norovirus leading 
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causes of foodborne deaths in the U.S. (Scallan et al., 2011a; 2011b; Morris, 2011). Due to its 
ubiquitous and halophilic nature and its ability to proliferate at refrigerated temperatures, L. 
monocytogenes is considered as a major concern for further processed, value-added, and ready-
to-eat meat products (Juneja and Sofos, 2010). 
Similar to ready-to-eat products, cooked leftover food, both in the domestic environment 
and at commercial establishments, has reduced levels of background microflora and in case of 
cross-contamination during refrigerated storage may harbor and support growth of foodborne 
pathogens (Murphy and Berrang, 2002; Murphy et al., 2001; 2003), especially psychotropic 
pathogens such as L. monocytogenes and Yersinia enterocolitica (Jay, 2005). 
Although generally foodborne diseases are linked to food consumed outside the home 
(Kennedy et al., 2005), epidemiological investigations indicate that poor hygienic practices in the 
domestic environment may also be responsible for foodborne disease episodes (Redmond et al., 
2003). Infrequent hand washing, poor hand-washing technique, lack of hand-washing prior to 
food preparation, inadequate cleaning of kitchen surfaces, involvement of pets in the kitchen, 
touching of face, mouth, nose and/or hair during preparation of food ( Jay et al., 1999),  as well 
as improper storage, and inadequate cooking and reheating (James and Evans 1992; Griffith et 
al., 1994)  are some of the practices that could potentially result in introduction of pathogens of 
public health concern into food products, and allow their survival and multiplication to levels of 
concern. In recent years, various studies have detected foodborne pathogens, including L. 
monocytogenes, on kitchen surfaces, dish cloths, sinks, drains, and refrigerators (Jackson et al., 
2007; Azevedo et al., 2003; Kilonzo-Nthenge et al., 2008). These scenarios may also happen in 
commercial catering establishments. It has been shown that the microbiological profile of cooked 
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chicken stored in refrigerators is very similar to microbial profiles of swabs taken from the 
kitchen environments (Toule and Mutphy, 1978).   
L. monocytogenes is widely distributed in the environment including the domestic 
environment and commercial food preparation areas as well as different processed and raw food 
products (Gandhi  and Chikindas, 2007). Although rare in occurrence, as compared to other 
major foodborne diseases, listeriosis caused by L. monocytogenes is an important severe illness, 
being responsible for 3.8 % of foodborne hospitalizations and 27.4% of foodborne disease deaths 
in the United States (Ryser and Marth, 2007). The very young, elderly, pregnant women and the 
immunocompromized are the most susceptible groups (Ryser and Marth, 2007). Due to the 
presence of L. monocytogenes in a wide array of environments, its halophilic nature, its potential 
to form biofilms, and its ability to survive and multiply at refrigeration temperatures it has been 
of special interest in academic and industrial research in ready-to-eat food products (Sofos and 
Geornaras, 2010; Sofos 2008; 2009). 
L. monocytogenes has been isolated both from domestic and industrial refrigerated areas  as 
well foods stored under  refrigeration conditions (Sergelidis et al., 2007; Azevedo et al., 2003; 
Walker et al., 1990). The multiplication ability of L. monocytogenes inoculated on cooked food 
has been explained by increased hydrolysis of macromolecules and bioavailability of nutrients on 
the surface of cooked chicken as a result of cooking (Damodaran et al., 2008). 
The effectiveness of microwave treatments against surface inoculated L. monocytogenes has 
been investigated in some recent studies. Rodriguez-Marval et al. (2009) demonstrated that 
inoculated L. monocytogenes on surface of frankfurters could be reduced by 3.7 log CFU/g after 
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75 s of microwaving. Similarly, Shen et al. (2009) showed that 30 s of microwaving resulted in 
0.8-1.3 log CFU/g reduction of inoculated L. monocytogenes. 
For investigating the effects of the stove top reheating method, Adekunle et al. (2009) have 
shown that pan-frying methods during storage of pork scrapple resulted in more than 6 log 
CFU/g reduction of inoculated L. monocytogenes. Previous studies have also investigated 
effectiveness of different reheating instruments. Different pathogen reduction potential of 
various instruments have been explained by different heat transfer principles wherein oven 
treatment, convection and in stove top treatment conduction are the primary modes of heat 
transfer (Adler et al., 2009). 
In addition to adding value and improving palatability, marinating ingredients may provide 
improvement in shelf life through their antimicrobial properties. Due to presence of L. 
monocytogenes in a wide array of environments, its halophilic nature, the potential to form 
biofilms, and its ability to survive and multiply at refrigeration temperature, this pathogen has 
been linked to various recent outbreaks and has been isolated from many food processing and 
domestic environments (Jay, 2005). 
While some marinating formulations have been shown to have little to no effects on 
reducing microbial load of poultry products during storage (Perko-Makela et al., 2000), some 
studies suggest marinating ingredients can reduce foodborne pathogens after application and 
during storage. Bjorkroth et al. (2000) showed tomato-based marination can inhibit the growth of 
lactic acid bacteria associated with gaseous spoilage of modified-atmosphere-packaged raw 
chicken meat. In two similar studies, Pathania et al. (2010a, 2010b) showed teriyaki and lemon 
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pepper marinates could both reduce the Salmonella load on chicken skin and red meat during 
aerobic storage.  
Objectives of this dissertation are: 
 Compare biofilm formation of E. coli O157:H7, a mixture of all six E. coli O26, O45, 
O103, O111, O121, and O145, and two or three phenotypes (drug susceptible, MDR, and 
MDR-AmpC) of S. Typhimurium and S. Newport at temperatures of 4, 15, and 25°C. 
 Decontamination of one-week mature biofilms of the above-mentioned pathogens using 
water and quaternary ammonium compound-based and acid-based sanitizers. 
 Compare the lactic acid resistance of individual strains of wild-type and spontaneous 
rifampicin-resistant variants of six STEC serogroups, O26, O45, O103, O111, O121 and 
O145, and antibiotic susceptible and multidrug resistant (MDR and/or MDR-AmpC) S. 
Newport and S. Typhimurium, to that of a wild-type and rifampicin-resistant variants of 5 
strains of E. coli O157:H7 tested as a mixture. 
 Determine whether lactic acid resistance of non-O157 STEC as well as multidrug 
resistant and susceptible Salmonella is different than E. coli O157:H7 inoculated on beef 
trimming. 
 Investigate survival and multiplication of background microflora and inoculated L. 
monocytogenes on cooked boneless skinless chicken breasts stored aerobically at 7 °C 
and investigate the effects of three reheating methods, applied at 0, 1, 2, 4, and 7 days of 
storage, against the pathogen and background microflora of the inoculated chicken meat. 
 Evaluate the effect of three commercially formulated (tomato-based, soy sauce-based, 
and lemon based), and three domestically available (tomato juice, soy sauce, and lemon 
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juice) marinades against post-cooking inoculated L. monocytogenes on chicken breasts, 
during a 7-day aerobic storage period at 7°C.  
















Biofilm formation by O157 and non-O157 Shiga toxin-producing 
Escherichia coli and multidrug-resistant and susceptible Salmonella 
Typhimurium and Newport at 4, 15, and 25°C and their inactivation by 
acid- and quaternary ammonium compound-based sanitizers 
SUMMARY 
Compared to planktonic cells, bacterial biofilms are more resistant to sanitizing agents, 
causing crucial challenges for their inactivation on various food environments. This study 
compared biofilm formation by seven serogroups of Escherichia coli (i.e., O157, O26, O45, 
O103, O111, O121, O145) and two or three phenotypes of Salmonella Newport and S. 
Typhimurium (i.e., susceptible, multidrug-resistant [MDR], and/or multidrug-resistant  with 
acquired ampC gene [MDR-AmpC]). One-week mature biofilms were also exposed to water and 
two commercially available quaternary ammonium compound-based (QAC) and acid-based 
(AB) sanitizers. Seven strain mixtures of the above-mentioned pathogen groups were separately 
spot-inoculated onto the surface of stainless steel coupons for target inoculation of 2 log 
CFU/cm
2
. Coupons were then stored statically, partially submerged in 10% (w/v) non-sterilized 
meat homogenate at 4, 15, and 25°C. Microbial counts on days 0, 1, 4, and 7 and survivors after 
exposure (submersion in 30 ml for 1 min) to water, QAC and AB of one-week mature biofilms 
were enumerated using selective and non-selective media. At 4°C, pathogen counts on 
inoculation day ranged from 1.6±0.4 to 2.4±0.6 log CFU/cm
2 
and changed to 1.2±0.8 to 1.9±0.8 
on day-7 with no appreciable difference among the pathogen groups. After treatment with QAC 
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and AB on day-7, counts were reduced (P<0.05) to less than 0.7±0.6 and 1.2±0.5, respectively, 
with similar trends among the inoculated pathogen counts. Biofilm formation was more 
enhanced at higher temperatures. E. coli O157:H7, as an example, increased (P<0.05) from 
1.4±0.6 and 2.0±0.3 on day-0 to 4.8±0.6 and 6.5±0.2 on day-7 at 15, and 25°C, respectively. As 
compared to 4°C, after sanitation, more survivors were observed for 15 and 25°C treatments with 
no appreciable differences among the seven pathogen groups. MDR-AmpC S. Newport, as an 
example, were reduced to <1.6±1.3 and 1.9±0.9 after exposure to QAC and AB at 15°C,  while 
at 25°C they were reduced to 5.5±0.5 and 6.0±0.4, respectively. Overall it was observed that 
patterns of growth and susceptibility to QAC and AB sanitizers were similar among the seven 
tested pathogens, with enhanced biofilm formation capability and high numbers of survivors at 
higher temperatures. 
INTRODUCTION  
Foodborne pathogenic E. coli and Salmonella serovars are of major concern in primary and 
further processing of foods (Ahn et al., 2009; Jahanner and Romer, 2010). Recent 
epidemiological investigations estimate that every year in the United States E. coli O157:H7 is 
responsible for 3,268 illness episodes with 46.2% and 0.5% hospitalization and death rates, 
respectively (Scallan et al., 2011). Along with E. coli O157:H7, in recent years other serogroups 
of shiga toxin-producing E. coli (STEC) have been involved in foodborne episodes. They include 
E. coli O26, O45, O103, O111, O121, and O145 serogroups which are responsible for the 
majority of episodes of non-O157 STEC related foodborne illnesses in the United States 
(Bettelheim, 2007; Mathusa et al., 2010; Grant et al., 2011). It is estimated that 1,579 illness 
episodes, with a 12.8% hospitalization rate and a 0.3% death rate are caused by non-O157 STEC 
every year (Scallan et al., 2011).  
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Pathogenic Salmonella (nontyphoidal) is the leading cause of foodborne deaths in the United 
States, being responsible for 1,229,007 illness episodes, with a 27.2% hospitalization rate and a 
0.5% death rate (Scallan et al., 2011). In addition, Salmonella, multidrug resistant (MDR) and 
MDR with acquired ampC gene (MDR-AmpC) Salmonella serovars in the food chain cause 
challenges in antibiotic treatment of salmonellosis in hospitals (Bosilevac et al., 2009; Arthur, et 
al., 2004; Boyle et al., 2007; Anonymous, 2012). Recently it has been shown that as high as 
0.6% of ground meat samples may harbor drug-resistant Salmonella (Bosilevac et al., 2009) with 
approximately 7% of them displaying the MDR-AmpC phenotype (Zhao et al., 2009). 
Bacterial biofilms were first described in 1943 (Zobell, 1943) and currently are considered 
as a major challenge in sanitation and hygiene of food processing (Simoes et al., 2010; Shi and 
Zhu, 2009; Chmielewski and Frank, 2003). Biofilms are a community of viable and noviable 
cells of a single or a collection of species anchored to a surface and covered with a layer of 
extracellular polymeric substances that makes biofilms potentially resistant to cleaning and 
sanitation practices in food processing areas (Shi and Zhu, 2009; Chmielewski and Frank, 2003). 
Improper cleaning and sanitation of food contact surfaces has been a contributing factor to many 
foodborne illness episodes (Shi and Zhu, 2009; Chmielewski and Frank, 2003).    
Quaternary ammonium compound- and acid- based sanitizers are among the most common 
sanitizers used in food processing (Hegstad et al., 2012; Farrell et al., 1998) and have been 
extensively investigated against foodborne pathogens (Fratamico et al., 1996; Farrell et al., 1998; 
Sundheim et al.,1998;  Joseph et al.,2001; Ellebracht et al., 2005; Uhlich et al., 2006). 
Although some recent studies have targeted inactivation of E. coli O157:H7 and Salmonella 
biofilms on food processing surfaces (Hood and Zottola, 1997; Stopforth et al., 2003; Silagyi et 
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al., 2009; Bodur and Cagri-Mehmetoglu, 2012; Beauchamp et al., 2012; Wang et al., 2012), only 
limited work is available comparing biofilm formation and inactivation of pathogenic E. coli and 
Salmonella at various temperatures. In addition, due to involvement of E. coli O157:H7 in 
numerous national and international foodborne episodes in the last few decades, this pathogen 
has been the primary target for control in food processing environments (Sofos, 2009; Oliver et 
al., 2009) and thus limited literature is available on biofilm formation and inactivation of 
emerging non-O157 serotypes of shiga toxin-producing E. coli and multidrug resistant 
Salmonella as compared to E. coli O157:H7. 
This study was a comparative investigation of biofilm formation of E. coli O157:H7, a mixture 
of all six E. coli O26, O45, O103, O111, O121, and O145, and two or three phenotypes (drug 
susceptible, MDR, and MDR-AmpC) of S. Typhimurium and S. Newport. In addition to biofilm 
formation at temperatures of 4, 15, and 25°C, three decontamination interventions (water, 
quaternary ammonium compound-based and acid-based) were tested against one-week mature 
biofilms of the above-mentioned pathogen groups. It should be noted that chemical sanitizing 
agents are recommended to be used after thorough cleaning of equipment (Beauchamp et al., 
2012).  In this study the target was to determine any differences in sensitivity to sanitizers among 
the pathogen groups when they might present in conditions that might not be easy to clean. 
MATERIALS AND METHODS 
Bacterial strains.  To facilitate selective enumeration of E. coli strains in the presence of the 
natural meat homogenate microflora, rifampicin-resistant (100 μg/ml) variants of wild-type E. 
coli strains were selected by a method described by Kaspar and Tamplin (1993). A four stain 
mixture of rifampicin-resistant E. coli O157:H7 and a six strain mixture (one from each 
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serogroup) of rifampicin-resistant E. coli O26, O45, O103, O111, O121, and O145 were used in 
this study. Salmonella strains represented two (susceptible, and MDR-AmpC for S. Newport) or 
three (susceptible, MDR, and MDR-AmpC for S. Typhimurium) antibiotic resistant phenotypes. 
Prior to this experiment, antibiotic resistance profiles of the Salmonella isolates was confirmed 
using the Sensititre® antimicrobial susceptibility system (Trek Diagnostic Systems, Cleveland, 
OH) as described by Geornaras et al. (2011). Four-strain mixtures of each of the antibiotic 
resistant phenotypes of S. Newport and Typhimurium were used in this study.  
Both wild-type and rifampicin-resistant variants of E. coli O157:H7 strains needed for this study 
were available at the Pathogen Reduction Laboratory of the Center for Meat Safety and Quality 
of Colorado State University (CSU), while remaining wild-type E. coli and Salmonella strains 
used in this study were kindly provided by Dr. Chitrita DebRoy (E. coli Reference Center, The 
Pennsylvania State University, University Park, PA), Dr. Pina Fratamico (Eastern Regional 
Research Center, USDA-ARS-NAA, Wyndmoor, PA), Dr. Tommy Wheeler (U.S. Meat Animal 
Research Center, USDA-ARS-NPA, Clay Center, NE), Dr. Martin Wiedmann (Department of 
Food Science, Cornell University, Ithaca, NY) and Dr. Shaohua Zhao (Center for Veterinary 
Medicine, U.S. FDA, Laurel, MD). A list of these strains, their identification codes, and isolation 
sources are reported in a recent publication (Geornaras et al., 2011). 
Inocula preparation.  Each isolate was individually prepared by transferring a loop-full from a 
stock kept frozen into 10 ml of tryptic soy broth (TSB; Difco, Becton Dickinson, Sparks, MD) 
(for Salmonella strains) or TSB supplemented with rifampicin (100 μg/ml, Sigma-Aldrich, St. 
Louis, MO; TSB+rif) (for E. coli strains). The inoculated tubes were stored at 35°C and 
subcultured after 20-24 h, by transferring 0.1 ml of bacterial suspension into 10 ml sterile TSB 
(for Salmonella strains) or TSB+rif (for E. coli strains). The subculture tubes were incubated at 
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35°C for 20-24 h and were then streak-plated onto xylose lysine deoxycholate agar (XLD; 
Acumedia, Lansing, MI) (for Salmonella strains) or tryptic soy agar (TSA; Acumedia, Lansing, 
MI) supplemented with 100 μg/ml rifampicin (TSA+rif) (for E. coli strains), and were incubated 
at 35°C for 24 h. These plates with purified cultures were stored at 4ºC and were used for 
preparation of the strain mixtures used in the study. 
Prior to the experiment, for each strain individually, single colonies from the above-mentioned 
purified plates were activated by suspending each colony into 10 ml of TSB (for Salmonella 
strains) or TSB+rif (for E. coli strains), incubating at 35°C for 20-24 h, followed by subculturing 
the strains by transferring 0.1 ml of bacterial suspension into 10 ml sterile TSB (for Salmonella 
strains) or TSB+rif (for E. coli strains) and incubation at 35°C for 20-24 h. Individually sub-
cultured strains were then combined to obtain seven inocula of (i) a four-strain mixture of 
rifampicin-resistant  E. coli O157:H7, (ii) a six strain mixture of rifampicin-resistant E. coli, 
including single strains of E. coli O26, O45, O103, O111, O121, and O145 (non-O157 E. coli), 
(iii) a four-strain mixture of susceptible S. Typhimurium, (iv) a four-strain mixture of MDR S. 
Typhimurium, (v)  a four-strain mixture of MDR-AmpC S. Typhimurium, (vi) a four-strain 
mixture of susceptible S. Newport, and (vii) a four-strain mixture of MDR-AmpC S. Newport. 
Each strain mixture was then centrifuged at 4,629 g for 15 min, washed with 10 ml phosphate-
buffered saline (PBS, pH 7.4; 0.2 g/liter KH2PO4, 1.5 g/liter Na2HPO4·7H2O, 8.0 g/liter NaCl, 
and 0.2 g/liter KCl), centrifuged (4,629 g at 4°C for 15 min) again, and  resuspended in 10 ml 
PBS. 
Preparation of homogenate and inoculation of stainless steel coupons. Previously used 
stainless steel coupons (type 304, #2b finish, [2 x 5 x 0.8 cm]) were washed and sterilized as 
described by Beauchamp et al. (2012). Specifically, coupons were washed and rinsed with soap, 
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water, 99% acetone (Fisher Scientific, Fair Lawn, NJ), and 70% ethyl alcohol (Fisher Scientific, 
Fair Lawn, NJ), to remove food residues, and then autoclaved for sterility. Dried and sterilized 
coupons were then spot-inoculated with 0.1 ml of 1:1000 diluted bacterial suspension of each of 
the above-mentioned strain mixtures and maintained under a biosafety cabinet for 60 min for 
attachment of the cells onto the surface of coupons. Inoculated coupons were then aseptically 
transferred into 50 ml polypropylene sterile tubes (Fisher Scientific, Fair Lawn, NJ) containing a 
10% non-sterile meat homogenate. The homogenate was prepared by 2 min homogenization 
(Masticator, IUL Instruments, Barcelona, Spain) of lean fresh beef (5% fat content) with distilled 
water to yield a 10% (w/v) homogenate. Coupons remained half-submerged in the homogenate 
in an upright tilted position and were incubated statically under aerobic conditions at 4, 15, and 
25ºC for seven days. Attachment time and conditions of this experiment were chosen based on 
preliminary experiments to optimize formation and attachment of biofilm mass on stainless steel 
coupons (date not shown). 
Formation and inactivation of biofilms. For investigating formation of biofilms at 4, 15, and 
25ºC, two hours after inoculation (day-0) and on days 1, 4, and 7, inoculated coupons were 
analyzed for microbial populations. Decontamination of the coupons was investigated on day-7 
of the experiment, by submerging coupons in 30 ml of treatment solution for 60 seconds. These 
solutions were (i) sterilized water, (ii) Oasis-146®, Multi-Quat Sanitizer (Ecolab, Inc., St. Paul, 
MN), and (iii) Vortexx®-Acid Liquid Sanitizer (Ecolab, Inc., St. Paul, MN). These sanitizers 
were chosen due to wide-spread use of such compounds in food processing (Hegstad et al., 2012; 
Farrell et al., 1998). Manufacturer’s of these two selected sanitizer products have multiple 
concentration recommendations, maximum general disinfection concentration for Oasis-146®, 
Multi-Quat Sanitizer (referred as QAC in the rest of this publication), and maximum 
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concentration for food contact surfaces for Vortexx®-Acid Liquid Sanitizer (referred as AB in 
the rest of this publication), were selected in this study. The QAC  (Alkyl [C4, 50%; C12, 40%; 
C16, 10%]) had ingredients of dimethyl benzyl ammonium chloride (3.00%), octyl decyl 
dimethyl ammonium chloride (2.25%), octyl dimethly ammonium chloride (1.35%), dioctyl 
dimethyl ammonium chloride (0.90%), other ingredients (92.50%) and manufacturer’s 
recommendation for general disinfection was 1 fl. Oz per gallon of water or (8 ml/liter). The AB 
had ingredients of hydrogen peroxide (6.9%), peroxy acetic acid (4.4%), octanoic acid (3.3%), 
inert ingredients (85.4%) and maximum manufacturer’s recommendation for food contact 
surfaces are 2 fl. Oz per 6 gallon of water (2.6 ml/liter). 
Microbiological and pH analyses. Prior to microbiological analysis, each side of each coupon 
was rinsed with 10 ml sterile water to remove loosely attached cells. For studying the formation 
of biofilms on days 0, 1, 4, and 7 and for studying the decontamination effects of the sanitizers 
on day 7, rinsed and/or treated coupons were placed inside a sterile test tube with 40 ml D/E 
neutralizing broth (Difco, Becton Dickinson, Sparks, MD) and with 10 sterile glass beads ( 4mm 
diameter). The tube was then vortexed for two min (3200 rpm) to remove attached biofilm cells 
(Stopforth et al., 2002, Giaouris et al., 2005). Immediately after vortexing, sample aliquots (1 
ml) were 10-fold serially diluted in PBS and appropriate dilutions were spread-plated onto TSA 
(for enumeration of background microflora), TSA supplemented with 100 μg/ml rifampicin 
(TSA+rif) (for E. coli strain-mixtures), or  Xylose-Lysine-Tergitol 4 (XLT-4) agar (Acumedia) 
(for Salmonella strain-mixtures). Colonies were counted after incubation of plates at 35°C for 24 
h. The detection limit of the analysis was 0.3 log CFU/cm
2
. Selective medium for enumeration of 
Salmonella strains were chosen after a preliminary experiment using different selective media 
(Comparing XLD and XLT-4 media) to assure selection and differentiation of Salmonella 
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colonies from background microflora (date not shown). On days 0, 1, 4, and 7, pH (Denver 
Instrument, Arvada, CO) of the homogenate was measured using standard laboratory procedures 
as described by Byelashov et al. (2010). 
Design and statistical analyses. This study was conducted in two biologically independent 
repetitions each having three replicates per analysis and thus each reported value is a mean of six 
observations. Microbiological counts were converted to log CFU/cm
2
 and the study was 
considered as a randomized complete block design with each biologically independent repetition 
as a blocking factor. The log-transformed bacterial counts were analyzed using analysis of 
variance (ANOVA) procedure followed by Tukey-adjusted mean separation to compare 
microbial counts of the seven pathogen groups on each storage day of analysis and after each 
treatment on day-7. A Tukey-adjusted ANOVA were also used to compare microbial counts of 
each of the seven inoculated pathogens on each day of storage (comparing counts of days 0, 1, 4, 
and 7 for each pathogen) or after each decontamination intervention (comparing counts of non-
treated, water-washed, QAC-, and AB-treated samples for each pathogen). Data of the three 
storage temperatures (4, 15, and 25ºC) were obtained in three separated experiments thus dataset 
of each temperature was analyzed independently. All statistical analyses were performed using 
general linear model and mixed procedures of SAS9.2 software (SAS Inst., Cary, NC). The 
analysis was conducted at type one error level of 5% (α= 0.05). 
RESULTS AND DISCUSSION 
Bacterial counts of homogenate and pH values. At 4°C, pH values of homogenates on 
days 0, 1, 4, and 7 were 5.47±0.11, 5.41±0.12, 4.04±0.86, and 4.78±0.16, respectively. 
Corresponding values were 5.17±0.52, 4.84±0.21, 6.00±0.34, and 7.14±0.53 for samples of 15°C 
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and 5.05±0.44, 4.08±0.48, 6.29±0.41, and 7.32±0.52 for samples of 25°C. Values of pH of non-
inoculated homogenate, water, QAC and AB sanitizers were 5.29±0.36, 6.78±0.63, 5.50±0.81, 
and 3.17±0.47, respectively.  Microbial counts of the meat used for preparation of homogenate 
were 5.6±0.5 CFU/g and counts of bacterial suspension before inoculation of coupons were 
5.7±0.2, 6.0±0.1, 5.8±0.4, 5.9±0.4, 5.6±0.3, 5.9±0.4, and 5.8±0.5 log CFU/ml for E. coli 
O157:H7, Non-O157 E. coli serovars, Susceptible S. Typhimurium, MDR S. Typhimurium, 
MDR-AmpC S. Typhimurium, Susceptible S. Newport, and MDR-AmpC S. Newport, 
respectively. 
Biofilm formation and inactivation at 4°C. Section A of Figure 3.1 (Appendix Tables A1 and 
A2) shows biofilm formation and inactivation of the pathogen groups at 4°C (counts of selective 
media). Pathogen counts on day-0 ranged from 1.6±0.4 log CFU/cm
2 
(for E. coli O157:H7) to 
2.4±0.6 (for MDR-AmpC S. Newport) with no differences (P≥0.05) among the seven pathogen 
groups. After seven days of storage these values ranged from 1.2±0.8 (for E. coli O157:H7) to 
1.9±0.8 (for MDR-AmpC S. Newport). The differences in biofilm formation among the seven 
pathogen groups on day-7 were not statistically significant (P≥0.05). For all seven pathogen 
groups, there was no increase (P≥0.05) of biofilm mass from day-0 to day-7 at 4°C. At this 
temperature (4°C), except for susceptible S. Typhimurium which had lower (P<0.05) biofilm 
counts after treatment with water compared to other pathogen groups, the remaining six pathogen 
groups were affected similarly (P≥0.05) by water washing. Treatment with QAC reduced 
(P<0.05) all five Salmonella inocula to less than the detection limit and reduced O157:H7 and 
non-O157 E. coli to <0.7±0.6 and <0.4±0.1 log CFU/cm
2
, respectively. For five out of seven 
pathogen groups (i.e., five Salmonella inocula), QAC was more effective than water for cell 
reduction (P<0.05) at 4°C. At the chosen concentration, treatment with AB did not reduce 
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(P≥0.05) any of the pathogens’ biofilm counts compared to non-treated samples or samples 
treated with water (Table 3.1).  It should be noted that the concentration chosen for QAC is the 
manufacturer’s maximum recommendation for general disinfection and the concentration chosen 
for AB is the manufacturer’s maximum recommended concentration for inactivation of food 
contact surfaces. It should be noted that chemical sanitizing agents are recommended to be used 
after thorough cleaning of equipment (Beauchamp et al., 2012).  In this study the target was to 
determine any differences in sensitivity to sanitizers among the pathogen groups when they 
might be present in conditions that might not be easy to clean. 
In contrast to pathogen counts, those from non-selective media (i.e.,  TSA), representing both 
inoculated pathogen counts and background microflora of the meat homogenate, increased 
extensively during the seven day storage at 4°C. Section A of Figure 3.2 (Appendix Tables A3 
and A4) shows the biofilm formation and inactivation of the pathogen groups and background 
microflora combined at 4°C (i.e., , counts of non-selective media). On day-0 and day-7, the non-
selective biofilm counts were not statistically different (P≥0.05) among the seven pathogen 
groups. These counts ranged from 2.2±0.3 to 2.8±0.6 on day-0 and increased (P<0.05) to 5.5±0.1 
to 5.7±0.2 on day-7. Treatment with water did not reduce (P≥0.05) non-selective counts of any 
of the seven pathogen groups. Treatment with AB yielded results similar to water, except for one 
pathogen group (MDR-AmpC S. Newport); the remaining reductions of non-selective counts 
were not different (P≥0.05) than counts of coupons treated with water. Treatment with QAC 
reduced non-selective counts by 2.3-3.4 log CFU/cm
2
 and had significantly (P<0.05) lower 
counts than non-treated samples and samples treated with water and AB (Table 3.4). 
Biofilm formation and inactivation at 15°C. Section B of Figure 3.1 (Appendix Tables A5 and 
A6) shows biofilm formation and inactivation of the pathogen groups at 15°C (counts of 
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selective media). On each of days 0, 1, 4, and 7, biofilm counts of the seven pathogen groups 
were not different (P≥0.05) indicating similar biofilm formation at this temperature. Counts on 
day-0 ranged from 1.3±0.8 log CFU/cm
2
 (for susceptible S. Typhimurium) to 2.3±0.4 (for MDR 
S. Typhimurium). These counts increased (P<0.05) on day-7 (for all seven pathogen groups) and 
ranged from 3.8±0.5 log CFU/cm
2
 (for susceptible S. Typhimurium) to 4.9±0.6 (for non-O157 E. 
coli). Treatment with water on day-7 was not effective (P≥0.05) in reducing any of the seven 
pathogen groups. Treatment with AB was not also effective against the four pathogen groups 
(O157 and non-O157 E. coli, susceptible S. Typhimurium, and susceptible S. Newport), while it 
reduced (P<0.05) the counts of MDR and MDR-AmpC S. Typhimurium and MDR-AmpC S. 
Newport by 1.0, 2.1, and 2.6 log CFU/cm
2
, respectively. Treatment with QAC reduced all 
pathogen counts more effectively (P<0.05) than non-treated and water-treated samples. The 
reductions caused by this treatment were 2.6, 3.0, 1.5, 2.2, 3.1, 2.9, and <2.9 log CFU/cm
2 
for E. 
coli O157:H7, non-O157 E. coli, susceptible S. Typhimurium, MDR S. Typhimurium, MDR-
AmpC S. Typhimurium, susceptible S. Newport, and MDR-AmpC S. Newport, respectively 
(Table 3.3). 
Section B of Figure 3.2 (Appendix Tables A1 and A2) shows biofilm formation and inactivation 
of the pathogen groups and background microflora combined at 15°C (i.e., counts of non-
selective media). Similar to 4°C, non-selective counts increased more extensively than pathogens 
during the seven-day storage. On day-0 these counts ranged from 2.2±0.2 (for susceptible S. 
Typhimurium) to 2.6±0.4 (for MDR S. Typhimurium) with no difference (P≥0.05) among the 
seven pathogen groups. These counts increased to 6.3±0.2 (for MDR-AmpC S. Newport) and 
6.6±0.2 (for MDR-AmpC S. Typhimurium) with similar trends (P≥0.05) across the seven 
pathogen groups. Treatment with water on day-7 did not reduce (P≥0.05) counts. Similarly, 
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treatment with AB did not reduce (P≥0.05) non-selective counts of six out of seven pathogen 
groups. MDR-AmpC S. Typhimurium were reduced (P<0.05) by this treatment showing 




counts). QAC was effective (P≥0.05) against the seven pathogen groups and was more effective 
(P<0.05) than non-treated samples and samples treated with water and AB, reducing the non-
selective counts by 0.8 to 1.6 log CFU/cm
2
 (Table 3.5). 
Biofilm formation and inactivation at 25°C. Section C of Figure 3.1 (Appendix Tables A3 and 
A4) shows biofilm formation and inactivation of the pathogen groups at 25°C (counts of 
selective media). On day-0, these counts ranged from 1.5±0.8 log CFU/cm
2
 (for susceptible S. 
Typhimurium) to 2.0±0.8 (for non-O157 E. coli), and were not different (P≥0.05) among the 
seven groups. By day-7 counts increased to 3.3±0.7, 2.9±0.5, 4.2±0.4, 4.3±0.4, 4.1±1.0, 4.3±0.4, 
and 4.3±0.5 log CFU/cm
2
 for E. coli O157:H7, non-O157 E. coli, susceptible S. Typhimurium, 
MDR S. Typhimurium, MDR-AmpC S. Typhimurium, susceptible S. Newport, and MDR-AmpC 
S. Newport, respectively. Counts of all five Salmonella inocula were not statistically different 
(P≥0.05) from each other, but, they were greater (P<0.05) than counts of E. coli O157:H7 and 
non-O157 E. coli. On day-7, treatment with water and AB resulted in no (P≥0.05) reduction 
compared to non-treated samples, while six out of seven (all except for non-O157 E. coli) were 
reduced (P<0.05) due to treatment with QAC (Table 3.3). 
 Section C of Figure 3.2 (Appendix Tables A5 and A6) shows the biofilm formation and 
inactivation of the pathogen groups and background microflora combined at 25°C (i.e., counts of 
non-selective media). Non-selective counts of all seven pathogen groups were not different 
(P≥0.05) from each other on either days of 0, 1, 4, and 7, and they all increased (P<0.05) during 
the seven day storage. These counts ranged from 2.0±0.5 log CFU/cm
2
 (for susceptible S. 
28 
 
Typhimurium) to 2.3±0.4 (for E. coli O157:H7) on day-0 to 6.4±0.6 (for E. coli O157:H7) to 
7.1±0.4 (for MDR S. Typhimurium) on day-7. Non-selective counts of any of the seven pathogen 
groups treated with water were not lower (P≥0.05) than non-treated counts. Similar to 4 and 
15°C, non-selective counts of AB-treated samples of all seven pathogen groups were not 
different (P≥0.05) than counts of non-selective counts of water-treated samples. Except for non-
O157 E. coli, all non-selective counts of all pathogen groups were reduced by (P<0.05) 0.6 to 1.6 
log CFU/cm
2
 as a result of treatment with QAC (Table 3.6). 
Overall comparison of pathogen types relative to biofilm formation and inactivation. Due to 
increased concerns about MDR and MDR-AmpC salmonella serovars presence in the food 
chain, control of these pathogens is  among the most important  concerns in microbiological 
safety of food (Bosilevac et al., 2009; Arthur et al., 2004). In our study, at vast majority of time 
intervals, temperatures and inactivation treatments, MDR and MDR-AmpC phenotypes of 
Salmonella were equally or less resistant to interventions than susceptible Salmonella serovars, 
indicating that validating a cleaning and sanitation procedure against susceptible Salmonella 
serovars will most probably be equally effective for the control of drug-resistant phenotypes as 
well. Low tolerance of drug resistant Salmonella relative to susceptible Salmonella serovars was 
discussed and investigated in study of Morosini et al. (2000). They showed that acquisition, 
maintenance, and expression of ampC and other drug resistant genes may cost Salmonella 
serovars reduction in lifestyle attributes making MDR and MDR-AmpC phenotypes of 
Salmonella potentially less resistant to antimicrobial intervention. 
Control of foodborne pathogenic non-O157 serogroups of E. coli is also a concerntopics in 
microbiological food safety (Bettelheim, 2007; Mathusa et al., 2010; Grant et al., 2011). This 
29 
 
study indicated that control of these pathogen groups on stainless steel material can be achieved 
with similar interventions validated against E. coli O157:H7. 
Overall temperature effect on biofilm formation and inactivation. Under the conditions of 
our study, reduced efficacy of the chemicals as a result of increased temperature of the 
environment during biofilm formation was observed. treatments with a quaternary ammonium 
compound-based sanitizer, were able to reduce biofilm mass of one-week mature biofilm to less 
than detection limited for most pathogen groups when tested at 4°C while same treatment at 
25°C left behind over 100 pathogenic cell/cm
2
 on the surface of stainless steel. A study by Ryu 
et al. (2004) showed similarly  higher biofilm formation and lower susceptibility to sanitizers as 
temperature increases. This may indicate the need for cleaning protocols for different areas of 
processing, depending upon environment temperature. 
Sanitizers tested in this study have been previously shown to be efficient in inactivation of 
planktonic cells. Farrell et al. (1998) and Sundheim et al. (1998) showed proper utilization of 
peroxyacetic acid-based and quaternary ammonium compounds-based sanitizers can reduce the 
counts of E. coli O157:H7 to below detection limit. Fratamico et al. (1996), Joseph et al. (2001), 
Uhlich et al. (2006), and Ellebracht et al. (2005) reached similar conclusions examining a 
selection of food processing sanitizers. In our study, we observed low efficacy of sanitizers 
against one-week mature biofilms at three tested temperatures. Nearly for all the seven tested 
pathogen groups grown at 4, 15, and 25°C, we observed low efficacy of the peroxyacetic-based 
sanitizer for inactivation of one-week mature biofilm, at the highest manufacturers recommended 
concentration for inactivation of food contact surfaces. The quaternary ammonium compound-
based sanitizer tested in this study, especially at higher temperatures of biofilm formation, was 
not capable of complete sanitation of the surfaces as well when tested at the maximum 
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recommended concentration for general disinfection. This confirms and reinforces the need for 
incorporating proper cleaning including physical scrubbing before applying sanitizers for 
effective removal of biofilms from processing area. A recent study of biofilm formation and 
inactivation of E. coli O157:H7 also recommended use of mechanical forces and potentially 
higher concentration of sanitizers to achieve microbiological destruction during cleaning and 
sanitation in food processing areas (Beauchamp et al., 2012). 
Overall, for decontamination of stainless steel coupons from biofilms of foodborne pathogenic 
bacteria, low efficacy of quaternary ammonium compound-based and peroxyacetic-based 
chemical decontamination was observed. These sanitizers were previously validated to be 
effective in removal of planktonic cells. This decrease in efficacy was more notable as a result of 
increase in temperature of the biofilm environment. Seven tested pathogen groups in this study 
had similar biofilm formation and susceptibility to chemical decontamination indicating that a 
successful cleaning and sanitation program validated against E. coli O157:H7 will most probably 













Table  3.1. Biofilm decontamination at 4°C for the seven pathogen groups (selective media counts). 
  Treatments on Day 7* 
  Control  Water  QUAT-146®  VORTEXX® 
Escherichia coli O157:H7**  
1.2±0.8 aA  1.2±0.5 abA  <0.7±0.6 aA  1.2±0.5 abA 
Non-O157 Escherichia coli serovars  
1.4±0.3 aA  2.0±0.5 aA  <0.4±0.1 aB  1.4±0.5 aA 
Susceptible Salmonella Typhimurium  
1.9±0.4 aA  0.6±0.0 bB  <0.3 aB  <0.5±0.2 bB 
MDR Salmonella Typhimurium    
1.7±1.0 aA  1.5±0.5 abA  <0.3 aB  <0.9±0.4 abAB 
MDR-AmpC Salmonella Typhimurium  
1.5±0.3 aA  1.5±0.8 abA  <0.3 aB  <0.9±0.6 abAB 
Susceptible Salmonella Newport  
1.4±0.6 aA  1.3±0.7 abAB  <0.3 aC  <0.6±0.3 bBC 
MDR-AmpC Salmonella Newport  
1.9±0.8 aA  1.2±0.7 abA  <0.3 aB  <1.0±0.4 abAB 
* Control (no treatment) and complete immersion in 30 ml of treatment solution for 60 seconds of (1) sterilized water, (2) Oasis-146®, Multi-Quat Sanitizer. 
(Alkyl [C4, 50%; C12, 40%; C16, 10%]). Ingredients: Dimethyl benzyl ammonium chloride (3.00%), Octyl decyl dimethyl ammonium chloride (2.25%), Octyl 
dimethly ammonium chloride (1.35%), Dioctyl dimethyl ammonium chloride (0.90%), other ingredients (92.50%). Manufacturer’s recommendation for General 
Disinfection: 1 fl. Oz per gallon of water or (8 ml/liter), and (3) Vortexx®. Ingredients: Hydrogen Peroxide (6.9%), Peroxy acetic acid (4.4%), Octanoic acid 
(3.3%), inert ingredients (85.4%). Maximum Manufacturer’s recommendation for food contact surfaces: 2 fl. Oz per 6 gallon of water (2.6 ml/liter). 








Table 3.2 . Biofilm decontamination at 15°C for the seven pathogen groups (selective media counts). 
 Treatments on Day 7* 
  Control  Water  QUAT-146®  VORTEXX® 
Escherichia coli O157:H7**  
4.8±0.6 abA  4.0±1.1 aA  2.2±1.4 aB  3.5±0.8 aAB 
Non-O157 Escherichia coli serovars  
4.9±0.6 aA  4.3±0.9 aA  1.9±1.0 aB  3.3±1.1 abAB 
Susceptible Salmonella Typhimurium  
3.8±0.5 bA  3.9±0.8 aA  2.3±1.0 aB  3.0±0.4 abAB 
MDR Salmonella Typhimurium    
4.2±0.6 abA  4.1±0.5 aA  2.0±0.6 aC  3.2±0.3 abB 
MDR-AmpC Salmonella Typhimurium  
4.7±0.6 abA  4.3±0.6 aA  1.6±0.8 aB  2.6±1.1 abB 
Susceptible Salmonella Newport  
4.5±0.4 abA  4.1±0.3 aAB   2.7±1.1 aC  3.0±0.8 abBC 
MDR-AmpC Salmonella Newport  
4.5±0.8 abA  4.1±0.5 aA  <1.6±1.3 aB  1.9±0.9 bB 
* Control (no treatment) and complete immersion in 30 ml of treatment solution for 60 seconds of (1) sterilized water, (2) Oasis-146®, Multi-Quat Sanitizer. 
(Alkyl [C4, 50%; C12, 40%; C16, 10%]). Ingredients: Dimethyl benzyl ammonium chloride (3.00%), Octyl decyl dimethyl ammonium chloride (2.25%), Octyl 
dimethly ammonium chloride (1.35%), Dioctyl dimethyl ammonium chloride (0.90%), other ingredients (92.50%). Manufacturer’s recommendation for General 
Disinfection: 1 fl. Oz per gallon of water or (8 ml/liter), and (3) Vortexx®. Ingredients: Hydrogen Peroxide (6.9%), Peroxy acetic acid (4.4%), Octanoic acid 
(3.3%), inert ingredients (85.4%). Maximum Manufacturer’s recommendation for food contact surfaces: 2 fl. Oz per 6 gallon of water (2.6 ml/liter). 








Table 3.3 . Biofilm decontamination at 25°C for the seven pathogen groups (selective media counts). 
 Treatments on Day 7* 
 Control  Water  QUAT-146®  VORTEXX® 
Escherichia coli O157:H7** 
3.3±0.7 bcAB  2.6±0.7 bcAB  2.2±0.4 aB  3.5±0.9 aA 
Non-O157 Escherichia coli serovars 
2.9±0.5 cAB  2.3±0.6 cB  2.7±0.9 aAB  3.5±0.7 aA 
Susceptible Salmonella Typhimurium 
4.2±0.4 abA  4.0±0.6 aA  2.3±0.8 aB  4.0±0.8 aA 
MDR Salmonella Typhimurium   4.3±0.4 aA  4.2±0.4 aAB  2.9±0.6 aB  4.4±0.7 aA 
MDR-AmpC Salmonella Typhimurium 
4.1±1.0 abA  3.7±0.5 abAB  3.0±0.4 aB  4.4±0.4 aA 
Susceptible Salmonella Newport 4.3±0.4 abA  4.1±0.6 aA  3.0±0.6 aB  4.4±0.4 aA 
MDR-AmpC Salmonella Newport 4.3±0.5 abA  3.9±0.8 aA  2.5±1.1 aB  4.3±0.6 aA 
* Control (no treatment) and complete immersion in 30 ml of treatment solution for 60 seconds of (1) sterilized water, (2) Oasis-146®, Multi-Quat Sanitizer. 
(Alkyl [C4, 50%; C12, 40%; C16, 10%]). Ingredients: Dimethyl benzyl ammonium chloride (3.00%), Octyl decyl dimethyl ammonium chloride (2.25%), Octyl 
dimethly ammonium chloride (1.35%), Dioctyl dimethyl ammonium chloride (0.90%), other ingredients (92.50%). Manufacturer’s recommendation for General 
Disinfection: 1 fl. Oz per gallon of water or (8 ml/liter), and (3) Vortexx®. Ingredients: Hydrogen Peroxide (6.9%), Peroxy acetic acid (4.4%), Octanoic acid 
(3.3%), inert ingredients (85.4%). Maximum Manufacturer’s recommendation for food contact surfaces: 2 fl. Oz per 6 gallon of water (2.6 ml/liter). 










Table 3.4. Biofilm decontamination at 4°C for the seven pathogen groups and background microflora (non-selective media counts). 
  Treatments on Day 7* 
  Control  Water  QUAT-146®  VORTEXX® 
Escherichia coli O157:H7**  
5.5±0.2 aA  5.3±0.1 aA  3.2±0.6 aB  5.3±0.3 aA 
Non-O157 Escherichia coli serovars  
5.5±0.2 aA  5.3±0.1 aAB  2.7±0.4 aC  5.0±0.3 abB 
Susceptible Salmonella Typhimurium  
5.7±0.2 aA  5.3±0.2 aAB  2.8±0.5 aC  4.9±0.3 abB 
MDR Salmonella Typhimurium    
5.4±0.2 aA  5.3±0.2 aAB  2.2±0.6 aC  4.6±0.5 abB 
MDR-AmpC Salmonella Typhimurium  
5.7±0.4 aA  5.3±0.1 aA  2.8±0.4 aB  4.4±0.8 bC 
Susceptible Salmonella Newport  5.5±0.1 aA  5.4±0.1 aA  2.9±0.5 aC  4.7±0.4 abB 
MDR-AmpC Salmonella Newport  
5.6±0.4 aA  5.1±0.4 aAB  2.2±0.6 aC  4.5±0.5 abB 
* Control (no treatment) and complete immersion in 30 ml of treatment solution for 60 seconds of (1) sterilized water, (2) Oasis-146®, Multi-Quat Sanitizer. (Alkyl [C4, 50%; C12, 40%; C16, 10%]). 
Ingredients: Dimethyl benzyl ammonium chloride (3.00%), Octyl decyl dimethyl ammonium chloride (2.25%), Octyl dimethly ammonium chloride (1.35%), Dioctyl dimethyl ammonium chloride 
(0.90%), other ingredients (92.50%). Manufacturer’s recommendation for General Disinfection: 1 fl. Oz per gallon of water or (8 ml/liter), and (3) Vortexx®. Ingredients: Hydrogen Peroxide (6.9%), 
Peroxy acetic acid (4.4%), Octanoic acid (3.3%), inert ingredients (85.4%). Maximum Manufacturer’s recommendation for food contact surfaces: 2 fl. Oz per 6 gallon of water (2.6 ml/liter). 










Table 3.5 . Biofilm decontamination at 15°C for the seven pathogen groups and background microflora (non-selective media counts). 
  Treatments on Day 7* 
  Control  Water  QUAT-146®  VORTEXX® 
Escherichia coli O157:H7**  6.5±0.2 aA  6.5±0.1 aA  5.2±0.7 aB  6.3±0.3 aA 
Non-O157 Escherichia coli serovars  
6.4±0.3 aA  6.5±0.1 aA  4.8±1.1 aB  6.4±0.3 aA 
Susceptible Salmonella Typhimurium  
6.4±0.3 aA  6.5±0.2 aA  5.3±0.6 aB  6.4±0.3 aA 
MDR Salmonella Typhimurium    
6.4±0.3 aA  6.6±0.2 aA  5.0±0.5 aB  6.3±0.2 aA 
MDR-AmpC Salmonella Typhimurium  
6.6±0.2 aA  6.6±0.3 aA  5.7±0.5 aB  5.9±0.5 aB 
Susceptible Salmonella Newport  
6.5±0.3 aA  6.7±0.3 aA  5.6±0.6 aB   6.4±0.3 aA 
MDR-AmpC Salmonella Newport  
6.3±0.2 aA  6.4±0.2 aA  5.5±0.5 aB   6.0±0.4 aAB 
* Control (no treatment) and complete immersion in 30 ml of treatment solution for 60 seconds of (1) sterilized water, (2) Oasis-146®,, Multi-Quat Sanitizer. (Alkyl [C4, 50%; 
C12, 40%; C16, 10%]). Ingredients: Dimethyl benzyl ammonium chloride (3.00%), Octyl decyl dimethyl ammonium chloride (2.25%), Octyl dimethly ammonium chloride 
(1.35%), Dioctyl dimethyl ammonium chloride (0.90%), other ingredients (92.50%). Manufacturer’s recommendation for General Disinfection: 1 fl. Oz per gallon of water or (8 
ml/liter), and (3) Vortexx®. Ingredients: Hydrogen Peroxide (6.9%), Peroxy acetic acid (4.4%), Octanoic acid (3.3%), inert ingredients (85.4%). Maximum Manufacturer’s 










Table 3. 6. Biofilm decontamination at 25°C for the seven pathogen groups and background microflora (non-selective media counts). 
  Treatments on Day 7* 
  Control  Water  QUAT-146®  VORTEXX® 
Escherichia coli O157:H7**  
6.4±0.6 aA  6.9±0.7 aAB  5.7±0.9 aB   6.3±0.3 aAB 
Non-O157 Escherichia coli serovars  
6.5±0.6 aA  6.8±0.3 aA  5.9±0.8 aA  6.2±0.4 aA 
Susceptible Salmonella Typhimurium  
7.0±0.2 aA  7.1±0.8 aA  5.4±0.6 aB  6.4±0.4 aA 
MDR Salmonella Typhimurium    
7.1±0.4 aA  6.5±0.5 aAB  6.0±0.4 aB  6.7±0.5 aA 
MDR-AmpC Salmonella Typhimurium  
6.5±0.5 aA  6.7±0.5 aAB  5.9±0.5 aB  6.4±0.5 aAB 
Susceptible Salmonella Newport  
7.1±0.4 aA  7.1±0.3 aA  6.1±0.7 aB    6.5±0.7 aAB 
MDR-AmpC Salmonella Newport  
7.0±0.1 aA  6.4±0.3 aAB  6.0±0.5 aB   6.3±0.5 aB 
* Control (no treatment) and complete immersion in 30 ml of treatment solution for 60 seconds of (1) sterilized water, (2) Oasis-146®, Multi-Quat Sanitizer. (Alkyl [C4, 50%; 
C12, 40%; C16, 10%]). Ingredients: Dimethyl benzyl ammonium chloride (3.00%), Octyl decyl dimethyl ammonium chloride (2.25%), Octyl dimethly ammonium chloride 
(1.35%), Dioctyl dimethyl ammonium chloride (0.90%), other ingredients (92.50%). Manufacturer’s recommendation for General Disinfection: 1 fl. Oz per gallon of water or (8 
ml/liter), and (3) Vortexx®. Ingredients: Hydrogen Peroxide (6.9%), Peroxy acetic acid (4.4%), Octanoic acid (3.3%), inert ingredients (85.4%). Maximum Manufacturer’s 
recommendation for food contact surfaces: 2 fl. Oz per 6 gallon of water (2.6 ml/liter). 








































































O157  nSTEC S.T.  Susceptible S.T.  MDR S.T.  MDR- AmpC S.N. Susceptible S.N. MDR-AmpC 
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Figure 3.1 (Data in Appendix Tables A1 to A3 Biofilm formation counts of selective media e.g. pathogen counts) of the selected foodborne 
pathogenic E. coli and Salmonella serovars at A. 4°C, B. 15°C, and C. 25 °C. Bars from left to right represent counts of E. coli O157:H7 (O157), six serogroups 
mixture of non-O157 shiga toxin-producing E. coli (nSTEC), drug susceptible S. Typhimurium (S.T. Susceptible), multidrug resistant S. Typhimurium (S.T. 
MDR), multidrug resistant with acquired AmpC  gene S. Typhimurium (S.T. MDR-AmpC), drug susceptible S. Newport (S.N. Susceptible), and multidrug 















































































O157  nSTEC S.T.  Susceptible S.T.  MDR S.T.  MDR- AmpC S.N. Susceptible S.N. MDR-AmpC 
C
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Figure 3.2 (Data in Appendix Tables A4 to A6). Biofilm formation (counts of non-selective media e.g. background microflora and pathogen counts) 
at A. 4°C, B. 15°C, and C. 25°C. Bars from left to right represent counts of E. coli O157:H7 (O157), six serogroups mixture of non-O157 shiga toxin-producing 
E. coli (nSTEC), drug susceptible S. Typhimurium (S.T. Susceptible), multidrug resistant S.Typhimurium (S.T. MDR), multidrug resistant with acquired AmpC  






Lactic acid resistance of Shiga toxin-producing Escherichia coli and 
multidrug-resistant and susceptible Salmonella Typhimurium and 
Newport in meat homogenate 
SUMMARY  
This study compared resistance to lactic acid of individual strains of six serogroups of wild-
type and rifampicin resistant non-O157 shiga toxin-producing Escherichia coli and susceptible, 
multidrug-resistant (MDR), and/or MDR with acquired ampC gene (MDR-AmpC) Salmonella 
Newport and Typhimurium against E. coli O157:H7 (5-strain mixture). After inoculation (6 log 
CFU/ml) of a sterile 10% (w/w) beef homogenate (28 ml homogenate, 0.3 ml inoculum), lactic 
acid (1.7 ml, 88%) was added for a target concentration of 5%. Before acid addition (control), 
two seconds after acid addition (time-0), 2, 4, 6 and 8 min after addition of acid, aliquots were 
analyzed (two repetitions, three acid challenges per strain/mixture) for survivors. Inoculated 
counts (6.1±0.1 log CFU/ml) of wild-type E. coli O157:H7 mixture were reduced (P<0.05) to 
1.1±0.2 by the end of the 8-min acid challenge, while the rifampicin-resistant E. coli O157:H7 
mixture, inoculated at 5.9±0.2, reached the detection limit (<1.0 log CFU/ml) after 6 min of 
exposure. Of the wild-type non-O157 and of the rifampicin-resistant variants strains, irrespective 
of serogroup, 85.7% (30 out of 35 strains) and 82.9% (29 out of 35) reached the detection limit 
within 0 to 6 min of exposure, respectively. Of the Salmonella strains, 87.9% (29 out of 33 
isolates) reached the detection limit within 0 to 4 min of exposure, irrespective of serovar or 
antibiotic resistance phenotype. Results of non-log-linear microbial survivor curve analyses 
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indicated that the non-O157 E. coli serogroups and multidrug-resistant and susceptible 
Salmonella strains required less time for a 4D reduction compare to E. coli O157:H7. Overall, 
the results of this acid challenge showed, for nearly all strains and time intervals, that individual 
strains of wild-type and rifampicin-resistant non-O157 E. coli and S. Newport and Typhimurium 
were less (P<0.05) acid tolerant than the E. coli O157:H7 5-strain mixture.  
INTRODUCTION 
E. coli O157:H7 and other shiga toxin-producing E. coli (STEC) serotypes are major 
concerns in primary and further processing of muscle foods as they have been involved in 
various foodborne episodes in recent years (Bosilevac et al., 2009). Pathogenic E. coli serovars, 
and especially enterohemorrhagic E. coli (EHEC) strains, are capable of producing shiga toxins 
that may lead to Hemolytic Uremic Syndrome (HUS) a potentially life-threatening kidney 
complication in infected people.  HUS is characterized by hemolytic anemia and acute renal 
failure and is primarily a concern for children, the elderly, and individuals with suppressed 
immune system (Ahn et al., 2009; Jahanner and Romer, 2010).  
After outbreaks of gastrointestinal illnesses in 1983, E. coli O157:H7 was first recognized as 
a pathogenic agent capable of causing HUS. After major outbreaks, including a multistate Pacific 
Northwest outbreak of E. coli O157:H7 in 1992-1993 (Bell et al., 1994), and an outbreak of 
ground beef and beef trimming contaminated with E. coli O157:H7 in August 1997 and July 
2002, this pathogen became the first microbial agent to be declared as an adulterant in food 
products by the U.S. Food Safety Inspection Service (FSIS, 1999). Emergence of this pathogen 
has led to much advancement in food regulation and production systems including mandatory 
Hazards Analysis Critical Control Point (HACCP) based food safety management systems for 
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meat producers (Sofos, 2009; Oliver et al., 2009). Most recent epidemiological investigations 
estimate that every year in the United States E. coli O157:H7 is responsible for 3,268 illness 
episodes with 46.2% and 0.5% hospitalization and death rates, respectively (Scallan et al., 2011). 
Along with E. coli O157:H7 in recent years other serotypes of EHEC have been involved in 
foodborne episodes, including a recall of ground beef associated with E. coli O26 by a 
Pennsylvania company (USDA-FSIS, 2010), a recall of ground beef contaminated with E. coli 
O111 in Japan (USDA-FSIS, 2011), and an outbreak through consumption of beef sausage 
contaminated with E. coli O26 in Denmark (Ethelberg et al., 2009). E. coli O26, O45, O103, 
O111, O121, and O145 serotypes are responsible for the majority of episodes of foodborne 
illness and HUS associated with non-O157 STEC in the United States (Bettelheim, 2007; 
Mathusa et al., 2010; Grant et al., 2011). It is estimated that 1,579 illness episodes, with a 12.8% 
hospitalization rate and a 0.3% death rate are related to non-O157 STEC every year (Scallan et 
al., 2011). 
Recent investigations show that 0.3 to 19.7% of feedlot cattle, 0.7 to 27.3% of cattle on 
irrigated pasture, and 0.9 to 6.9% of cattle in rangeland forage carry STEC serotypes in their 
gastrointestinal system, while at slaughtering facilities, prevalence of STEC serotypes ranges 
from 0.2 to 27.8% (Hussein and Bollinger, 2005a). In a one year study of beef processing plants 
(Barkocy-Gallagher et al., 2003) it was shown that 60.6% and 56.6% of cattle hides, 5.9% and 
19.4% of cattle manures samples, and 26.7% and 58.0% of carcasses were contaminated with 
O157 and non-O157 STEC, respectively. 
Pathogenic Salmonella (nontyphoidal) is the leading cause of foodborne deaths in the United 
States, being responsible for 1,229,007 illness episodes, with a 27.2% hospitalization rate and a 
0.5% death rate (Scallan et al., 2011). In addition, Salmonella, multidrug resistant (MDR) and 
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MDR with acquired ampC gene (MDR-AmpC) Salmonella serovars in the food chain cause 
challenges in antibiotic treatment of salmonellosis in hospitals (Bosilevac et al., 2009; Arthur, et 
al., 2004; Boyle et al., 2007; Anonymous, 2012). Recently it has been shown that as high as 
0.6% of ground meat samples may harbor drug-resistant Salmonella (Bosilevac et al., 2009) with 
approximately 7% of them displaying a MDR-AmpC phenotype (Zhao et al., 2009). 
Due to involvement of E. coli O157:H7 in numerous national and international foodborne 
episodes in the last few decades, this pathogen has been the primary target for control in beef 
processing (Sofos, 2009; Oliver et al., 2009). Lactic acid is one of most common antimicrobial 
intervention in primary processing of fresh beef and its efficacy has been investigated in many 
recent studies (Cutter et al., 2000; Castillo et al., 2001; Harris et al., 2006; Arthur et al., 2008). 
The purpose of this study was to compare the lactic acid resistance of individual strains of 
wild-type and spontaneous rifampicin-resistant variants of six STEC serogroups, O26, O45, 
O103, O111, O121 and O145, and antibiotic susceptible and multidrug resistant (MDR and/or 
MDR-AmpC) S. Newport and S. Typhimurium, to that of a wild-type and rifampicin-resistant 
variants of 5 strains of E. coli O157:H7 tested as a mixture. 
MATERIALS AND METHODS 
E. coli strains. Four to seven individual strains from each of six non-O157 STEC serogroups 
(i.e., O26, O45, O103, O111, O121, and O145) were used in this study. They were kindly 
provided by Dr. Chitrita DebRoy (E. coli Reference Center, The Pennsylvania State University, 
University Park, PA), Dr. Pina Fratamico (Eastern Regional Research Center, USDA-ARS-
NAA, Wyndmoor, PA), and Dr. Tommy Wheeler (U.S. Meat Animal Research Center, USDA-
ARS-NPA, Clay Center, NE). A list of these strains, their identification codes, and isolation 
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sources are reported by Geornaras et al. (2011) and are presented in Table 4.1. In addition to 
these wild-type strains, to facilitate selective enumeration from the natural meat microflora, 
rifampicin-resistant (100 μg/ml) variants were selected by a method described by Kaspar and 
Tamplin (1993). Wild-type and rifampicin-resistant variants of E. coli O157:H7 strains used in 
this study were ATCC 43888, ATCC 43895, C1-057, C1-072, and C1-109 (Carlson et al., 2009) 
and were available in the Pathogen Reduction Laboratory of the Center for Meat Safety and 
Quality of Colorado State University. Lactic acid resistance was tested on both, wild-type 
(parental) and rifampicin-resistant strains, of non-O157 and O157 STEC as well as Salmonella 
strains. 
Salmonella strains. Individual strains of each of MDR and/or MDR-AmpC and susceptible S. 
Newport and S. Typhimurium were used in this study. They were kindly provided by Dr. Martin 
Wiedmann (Department of Food Science, Cornell University, Ithaca, NY) and Dr. Shaohua Zhao 
(Center for Veterinary Medicine, U.S. FDA, Laurel, MD). A list of these strains, their 
identification codes, and isolation sources are reported by Geornaras et al. (2011) and are 
presented in Tables 4.2 and 4.3.  The antibiotic resistance profiles of the Salmonella isolates 
were confirmed using the Sensititre® antimicrobial susceptibility system (Trek Diagnostic 
Systems, Cleveland, OH), specifically panel CMV2AGNF which was designed for the National 
Antimicrobial Resistance Monitoring System (NARMS). With this panel, minimum inhibitory 
concentrations (MIC) were determined, in accordance with the manufacturer’s instructions, for 
ampicillin, amoxicillin/clavulanic acid, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, 
ciprofloxacin, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfisoxazole, tetracycline, 
and trimethoprim/sulfamethoxazole. It should be noted that azithromycin was also included on 
the panel but no breakpoints were found for this antimicrobial (Geornaras et al., 2011). 
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Salmonella strains with a MDR phenotype were resistant to at least ampicillin, chloramphenicol, 
streptomycin, sulfisoxazole, and tetracycline (ACSSuT), and strains with a MDR AmpC 
phenotype were resistant to at least ACSSuT, amoxicillin-clavulanic acid and ceftiofur, and had 
a decreased susceptibility to ceftriaxone (MIC ≥2 μg/ml) (CDC, 2009; Greene, 2008).  
Preparation of strains and mixtures. Strains were individually prepared and subcultured at 
35°C for 20-24 h in 10 ml tryptic soy broth (TSB; Difco, Becton Dickinson, Sparks, MD) (for 
Salmonella, and wild-type STEC strains) or TSB supplemented with rifampicin (100 μg/ml, 
Sigma-Aldrich, St. Louis, MO; TSB+rif) (for rifampicin-resistant STEC strains). Broth cultures 
were then streak-plated onto tryptic soy agar (TSA; Acumedia, Lansing, MI) (for wild-type 
STEC strains), TSA supplemented with 100 μg/ml rifampicin (TSA+rif) (for rifampicin-resistant 
STEC strains), or xylose lysine deoxycholate (XLD) agar (Acumedia) (for Salmonella strains); 
plates were incubated at 35°C for 24 h. Inocula of each strain were prepared by suspending 
single colonies from the above-mentioned cultured plates into 5 ml phosphate-buffered saline 
(PBS, pH 7.4; 0.2 g/liter KH2PO4, 1.5 g/liter Na2HPO4·7H2O, 8.0 g/liter NaCl, and 0.2 g/liter 
KCl). The bacterial suspensions were standardized to a 0.5 McFarland standard (cell 
concentration of approximately 1.5×10
8
 CFU/ml) using a spectrophotometer (600 nm) and 
Nephelometer (Sensititre, Trek Diagnostics). For the inoculum comprised of a composite of five 
E. coli O157:H7 strains, bacterial suspensions to a 0.5 McFarland standard were initially 
prepared for each of the five strains separately, before combining the strains. All bacterial 
suspensions were diluted tenfold in PBS before use. 
Lactic acid intervention. The lactic acid treatment was performed in a beef homogenate 
acidified with 5% lactic acid. The 10% (w/w) homogenate was prepared by 2 min of 
homogenizing (Masticator, IUL Instruments, Barcelona, Spain) fresh beef with distilled water. 
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The homogenate was then passed through cheesecloth, and the liquid was sterilized by 
autoclaving. For each individual strain (non-O157 STEC or Salmonella) or strain mixture (E. 
coli O157:H7), 28 ml of the sterile homogenate was pipetted into a sterile 100 ml Erlenmeyer 
flask containing a sterile magnetic stirrer bar. The flask was placed onto a magnetic stirrer, and 
while stirring, 0.3 ml of the diluted bacterial suspension was added to the homogenate. The target 
inoculation level was approximately 6 log CFU/ml. Prior to addition of lactic acid, an aliquot (1 
ml) of the inoculated homogenate was removed for microbiological analysis to determine the 
inoculation level (untreated control). A 1.7 ml volume of lactic acid (88%, Purac America, 
Lincolnshire, IL) was then added to the stirred inoculated homogenate, giving a final 
concentration of approximately 5% lactic acid. Immediately after addition of the lactic acid (2 
seconds [time 0-min]), and at intervals of 2, 4, 6, and 8 min, 1 ml aliquots were removed from 
the flask for microbial analyses. Before and after addition of acid, pH (Denver Instrument, 
Arvada, CO) values of samples were measured using standard laboratory procedures described 
by Byelashov et al. (2010). 
Microbiological analyses. Aliquots (1 ml) removed from the treated homogenate at each time 
interval were neutralized in 9 ml D/E neutralizing broth (Difco), and subsequently serially 
diluted with 0.1% buffered peptone water (Difco). Appropriate dilutions were surface-plated on 
TSA (for Salmonella, and wild-type STEC strains), TSA+rif (for rifampicin-resistant STEC 
strains) and XLD agar (for Salmonella strains). Colonies were counted after incubation of plates 
at 35°C for 24-48 h. The detection limit of the analysis was 1.0 log CFU/ml. 
Statistical analyses. The study was conducted twice (two biologically-independent repetitions), 
with three acid interventions per strain or strain mixture (for E. coli O157:H7) within each 
repetition (total of six replicates). Each of the two repetitions was considered as a blocking factor 
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in a complete randomized block design. Mean microbial counts (log CFU/ml) of individual 
strains (or strain mixture) within each time interval (control, and 0, 2, 4, 6, 8 min) were 
compared statistically with ANOVA-based procedures followed by Dunnett’s-adjusted multiple 
comparison method for further mean separation using the PROC MIXED command of SAS9.2 
(SAS Institute, Inc., Cary, NC). Using this procedure, surviving microbial counts of the wild-
type non-O157 STEC strains (TSA counts), and Salmonella strains (TSA counts) within each 
time intervals, were compared with surviving counts of the wild-type 5-strain E. coli O157:H7 
mixture (TSA counts). Similarly, surviving counts of rifampicin-resistant non-O157 STEC 
strains (TSA+rif counts), and Salmonella strains (XLD counts) within each time interval, were 
compared to surviving counts of the rifampicin-resistant 5-strain E. coli O157:H7 mixture 
(TSA+rif counts). In addition to this analysis, a repeated measures analysis, using the PROC 
GLM command of SAS, was used to analyze the effect of lactic acid exposure on surviving 
counts within each strain (i.e., for mean separation of mean values of control, and 0, 2, 4, 6, 8 
min for each strain). For both analyses, P values less than 0.05 (P<0.05) were considered 
statistically significant. 
In order to determine the inactivation rates and time required to achieve a 4D reduction for 
the strains evaluated in this study, GInaFiT software, a non-log-linear microbial survivor curve 
were used. This model as described by Geeraerd et al. (2005) reports specific inactivation rates 
of Kmax expressed in the unit of 1/min, their associated standard error, and time required for 4D 
reduction. In order to calculate these values, log CFU counts of before exposure and 0, 2, 4, 6, 
and 8 min after exposure to lactic acid of  wild-type (parent) and rifampicin-resistant non-O157 
serogroups (i.e., O26, O45, O103, O111, O121, and O145), and the two or three phenotypes of 
Salmonella serovars (i.e., susceptible, MDR, and/or MDR-AmpC) were analyzed with the 
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GInaFiT software. Kmax values obtained for each serogroup of non-O157 E. coli and two or three 
phenotypes of Salmonella Newport and Typhimurium were compared statistically (Student-best 
t-test at α=0.05) to those obtained from a five-strain mixture of E. coli O157:H7. Furthermore a 
student based t-test procedure (α=0.05) was used to compare Kmax values of wild-type (parent) 
and rifampicin-resistant strains of E. coli serotypes and serogroups. Reduction of microbial 
counts in this study were investigated using the biphasic GInaFiT model and thus Kmax1 values 
express the inactivation rate of reduction phase while Kmax2 values correspond to the phase at 
which the tested pathogens counts are at or below the detection limit. Both Kmax values are in 
units of 1/min, hence lower values indicate longer times required to achieve a 4D reduction 
(Geeraerd et al., 2005). 
RESULTS AND DISCUSSION 
Acid resistance of E. coli strains. The pH of the beef homogenate ranged from 5.78±0.31 to 
5.91±0.30 before addition of lactic acid, and 2.32±0.18 to 2.64±0.70 after addition of lactic acid. 
Inoculated levels (6.1±0.1 log CFU/ml) of the wild-type E. coli O157:H7 5-strain mixture were 
reduced (P<0.05) to 1.1±0.2 log CFU/ml by the end of the challenge (i.e., 8 min of exposure). 
For the rifampicin-resistant E. coli O157:H7 5-strain mixture, inoculated levels of 5.9±0.2 log 
CFU/ml reached the detection limit at 6 min of exposure. Overall, for the wild-type non-O157 
STEC strains, irrespective of serotype, 85.7% (30 out of 35 strains) reached the detection limit 
(<1.0 log CFU/ml) within 0 min (i.e., 2 seconds following the addition of lactic acid to the 
inoculated beef homogenate) to 6 min of exposure (Figure 4.1 and Appendix Tables A7 to A12). 
Similarly, most (82.9%; 29 out of 35) of the rifampicin-resistant variants of the non-O157 STEC 
strains reached the detection limit within 0 (2 seconds) to 6 min of exposure (Figure 4.2 and 
Appendix Tables A7 to A12). 
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Nearly all strains of E .coli O26 tested in this experiment showed lower lactic acid resistance 
(P<0.05) than E. coli O157:H7 for times 0 (2 seconds) to 8 min (Figure 4.1, Appendix Table 
4A7). Similar results were obtained for both TSA counts (wild-type cells) and TSA+rif counts 
(rifampicin-resistant cells). Similar to E. coli O26, nearly all strains of E. coli O111, O103, O45, 
O121, and O145 showed lower (P<0.05) lactic acid resistance than the strain mixture of E. coli 
O157:H7 for the time intervals of control, 0 (2 seconds), 2, 4, 6, and 8 min (Figures 4.1 and 4.2, 
Appendix Tables A7 to A12). 
Results of recent studies show that 0.1 to 43.0% of carcasses in packing plants, 0.01 to 
43.3% of sub-primal cuts in packing plants, 0.1 to 4.4% of meat cuts in supermarkets, an average 
of 2.4% of meat products used in fast food chains, 0.1 to 54.2% of ground beef, and 0.1 to 4.4% 
of sausages in supermarket may  be contaminated with E. coli O157:H7 (Hussein and Bollinger, 
2005b). Similarly, 1.7 to 58.0% of sub-primal cuts in packing plants, 3.0 to 62.5% in 
supermarkets, an average of 3.0% of meat products used in fast food chains, 2.4 to 30.0% of 
ground beef, 17.0 to 49.2% of sausages, and 1.7 to 58.0% of carcasses in packing plants were 
contaminated with non-O157 STEC (Hussein and Bollinger, 2005b), confirming the concern that 
control of non-O157 STEC will continue to gain importance for assuring the safety of muscle 
foods. Overall, results of this acid challenge, conducted in a beef homogenate acidified with 5% 
lactic acid, showed that in most cases, individual strains of non-O157 STEC (wild-type and 
rifampicin-resistant) were less (P<0.05) acid tolerant than the E. coli O157:H7 5-strain mixture 
(wild-type and rifampicin-resistant) indicating that currently in-place lactic acid interventions in 
processing of red meat, validated to be efficient against E. coli O157:H7 are most probably 
efficient against the six tested serogroups of non-O157 STEC as well.  
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Acid resistance of Salmonella strains. Of the Salmonella isolates, 87.9% (29 out of 33 isolates) 
reached the detection limit within 0 to 4 min (based on TSA counts) or 0 to 2 min (based on 
XLD agar counts) of exposure, irrespective of Salmonella serotype or antibiotic resistance 
phenotype (Figures 4.3 and 4.4, Appendix Tables A13 to A17). Results of this study are in 
agreement with other investigations of multidrug-resistant salmonellae inoculated onto surface of 
fresh meat. It was shown that MDR Salmonella was reduced at least as effectively as E. coli 
O157:H7 and susceptible Salmonella when treated with antimicrobial interventions currently in 
use at most U.S. beef processing plants (Arthur et al., 2004). In a similar study, Hughes et al. 
(2010) showed that 3% lactic acid applied on beef briskets had similar pathogen reduction 
potential against both MDR and susceptible Salmonella. The present study showed the low acid 
tolerance of nearly all tested Salmonella strains as compared to E. coli O157:H7. In addition, for 
the majority of time intervals of strains, MDR and MDR-AmpC phenotypes of Salmonella were 
equally or less resistant to interventions than susceptible Salmonella serovars. Lower tolerance of 
drug-resistant Salmonella relative to its drug-susceptible serovars was reported in study of 
Morosini et al. (2000). They showed acquisition, maintenance, and expression of ampC and 
other drug resistant genes may cost Salmonella serovars reduction in lifestyle attributes making 
MDR and MDR-AmpC phenotypes of Salmonella potentially less resistant to antimicrobial 
interventions. 
Inactivation rates and time required to achieve 4D reductions. Tables 4.4 and 4.5 show Kmax1 
values indicating specific inactivation rates the during reduction phase after exposure to lactic 
acid. All tested serogroups of E. coli (i.e., O26, O45, O103, O111, O121, and O145) showed 
higher (P<0.05) Kmax1 values relative to those obtained from the five-strain mixture of E. coli 
O157:H7 by both wild-type cells and rifampicin-resistant variants. This indicates that the six 
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tested serogroups required shorter time for 4D reductions compared to E. coli O157:H7 and thus 
it can be concluded that these six serogroups were less lactic acid tolerant than E. coli O157:H7 
(Table 4.4). For the six non-O157 serogroups as well as the five-strain mixture of E. coli 
O157:H7, there were no differences (P≥0.05) between Kmax1 values of wild-type and rifampicin-
resistant variants indicating that at the conditions tested in this study, lactic acid resistant of wild-
type and rifampicin-resistant variants were not statistically different (P≥0.05) (Table 4.4). This 
finding is in agreement with the results of Kaspar and Tamplin (1993), showing wild-type and 
rifampicin resistant cells of foodborne pathogens behave similarly in response to antimicrobials 
and therefore can be used interchangeably in food microbiology laboratory challenge research. 
Use of rifampicin-resistant variants facilitates selective enumeration of the strains from the 
natural meat microflora (Kaspar and Tamplin, 1993).  
Similar to E. coli serogroups, all five  phenotypes of Salmonella serovars tested in this 
study, showed Kmax1 values higher (P<0.05) than  those obtained for the five-strain mixture of E. 
coli O157:H7. This indicates that they were more sensitive to lactic acid than the five-strain 
mixture of E. coli O157:H7. Kmax2 values correspond to the phase at which the tested pathogen 
counts are at or below the detection limit and thus predictably the differences among Kmax2 
values for the E. coli O157:H7, the six tested non-O157 E. coli serogroups, and the three 
phenotype for Salmonella Newport and Typhimurium were not appreciable (Tables 4.4 and 4.5); 
they ranged from 0.00±0.28 to 1.34±0.10. Results of non-log-linear microbial survivor curve 
analyses, indicated that the non-O157 E. coli serogroups and drug resistant and susceptible 




Overall, the results of the this acid intervention conducted in a beef homogenate acidified 
with 5% lactic acid, nearly all individual strains of antibiotic resistance and susceptible S. 
Newport and S. Typhimurium and non-O157 E. coli were less (P<0.05) acid tolerant than wild-
type and rifampicin-resistant E. coli O157:H7 5-strain mixtures. In other words, the six tested 
serogroups of non-O157 E. coli required shorter time for 4D reductions compared to E. coli 
O157:H7 and similarly all five  phenotypes of Salmonella serovars tested in this study coli  





















Table 4.1. Sources of non-O157 STEC strains evaluated. 
E. coli serotype Strain  Source Provided by* 
O26:H11  hSTEC_03 (O26-1) human Dr. Wheeler 
O26:H11  imp_113.1 (O26-2) beef Dr. Wheeler 
O26:H11  81.0211 (A1-006) antelope Dr. DebRoy 
O26  85.1150 (A1-007) pig Dr. DebRoy 
O26:H2  93.0494 (A1-008) human Dr. DebRoy 
O26  0.1302 (A1-009) cow Dr. DebRoy 
O26:H11  5.2217 (A1-010) human Dr. DebRoy 
    
O45  99E_2750 (O45-1) human Dr. Wheeler 
O45 O45-2 human Dr. Wheeler 
O45:H2 05-6545 human Dr. Fratamico 
O45:H2 96-3285 human Dr. Fratamico 
    
O103:H2 hSTEC_05 (O103-1) human Dr. Wheeler 
O103 MDR0089 (O103-2) beef Dr. Wheeler 
O103:H2 3.2607  (A1-011) horse Dr. DebRoy 
O103:H11 86.0765 (A1-012) mouse Dr. DebRoy 
O103:H2 87.1368 (A1-013) goat Dr. DebRoy 
O103:H2 90.1764 (A1-014) cow Dr. DebRoy 
O103:H2 92.0084 (A1-015) human Dr. DebRoy 
    
O111:H8 hSTEC_08 (O111-1) human Dr. Wheeler 
O111:NM 18DA (O111-2) human Dr. Wheeler 
O111 93.0523 (A1-001) human Dr. DebRoy 
O111 4.0005 (A1-002) cow Dr. DebRoy 
O111 4.0522 (A1-003) cow Dr. DebRoy 
O111 85.1154 (A1-004) pig Dr. DebRoy 
O111 93.0522 (A1-005) human Dr. DebRoy 
    
O121 10896 (O121-1) human Dr. Wheeler 
O121 imp_450 (O121-2) beef Dr. Wheeler 
O121:H19 97-3068 human Dr. Fratamico 
O121:NM 03-4064 human Dr. Fratamico 
O121:H19 08023 human Dr. Fratamico 
    
O145:NM hSTEC_22 (O145-1) human Dr. Wheeler 
O145 MAY109 (O145-2) beef Dr. Wheeler 
O145:NM 03-4699 human Dr. Fratamico 
O145:NM 83-75 human Dr. Fratamico 
O145:H28 07865 cow Dr. Fratamico 
*  Isolates kindly provided by Dr. Chitrita DebRoy (E. coli Reference Center, The Pennsylvania State University, University Park, PA), Dr. Pina Fratamico (Eastern 




 Table 4.2. Sources and antibiotic resistance profiles of Salmonella Newport strains evaluated. 


























S Susceptible Dr. Zhao 
FSL R6-
531 
human AMP, CHL, R, FIS, TET, AUG2, 







human AMP, CHL, STR, FIS, TET, AUG2, 







human AMP, CHL, STR, FIS, TET, AUG2, 







bovine AMP, CHL, STR, FIS, TET, AUG2, 







bovine AMP, CHL, STR, FIS, TET, AUG2, 







bovine AMP, CHL, STR, FIS, TET, AUG2, 







human AMP, CHL, STR, FIS, TET, AUG2, 







bovine AMP, CHL, STR, FIS, TET, AUG2, 









AMP, CHL, STR, FIS, TET, AUG2, 






pork chop AMP, CHL, STR, FIS, TET, AUG2, 








AMP, CHL, STR, FIS, TET, AUG2, 








AMP, CHL, STR, FIS, TET, AUG2, 








AMP, CHL, STR, FIS, TET, AUG2, 




a Per results of the Sensititre® antimicrobial susceptibility system CMV2AGNF panel (Trek Diagnostic Systems, Cleveland, OH). Antibiotics 
included on the panel include ampicillin (AMP), amoxicillin/clavulanic acid (AUG2), cefoxitin (FOX), ceftiofur (XNL), ceftriaxone (AXO), 
chloramphenicol (CHL), ciprofloxacin (CIP), gentamicin (GEN), kanamycin (KAN), nalidixic acid (NAL), streptomycin (STR), sulfisoxazole 
(FIS), tetracycline (TET), trimethoprim/sulfamethoxazole (SXT). MDR: resistant to at least ampicillin, chloramphenicol, streptomycin, 
sulfisoxazole, and tetracycline (ACSSuT). MDR-AmpC: resistant to at least ACSSuT, amoxicillin-clavulanic acid and ceftiofur, and a decreased 
susceptibility to ceftriaxone (MIC ≥ 2 μg/ml). S: sensitive. 1Department of Food Science, Cornell University, Ithaca, NY;2Center for Veterinary 





















S Susceptible Dr. Zhao
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S Susceptible Dr. Zhao 




S Susceptible Dr. Zhao 
 FSL R6-
215 
















AMP, CHL, STR, FIS, 
TET 
MDR Dr. Zhao 




AMP, CHL, STR, FIS, 
TET 
MDR Dr. Zhao 
 CVM N497 AMP, CHL, STR, FIS, 
TET 
MDR Dr. Zhao 
var. Copenhagen FSL S5-786 AMP, CHL, STR, FIS, 
TET, AUG2, XNL, 
AXO, FOX, KAN 
MDR-AmpC Dr. 
Wiedmann 
 FSL S5-916 AMP, CHL, STR, FIS, 
TET, AUG2, XNL, 
AXO, FOX, KAN 
MDR-AmpC Dr. 
Wiedmann 
var. Copenhagen FSL S5-385 AMP, CHL, STR, FIS, 
TET, AUG2, XNL, 
AXO, FOX, KAN 
MDR-AmpC Dr. 
Wiedmann 
var. O 5- 
(Copenhagen) 
CVM N176 AMP, CHL, STR, FIS, 
TET, AUG2, XNL, 
AXO, FOX 
MDR-AmpC Dr. Zhao 
 CVM 
33831 
AMP, CHL, STR, FIS, 
TET, AUG2, XNL, 
AXO, FOX, SXT, KAN 
MDR-AmpC Dr. Zhao 




AMP, CHL, STR, FIS, 
TET, AUG2, XNL, 
AXO, FOX, NAL, KAN 
MDR-AmpC Dr. Zhao 
      
      
      
a
 Per results of the Sensititre
®
 antimicrobial susceptibility system CMV2AGNF panel (Trek 
Diagnostic Systems, Cleveland, OH). Antibiotics included on the panel include ampicillin 
(AMP), amoxicillin/clavulanic acid (AUG2), cefoxitin (FOX), ceftiofur (XNL), ceftriaxone 
(AXO), chloramphenicol (CHL), ciprofloxacin (CIP), gentamicin (GEN), kanamycin (KAN), 
nalidixic acid (NAL), streptomycin (STR), sulfisoxazole (FIS), tetracycline (TET), 
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trimethoprim/sulfamethoxazole (SXT). MDR: resistant to at least ampicillin, chloramphenicol, 
streptomycin, sulfisoxazole, and tetracycline (ACSSuT). MDR-AmpC: resistant to at least 
ACSSuT, amoxicillin-clavulanic acid and ceftiofur, and a decreased susceptibility to ceftriaxone 
(MIC ≥ 2 μg/ml). S: sensitive. 
1
Department of Food Science, Cornell University, Ithaca, 
NY;
2






Table 4.4. Non-linear microbial survivor analysis for comparing inactivation rates of seven serotype/serogroups of parent and rifampicin-resistant 
shiga toxin-producing E. coli. Kmax1 and Kmax2 (parameter± SE ) values are specific inactivation rates for two phases of the biphasic curves fitted 
for each serotype/serogroups, expressing the inactivation rate of reduction phase (Kmax1 ) and the phase at which the tested pathogens reached the 
detection limit (Kmax2). Both values are expresses in 1/min units indicating longer time required for microbial cell reductions associated to smaller 
Kmax  values. 











 A five-strain mixture  Parent
 
 1.34±0.36 a  1.34±0.10a  7.20 
E. coli O157:H7
 
 A five-strain mixture  Rifampicin resistant  2.32±0.75 a  0.22±0.40b  6.64 
           
E. coli O26  7 single strains  Parent
 
 3.47±0.30 a*  0.03±0.29a*  2.72 
E. coli O26  7 single strains  Rifampicin resistant  4.19±0.29 a^  0.11±0.26a  2.24 
           
E. coli O45  4 single strains  Parent
 
 5.47±0.30a*  0.22±0.14a*  2.16 
E. coli O45  4 single strains  Rifampicin resistant  4.34±0.39a^  0.36±0.13a  2.34 
           
E. coli O103  7 single strains  Parent
 
 3.49±0.50a*  0.23±0.27a*  2.72 
E. coli O103  7 single strains  Rifampicin resistant  5.23±0.60a^  0.47±0.09a  2.26 
           
E. coli O111  7 single strains  Parent
 
 4.70±0.08a*  0.39±0.08a*  2.40 
E. coli O111  7 single strains  Rifampicin resistant  4.32±0.40a^  0.16±0.18a  2.16 
           
E. coli O121  5 single strains  Parent
 
 4.93±0.09a*  0.55±0.09a*  3.02 
E. coli O121  5 single strains  Rifampicin resistant  5.10±0.08a^  0.36±0.08a  2.64 
           
E. coli O145  5 single strains  Parent
 
 4.37±0.14a*  0.42±0.14a*  2.14 
E. coli O145  5 single strains  Rifampicin resistant  3.87±0.26a^  0.00±0.32a  2.40 
a Kmax values (parameter± SE, [1/min]) of parent cells of the six serotype of non-O157 E.coli followed by * are significantly (student-based t-test, P< 0.05) different than Kmax value of parent 
cells of E.coli O157:H7 mixture and Kmax values of rifampicin-resistant variants of the six serotype of non-O157 E.coli followed by ^ are significantly (student-based t-test, P<0.05) different 
than Kmax value of rifampicin-resistant E.coli O157:H7 mixture.
 
b P= parent cells; R= Rifampicin-resistant variants; Within each serotype (i.e., O157:H7 mixture, O26. O45, O103. O111. O121, and O145 values of Kmax values followed by same lowercase 




Table 4.5. Non-linear microbial survivor analysis for comparing inactivation rates of drug susceptible and resistant Salmonella serovars relative to 
parent and rifampicin-resistant E. coli O157:H7. Kmax1 and Kmax2 (parameter± SE ) values are specific inactivation rates for two phases of the 
biphasic curves fitted for each serotype/serovars, expressing the inactivation rate of reduction phase (Kmax1 ) and the phase at which the tested 
pathogens reached the detection limit (Kmax1). Both values are expresses in 1/min units indicating longer time required for microbial cell reductions 
associated to smaller Kmax  values. 











  A five-strain mixture  parent cells  1.34±0.36  1.34±0.10  7.20 
E. coli O157:H7  A five-strain mixture  Rifampicin-resistant  2.32±0.75  0.22±0.40  6.64 
           
Salmonella Typhimurium  4 single strains  Susceptible  4.18±0.61*  0.00±0.28*  2.24 
Salmonella Typhimurium  6 single strains  MDR  7.67±0.10*^  0.12±0.10*  1.32 
Salmonella Typhimurium  6 single strains  MDR-AmpC  7.12±0.08*^  0.14±0.08*  1.20 
Salmonella Newport  4 single strains  Susceptible  7.02±0.39*^  0.00±0.29*  1.36 
Salmonella Newport  13 single strains  MDR-AmpC  4.55±0.09*^  0.08±0.09*  1.60 
a
 Kmax values (parameter± SE, [1/min]) of Salmonella serovars followed by * are significantly (student-based t-test, P< 0.05) different than Kmax value of 
parent cells of E.coli O157:H7 mixture and Kmax values of Salmonella serovars followed by ^ are significantly (student-based t-test, P<0.05) different 
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Figure 4.1 (Data in Appendix Tables A7 to A12). Survival of wild-type non-O157 E. coli strains (log CFU/ ml) compared to 5-strain mixture of 
E. coli O157:H7 in beef homogenate as affected by 5% Lactic acid treatment at 25°C (TSA counts). The left bar (solid black) in all figures show 
counts of E. coli O157:H7 5-strain mixture (ATCC 43888, ATCC 43895, C1-057, C1-072, and C1-109), rest of the bars from left to right in for 
each serogroup represent isolation source (strain identification ID). E. coli O26: Human (hSTEC_03); Beef (imp_113.1); Antelope (81.0211); Pig 
(85.1150); Human (93.0494); Cow (0.1302); Human (5.2217). E. coli O45: Human (99E_2750); Human (O45-2); Human (05-6545); Human (96-
3285); E. coli O103: Human (hSTEC_05); Beef (MDR0089); Horse (3.2607); Mouse (86.0865); Goat (87.1368); Cow (90.1764); Human 
(92.0084). E. coli O111: Human (93.0523); Cow (4.0005); Cow (4.0522); Pig (85.1154); Human (93.522); Human (hSTEC_08); Human (18DA). 
E. coli O121: Human (10896); Beef (imp_450); Human (97-3068); Human (03-4064); Human (08023). E. coli O145: Human (hSTEC_22); Beef 
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Figure 4.2 (Data in Appendix Tables A7 to A12). Survival of rifampicin-resistant  non-O157 E. coli strains (log CFU/ ml) compared to 5-strain 
mixture of E. coli O157:H7 in beef homogenate as affected by 5% Lactic acid treatment at 25°C (TSA+rif counts). The left bar (solid balck) in all 
figures show counts of E. coli O157:H7 5-strain mixture (ATCC 43888, ATCC 43895, C1-057, C1-072, and C1-109), rest of the bars from left to 
right in for each serogroup represent isolation source (strain identification ID). E. coli O26: Human (hSTEC_03); Beef (imp_113.1); Antelope 
(81.0211); Pig (85.1150); Human (93.0494); Cow (0.1302); Human (5.2217). E. coli O45: Human (99E_2750); Human (O45-2); Human (05-
6545); Human (96-3285); E. coli O103: Human (hSTEC_05); Beef (MDR0089); Horse (3.2607); Mouse (86.0865); Goat (87.1368); Cow 
(90.1764); Human (92.0084). E. coli O111: Human (93.0523); Cow (4.0005); Cow (4.0522); Pig (85.1154); Human (93.522); Human 
(hSTEC_08); Human (18DA). E. coli O121: Human (10896); Beef (imp_450); Human (97-3068); Human (03-4064); Human (08023). E. coli 
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Figure 4.3 (Data in Appendix Tables A13 to A17). Survival of susceptible, MDR and/or MDR-AmpC Salmonella Newport and Typhimurium 
strains (log CFU/ ml) compared to 5-strain mixture of E. coli O157:H7 in beef homogenate as affected by 5% Lactic acid treatment at 25°C (TSA 
counts). Susceptible Salmonella Newport: Turkey (CVM N4505); Beef  ( CVM N18445); Turkey (CVM N1509); Human (FSL S5-639). MDR-
AmpC Salmonella Newport: Human (FSL R6-531); Human (FSL R8-  0104); Human (FSL S5-413); Bovine (FSL S5- 436); Bovine (FSL S5-
577); Bovine (FSL S5-920); Human (FSL R8-2926); Bovine (FSL R8-2350); Beef (CVM N635); Pork (CVM 22698); Beef (CVM 29461); Beef 
(CVM 22707); Beef (CVM N19852). Susceptible Salmonella Typhimurium: Chicken (CVM N7300); Beef (CVM N15788); Chicken (CVM 
N18534); Human (FSL S5-536). MDR Salmonella Typhimurium: Human (FSL R6-215); Bovine (FSL S9-165); Human (FSL R8-2540); 
Chicken (CVM N6431); Chicken (CVM 30662); Pork (CVM N497). MDR-AmpC Salmonella Typhimurium: Bovine (FSL S5-786); Bovine 
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Figure 4.4 (Data in Appendix Tables A13 to A17). Survival of susceptible, MDR and/or MDR-AmpC Salmonella Newport and Typhimurium 
strains (log CFU/ ml) compared to 5-strain mixture of E. coli O157:H7 in beef homogenate as affected by 5% Lactic acid treatment at 25°C (XLD 
counts). Susceptible Salmonella Newport: Turkey (CVM N4505); Beef  ( CVM N18445); Turkey (CVM N1509); Human (FSL S5-639). MDR-
AmpC Salmonella Newport: Human (FSL R6-531); Human (FSL R8-  0104); Human (FSL S5-413); Bovine (FSL S5- 436); Bovine (FSL S5-
577); Bovine (FSL S5-920); Human (FSL R8-2926); Bovine (FSL R8-2350); Beef (CVM N635); Pork (CVM 22698); Beef (CVM 29461); Beef 
(CVM 22707); Beef (CVM N19852). Susceptible Salmonella Typhimurium: Chicken (CVM N7300); Beef (CVM N15788); Chicken (CVM 
N18534); Human (FSL S5-536). MDR Salmonella Typhimurium: Human (FSL R6-215); Bovine (FSL S9-165); Human (FSL R8-2540); 
Chicken (CVM N6431); Chicken (CVM 30662); Pork (CVM N497). MDR-AmpC Salmonella Typhimurium: Bovine (FSL S5-786); Bovine 





Sensitivity to lactic acid of shiga toxin-producing Escherichia coli and 
susceptible and multidrug-resistant Salmonella Newport and 
Typhimurium inoculated on beef trimmings 
SUMMARY 
Shiga toxin-producing Escherichia coli and Salmonella are of concern in meat and there is 
interest as to whether lactic acid decontamination treatments are adequate for their reduction in 
beef trimmings. The efficacy of lactic acid (LA) decontamination of beef trimmings was 
evaluated against (i) six non-O157 Shiga toxin-producing E. coli (nSTEC) serogroups and (ii) 
antibiotic susceptible and multidrug resistant S. Newport and S. Typhimurium. The antimicrobial 
effects against these pathogens were compared to those obtained against E. coli O157:H7. Four-
strain mixture inocula of rifampicin-resistant E. coli serogroups O157:H7, O26, O45, O103, 
O111, O121 and O145, and antibiotic susceptible and multidrug resistant (MDR and/or MDR-
AmpC) S. Newport and S. Typhimurium were evaluated on beef trimmings (100-g pieces). The 
inoculated (3 log CFU/cm
2
) trimmings were immersed (30 s) in solutions of LA (5%, 25 and 
55°C). Pathogen populations on untreated and treated samples were enumerated (two or three 
repetitions, three samples each), and data were analyzed as a complete randomized block design. 
Initial levels (3.1-3.3 log CFU/cm
2
) of E. coli O157:H7 and nSTEC serogroups were reduced 
(P<0.05) by 0.7 (E. coli O157:H7) and 0.4-0.9 (nSTEC) log CFU/cm
2 
in 25°C LA-treated 
samples, and 1.4 (E. coli O157:H7) and 1.0-1.3 (nSTEC) log CFU/cm
2 
in 55°C LA-treated 
samples. No differences (P≥0.05) were obtained between surviving counts of the six nSTEC 
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serogroups and those of E. coli O157:H7. LA at 25°C and 55°C reduced (P<0.05) Salmonella 
counts (3.0-3.3 log CFU/ cm
2
) by 1.2-1.5 and 1.5-1.9 log CFU/cm
2
, respectively, while 
corresponding E. coli O157:H7 reductions were 0.5 and 1.2 log CFU/cm
2
, respectively. 
Reductions of Salmonella counts were not influenced by serovar or antibiotic resistance 
phenotype, and were similar (P≥0.05) or higher (P<0.05) than reductions of E. coli O157:H7. 
The results indicated that LA decontamination of beef trimmings can be as effective against the 
six nSTEC serogroups and antibiotic susceptible and multidrug resistant S. Newport and S. 
Typhimurium as it is against E. coli O157:H7. 
INTRODUCTION 
Shiga toxin-producing E. coli and Salmonella are of major concern in primary and further 
processing of meat and meat products (Jay et al., 2005). Due to prevalence of shiga toxin-
producing E. coli (STEC) and  Salmonella serovars in muscle foods (Barkocy-Gallagher et al., 
2003; Bosilevac et al., 2009), inactivation of these pathogens has been the subject of many recent 
academic and industrial investigations in pre- and post-harvest processing of muscle foods 
(Sofos, 2009; Oliver et al., 2009). Consumption of undercooked ground beef, roast beef, smoked 
meat products, sausages and nonintact steaks contaminated with O157 and non-O157 serotypes 
of E. coli is associated with reported outbreaks and sporadic cases of human illness (Hussein, 
2007; Hussein and Bollinger, 2005a, b). E. coli related foodborne illness symptoms range from 
mild diarrhea, abdominal pain, vomiting, and bloody diarrhea to hemorrhagic colitis (HC) and 
Hemolytic Uremic Syndrome (HUS) (Nataro and Kaper, 1998). Although rare in occurrence, 
HUS can affect infected hosts, especially infants, children and the elderly, and is characterized 
by thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure (Hussein, 
2007). From 1984 to 2007, 146 STEC outbreaks and sporadic cases of human illness had been 
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traced to consumption of beef contaminated with O157 and non-O157 serotypes of E. coli, with 
88% of the cases traced back directly to ground and nonintact beef (Hussein and Bollinger, 
2005a). Along with E. coli O157:H7, in recent years, other serotypes of EHEC have been 
involved in foodborne episodes. A recall of ground beef associated with E. coli O26 by a 
Pennsylvania company (USDA-FSIS, 2011), a recall of ground beef contaminated with E. coli 
O111 in Japan (USDA-FSIS, 2011), and an outbreak of beef sausage contaminated with E. coli 
O26 in Denmark (Ethelberg et al., 2009) are some of the most recent examples. E. coli O26, 
O45, O103, O111, O121, and O145 serotypes are responsible for the majority of episodes of 
foodborne illness and HUS, associated with non-O157 shiga toxin-producing E. coli in the 
United States (Bethelheim, 2007; Mathusa et al.,2010; Grant et al., 2011). Most recent 
epidemiological investigations estimate every year in the United States, E. coli O157:H7 is 
responsible for 3,268 illness episodes with 46.2% and 0.5% hospitalization and death rates, 
respectively (Scallan et al., 2011). Similarly, it is estimated that 1,579 illness episodes, with 
12.8% hospitalization rate and 0.3% death rate are caused by non-O157 STEC strains every year 
(Scallan et al., 2011). 
As one of the most researched pathogens, inactivation of salmonella by various 
interventions has been subject of research for more than 100 years (FDA, 2009). More than 30 
Salmonellosis outbreaks in the United States and around the world have been associated with 
fresh meat as well as processed low-moisture food products in recent years (FDA, 2009). In 
addition multidrug resistant (MDR) and multidrug resistant Salmonella serovars with acquired 
AmpC gene (MDR-AmpC) exist in the food chain and cause crucial challenges in antibiotic 
chemotherapy of foodborne Salmonellosis (Bosilevac et al., 2009; Arthur et al., 2008). Recent 
investigations indicate that 0.6% of ground meat samples may harbor drug-resistant Salmonella 
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(Bosilevac et al., 2009) with approximately 7% of them displaying a MDR-AmpC phenotype 
(Zhao et al., 2009).  Most recent epidemiological investigations estimate that every year in the 
United States, nontyphoidal Salmonella serovars are responsible for 1,229,007 illness episodes 
with 27.2% and 0.5% hospitalization and death rates, respectively (Scallan et al., 2011). A multi-
state outbreak linked to fresh ground beef contaminated with MDR strains of S. Typhimurium in 
2012 is a recent example of the involvement of MDR Salmonella serovars in foodborne episodes 
(Food Safety News, 2012). 
Due to involvement of E. coli O157:H7 in numerous national and international foodborne 
episodes in the last few decades, this pathogen had been the primary target of validation plans 
and food safety management systems (Sofos, 2009; Oliver et al., 2009). The purpose of this 
experiment was to determine whether lactic acid resistance of CDC’s top-six non-O157 STEC as 
well as multidrug resistant and susceptible Salmonella Newport and Typhimurium is different 
than E. coli O157:H7 inoculated on beef trimming. 
MATERIALS AND METHODS 
Preparation of bacterial strains and inoculation. In experiment one, 4-strain mixtures of food 
and human-disease associated E. coli O157:H7, and of each of O26, O45, O103, O111, O121, 
and O145 serogroups kindly provided by Drs. Wheeler , DebRoy, and  Fratamico (Table 5.1), 
and in experiment two 4-strain mixtures for each of MDR, MDR-AmpC, and susceptible S. 
Typhimurium, and MDR, MDR-AmpC S. Newport, kindly provided by Drs. Zhao and 
Wiedmann  (Table 5.2), were used.  
In the experiment of non-O157 STEC, in order to facilitate selective enumeration of the 
STEC inocula from the natural meat microflora of beef trimmings, rifampicin-resistant (100 
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μg/ml) variants of the STEC strains were selected as described by Kaspar and Tamplin (1993). 
Use of strains with a selective marker, like antibiotic resistance, also allows recovery of cells 
injured by exposure to chemical decontamination treatments, by plating the cells on a non-
selective medium (tryptic soy agar, in our studies) supplemented with the antibiotic (100 μg/ml 
rifampicin, in this studies). For both experiments, rifampicin-resistant variants of E. coli 
O157:H7 strains were used as controls and were available at the Pathogen Reduction Laboratory 
of the Center for Meat Safety and Quality of Colorado State University, and included ATCC 
43888, ATCC 43895, C1-057, and C1-072 (Carlson et al., 2009). 
Each strain was activated separately from a single colony of the stored stock as described by 
Yang et al. (2009b).  Each strain was then washed and centrifuged at 4,629 g for 15 min with 10 
ml of sterile saline (0.85% NaCl) and resuspended in 10 ml Phosphate-buffered Saline (PBS, 0.2 
g KH2PO4, 1.5 g Na2Hpo4.7H2O, 8.0 g NaCl, and 0.2 g KCl per liter) (Yang et al., 2009a). After 
suspension, four strains of each serotype were combined and tenfold serially diluted. The surface 
of the meat samples (area approximately 100 cm
2
) was then inoculated with 100 µL per side of 
the diluted composite of each pathogen serotype, with a 15 min interval between inoculation of 
each side, to achieve an initial inoculation level of approximately 3-4 Log CFU/g. 
Application of lactic acid and microbiological analyses. Inoculated meat samples were 
inserted into a bag (Whirl-Pak, Modesto, CA) with 150 mL of 5% lactic acid (Purac America 
INC., Lincolnshire, IL) at 25 or 55°C for 30 seconds, removed with sterile forceps and drained 
for 60 seconds on a sterile plastic strainer. Treated samples were then stored for 1 hour in a 4°C 
refrigerator to simulate the testing condition from an industrial setting to a testing laboratory. 
Prior and after lactic acid intervention, weights of the samples were recorded to determine the 
moisture uptake due to the intervention. Before and after acid intervention and 24 hour after 
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intervention, pH (Denver Instrument, Arvada, CO) values of samples were measured following 
standard procedures described by Byelashov et al. (2010). 
In order to stop action of lactic acid on cells, after acid intervention and exposure period, 
100 ml of D/E neutralizing broth (Becton, Dickinson and Company, Sparks, MD) was added to 
each sample.  Samples were then homogenized (Masticator, IUL Instruments, Barcelona, Spain) 
for 2 min (6 strokes per s), and serially diluted (10-fold) with 0.1% buffered peptone water 
(Difco, Becton Dickinson, Franklin Lakes, NJ) and spread-plated onto surface of  Trypticase Soy 
Agar (TSA, Becton, Dickinson and Company, Sparks, MD), TSA with 5 mg/liter Rifampicin 
(TSA+Rif), and modified SMAC (during Salmonella experiment only; mSMAC, Mc Conkey 
Sorbitol Agar with 20 mg/l novobiocin, and 2.5 mg/L Potasium Tellurite, Becton, Dickinson and 
Company, Sparks, MD) for rifampicin-resistant STEC, and TSA and Xylose lysine deoxycholate 
(XLD) medium (Neogen Corporation, Lansing, MI) for Salmonella serovars, and were counted 
after a incubation period of 24-48 hours at and 30°C. 
Statistical analysis.  The experiment with the non-O157 STEC serotypes was conducted 
separately from the study with the S. Newport/Typhimurium antibiotic resistance profiles. These 
studies were conducted twice (for S. Newport/Typhimurium) and three times (for the non O157 
STEC serotypes) with three samples analyzed per repetition (total of six and nine replicates, 
respectively). Each repetition was considered as a blocking factor in a complete randomized 
block design. Microbial counts, transformed into log CFU/cm
2
, were statistically compared with 
ANOVA-based procedures followed by Tukey-adjusted multiple comparison methods for further 
mean separation using the PROC MIXED command of SAS (v9.2). In addition to this analysis, a 
Tukey-adjusted ANOVA test, using the PROC GLM command of SAS, was used to compare 
counts of samples before and after antimicrobial treatment within each E. coli serotypes or S. 
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Newport/Typhimurium antibiotic resistance phenotypes. The pH values were statistically 
analyzed with a student-based t-test by PROC GLM. In all cases, P values less than 0.05 
(P<0.05) were considered statistically significant. 
RESULTS AND DISCUSSION 
It should be noted that the study with the non-O157 STEC serotypes was conducted 
separately from the study with the S. Newport and S. Typhimurium antibiotic resistance profiles. 
Thus, results are presented and discussed separately.  
In the experiment of non-O157 STEC, initial levels of inoculated E. coli O157:H7 and the 
six non-O157 STEC serogroups on beef trimmings ranged from 3.1 to 3.3 log CFU/cm
2
 (Figure 
5.1 and Appendix Table A18). Treatment of samples with lactic acid applied at 25 or 55°C 
reduced (P<0.05) E. coli O157:H7 counts by 0.7 and 1.4 log CFU/cm
2
, respectively. 
Corresponding reductions of the six non-O157 STEC serogroups were 0.4 to 0.9 and 1.0 to 1.3 
log CFU/cm
2
, respectively (Figure 5.1 and Appendix Table A18).  Trends in counts were similar 
for background microflora and inoculated pathogen as expressed by TSA counts (Figure 5.2 and 
Appendix Table A19). Overall, initial counts of total bacterial populations were 3.5 to 3.6 log 
CFU/cm
2
 on all inoculated trimmings. Total bacteria counts were reduced (P<0.05) by 0.7 to 1.1 
and 1.0 to 1.4 log CFU/cm2 following treatment with lactic acid at 25 or 55°C, respectively 
(Figures 5.1 and 5.2 and Appendix Tables A18 and A19). 
The pH of untreated beef trimmings was 5.41±0.31, and was reduced (P<0.05) to 4.12±0.32 
and 4.03±0.24 after treatment with 25 or 55°C lactic acid solutions, respectively. Following 
storage of samples at 4°C for 24 h, pH values of 5.44±0.33, 4.36±0.31, and 4.23±0.22 were 
obtained for untreated trimmings, and trimmings treated with 25 or 55°C lactic acid, 
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respectively. The moisture uptake of samples decontaminated with lactic acid ranged from 
4.7±1.2 to 6.71±1.7% for the 25°C solution, and 5.4±1.9 to 6.5±1.3% for the 55°C solution, with 
no difference among samples inoculated with different serogroups (P≥0.05). 
Six serogroups of non-O157 STEC and the E. coli O157:H7 strain mixture tested in this 
experiment showed similar (P≥0.05) resistance to lactic acid at 25°C;  microbial counts 
(TSA+rif) after treatment of non-O157 STEC were less than 0.3 log different than E. coli 
O157:H7 counts (P<0.05) (Figure 5.1 and Appendix Table A18). Similar to the above-mentioned 
counts of TSA+rif, microbial counts on TSA media (representing both inoculated pathogen and 
background microflora) for all seven E. coli serogroups were not statistically different (P≥0.05) 
for lactic acid treatment at 25°C (Figure 5.2 and Appendix Table A19). As expected, the lactic 
acid treatment at 55°C was more effective (P<0.05) for decontamination of meat samples than 
25°C and with no appreciable difference among the seven STEC serogroups (Figures 5.1 and 5.2 
and Appendix Tables A18 and A19). Overall, irrespective of lactic acid treatment (25 or 55°C), 
there were no appreciable differences in surviving counts among all six non-O157 STEC 
serogroups relative to   surviving counts of E. coli O157:H7, indicating that the six non-O157 
STEC can be controlled as effectively as E. coli O157:H7 by lactic acid intervention. 
In the experiment with Salmonella serovars, counts of inoculated populations of E. coli 
O157:H7 and Salmonella serovars on untreated beef trimmings were 3.0 to 3.3 log CFU/cm
2
 
(Figures 5.3 and 5.4 and Appendix Tables A20 and A21). E. coli O157:H7 counts were reduced 
(P<0.05) by 0.5 (TSA+rif) and 0.8 (mSMAC) log CFU/cm
2
 after treatment of samples with 25°C 
lactic acid, and 1.2 (TSA+rif) and 1.5 (mSMAC) log CFU/cm2 after treatment with 55°C lactic 
acid (Figures 5.3 and 5.4 and Appendix Tables A20 and A21). Overall, decontamination of 





, respectively (Figures 5.3 and 5.4 and Appendix Tables A20 and A21). Lactic 
acid decontamination of trimmings reduced (P<0.05) the pH of samples from 4.90±0.23 
(untreated control) to 4.22±0.21 (25°C solution) and 4.23±0.11 (55°C solution). The pH values 
of treated samples were 4.53±0.21 (25°C solution) and 4.60±0.11 (55°C solution) after 24 h at 
4°C. The moisture uptake of samples treated with 25 or 55°C solutions of lactic acid was 4.6±0.7 
to 6.6±1.8 % and 4.7±2.1 to 8.0±3.5 %, respectively, with no difference among the serogroups 
(P≥0.05). 
MDR S. Typhimurium,  MDR-AmpC S. Typhimurium and Newport, and susceptible S. 
Typhimurium and Newport after lactic acid treatment at 25°C showed lower (P<0.05) counts 
(TSA+rif) than E. coli O157:H7 and had with similar trends when treated at 55°C (Figures 5.3 
and 5.4 and Appendix Tables A20 and A21). TSA counts, representing both inoculated pathogen 
and background microflora, of samples inoculated with the five serovars of Salmonella were, 
however, not significantly (P≥0.05) different than E. coli O157:H7 in most cases (Figures 5.5 
and Appendix Tables A22). Salmonella counts, irrespective of serogroup or antibiotic resistance 
profile, were similar (P≥0.05) or lower (P<0.05; by 0.7-1.1 and 0.4-0.6 log CFU/cm2 compared 
with TSA+rif and mSMAC counts of E. coli O157:H7, respectively) than counts of E. coli 
O157:H7 following decontamination of samples with 25 or 55°C lactic acid solutions (Figures 
5.3 and 5.4 and Appendix Tables A20 and A21). 
Multidrug resistant (MDR) and MDR Salmonella serovars with acquired AmpC gene (MDR-
AmpC) appearance in the food chain causes crucial challenges in antibiotic chemotherapy of 
foodborne salmonellosis (Bosilevac et al., 2009; Arthur et al., 2008). Recent investigations 
indicate that 0.6% of ground meat samples may harbor drug-resistant Salmonella (Bosilevac et 
al., 2009), with approximately 7% of them displaying a MDR-AmpC phenotype (Zhao et al., 
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2009). Results of recent studies also show the wide-spread presence of STEC in muscle foods. It 
is estimated that 0.1 to 43.0% of carcasses in packing plants, 0.01 to 43.3% sub-primal cuts in 
packing plants, 0.1 to 4.4% of meat cuts in supermarkets, average of 2.4% meat products used in 
fast food chains, 0.1 to 54.2% of ground beef, and 0.1 to 4.4% of sausages in supermarket can be 
contaminated with O157 STEC (Hussein and Bollinger, 2005b). Similarly, 1.7 to 58.0% of sub-
primal cuts in packing plants, 3.0 to 62.5% in supermarkets, average of 3.0% of meat products 
used in fast food chains, 2.4 to 30.0% of ground beef, 17.0 to 49.2% of sausages, and 1.7 to 
58.0% of carcasses in packing plants were contaminated with non-O157 STEC (Hussein and 
Bollinger, 2005b). Although due to involvement of E. coli O157:H7 in numerous national and 
international foodborne episodes in last few decades, this pathogen had been the primary target 
of validation plans and food safety management systems (Sofos, 2009; Oliver et al., 2009), but 
results of this study show that these emerging pathogens are less or as acid tolerant as E. coli 
O157:H7 indicating that currently in-place lactic acid interventions in primary processing of red 













Table 5.1.  Shiga toxin-producing Escherichia coli strains used in the experiment. 
E. coli serogroup 
Strain (alternate ID given by 
providing institution)   
Source 
O26:H11  hSTEC_03 (O26-1) Human
1 
O26:H2  93.0494 (A1-008) Human
2 
O26  0.1302 (A1-009) Cow
2
 
O26:H11  5.2217 (A1-010) Human
2
 
   











   
O103 MDR0089 (O103-2) Beef
1
 
O103:H2 87.1368 (A1-013) Goat
2
 
O103:H2 90.1764 (A1-014) Cow
2
 
O103:H2 92.0084 (A1-015) Human
2
 
   
O111:H8 hSTEC_08 (O111-1) Human
1
 
O111 93.0523 (A1-001) Human
2
 
O111 4.0005 (A1-002) Cow
2
 
O111 4.0522 (A1-003) Cow
2
 
   
O121 10896 (O121-1) Human
1
 









   
O145:NM hSTEC_22 (O145-1) Human
1
 









   
O157:H7 ATCC 43895 Raw meat
4 
O157:H7 C1-057 Bovine fecal
4
 
O157:H7 C1-072 Bovine fecal
4
 
O157:H7 C1-109 Bovine fecal
4
 
Isolates kindly provided by (1) Dr. Tommy Wheeler (U.S. Meat Animal Research Center, USDA-ARS-
NPA, Clay Center, NE), (2) Dr. Chitrita DebRoy (E. coli Reference Center, The Pennsylvania State 
University, University Park, PA), (3) Dr. Pina Fratamico (Eastern Regional Research Center, USDA-
ARS-NAA, Wyndmoor, PA). (4) Isolates were available in center for red meat safety and quality of 
















Newport  Susceptible FSL S5-639 Human
1 
Newport Susceptible CVM N4505 Ground turkey
2 
Newport Susceptible CVM N18445 Ground beef
2
 
Newport Susceptible CVM N1509 Ground turkey
2
 
    
Newport MDR-AmpC FSL S5-436 Bovine
1
 
Newport MDR-AmpC FSL S5-920 Bovine
1
 
Newport MDR-AmpC CVM 22698 Pork chop
2
 
Newport MDR-AmpC CVM N19852 Ground beef
2
 
    
Typhimurium Susceptible FSL S5-536 Human
1
 
Typhimurium Susceptible CVM N7300 Chicken breast
2
 
Typhimurium Susceptible CVM N15788 Ground beef
2
 
Typhimurium Susceptible CVM N18534 Chicken breast
2
 
    
Typhimurium MDR FSL R6-215 Human
1
 
Typhimurium MDR FSL R8-2540 Human
1
 
Typhimurium MDR CVM N6431 Chicken breast
2
 
Typhimurium MDR CVM 30662 Chicken breast
2
 
    
Typhimurium MDR-AmpC FSL S5-786 Bovine
1
 
Typhimurium MDR-AmpC CVM N176 Chicken breast
2
 
Typhimurium MDR-AmpC CVM 33831 Cattle
2
 
Typhimurium MDR-AmpC CVM 30034 Ground turkey
2
 
    
Isolates kindly provided by (1)Dr. Martin Wiedmann (Department of Food Science, Cornell University, 









Figure 5.1 (Data in Appendix Table A18). Effects of lactic acid immersion interventions at 25°C and 55°C against 7 inoculated 
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Figure 5.2 (Data in Appendix Table A19). Effects of lactic acid immersion interventions at 25°C and 55°C against total bacterial populations 
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Figure 5.3 (Data in Appendix Table A20). Effects of lactic acid immersion interventions at 25°C and 55°C against inoculated E. coli O157:H7 
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Figure 5.4 (Data in Appendix Table A21). Effects of lactic acid immersion interventions at 25°C and 55°C against inoculated E. coli O157:H7 



















Lactic Acid at 25 
°C 
Lactic Acid at 55 
°C 
Untreated Control 
5% Lactic acid at 25°C 
5% Lactic acid at 5°C 
O157:H7  Susceptible Susceptible  MDR-Ampc  MDR-
Ampc 
 MDR 




















Figure 5.5 (Data in Appendix Table A22). Effects of lactic acid immersion interventions at 25°C and 55°C against total bacterial populations 
(TSA counts) on beef trimmings. 
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Effects of reheating against Listeria monocytogenes inoculated on 
cooked chicken breast meat stored aerobically at 7°C 
SUMMARY 
Presence of Listeria monocytogenes in domestic and foodservice environments has 
increased attention to handling practices during food preparation and storage. The objective of 
the present study was to evaluate survival and multiplication of L. monocytogenes inoculated on 
cooked chicken breasts which were stored aerobically at 7°C for 7 days. Reduction of pathogen 
cells by microwave, domestic oven, and stove top reheating was also evaluated. L. 
monocytogenes populations increased from 3.7±0.1 to 7.8±0.2 log CFU/g after 7 days. 
Microwave oven reheating for 90 seconds, and stove-top and oven-reheating to 70°C internal 
temperature reduced pathogen populations to <0.4-2.6, <0.4-4.8, and 1.4-5.9 log CFU/g, 
respectively; numbers of survivors after reheating were higher (P<0.05) in products stored for 
increasing length of time up to 7 days. At shorter microwaving times and lower product internal 
temperatures (stove-top and oven-reheating), similar reduction trends were observed but with 
higher levels of survivors after treatment. Although reheating methods in this study reduced L. 
monocytogenes contamination by 2-5 log CFU/g, growth of the pathogen during previous storage 
allowed high numbers of survivors after reheating, especially after 2 days of storage. This 
indicates that storage period, and type and intensity of reheating need to be considered for safe 





Cooked leftover food, both in the domestic environment and at foodservice establishments, 
has reduced levels of background microflora. In case of cross-contamination during refrigerated 
storage, leftover foods may harbor and support growth of foodborne pathogens (Murphy et al., 
2001), especially psychotropic pathogens such as Listeria monocytogenes and Yersinia 
enterocolitica (Jay et al., 2005; Juneja and Sofos, 2010). Many consumers tend to link foodborne 
illness to food consumed outside the home (Kennedy et al., 2005), but recent epidemiological 
investigations indicate that poor hygienic practices in the domestic environment is also a major 
contributing factor to foodborne disease episodes (Redmond et al., 2003). Infrequent hand-
washing, poor hand-washing technique, lack of hand-washing prior to food preparation, 
inadequate cleaning of kitchen surfaces, involvement of pets in the kitchen, touching of face, 
mouth, nose and/or hair during preparation of food (Jay et al., 1999),  as well as improper 
storage, and inadequate cooking and reheating (James et al., 1992; Griffth et al., 1994; 
Marklinder et al., 2004) are some of the practices that could potentially result in introduction of 
pathogens of public health significance into food products, and allow their survival and 
multiplication to levels of concern. Contamination in kitchen environment can be transferred to a 
food product during preparation and storage. It has been shown that the microbiological profile 
of cooked food stored in a kitchen refrigerator is very similar to microbial profiles of swabs 
taken from the same kitchen environments (Toule and Murphy, 1978). In recent years, various 
studies have detected foodborne pathogens, and specifically  L. monocytogenes, on kitchen 
surfaces, dish cloths, sinks, drains, and refrigerators (Gandhi et al., 2007; Jackson et al., 2007; 
Kilonzo-Nthenge et al., 2008) making leftovers potentially hazardous foods for contamination 
with L. monocytogenes.   
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Listeriosis caused by L. monocytogenes is a severe illness, being responsible for 19% of 
foodborne disease associated deaths in the United States (Scallan et al., 2011). The very young, 
elderly, pregnant women and the immunocompromized are the most susceptible groups (Ryser 
and Marth, 2007). Due to the presence of L. monocytogenes in a wide array of environments, its 
halophilic nature, its potential to form biofilms, and its ability to survive and multiply at 
refrigeration temperatures, it has been of special interest in academic and industrial research in 
recent years (Sofos 2008; Sofos 2009; Sofos and Geornaras, 2010). 
Chicken meat is gaining more popularity, both among domestic consumers and in 
foodservice establishments; while 30 years ago poultry accounted for approximately 21 % of 
meat consumption in the United States, it was recently estimated that it accounts for at least 37%, 
higher than the consumption of beef, pork, or lamb (AMIF 2009; Harley 2000). White muscle 
tissue (i.e., breast meat) of chicken is considered as one of the most popular cuts of meat for both 
domestic uses and commercial processing in the United States (AMIF 2009; Harley 2000), and 
has been involved in many foodborne outbreaks and recalls including a recall of 10,878 kg of 
cooked chicken breast contaminated with L. monocytogenes (FDA 2010).  
While many studies have targeted inactivation of L. monocytogenes in ready-to eat products 
(Murphy et al., 2001; Rodriguez-Marval et al., 2009; Shen et al., 2009) limited work has 
designed to investigate inactivation of L. monocytogenes during storage of leftover foods using 
domestically available appliances. Thus, the objective of this study was to investigate survival 
and multiplication of background microflora and inoculated L. monocytogenes on cooked 
boneless skinless chicken breasts stored aerobically at 7 °C. The effects of three reheating 
methods, applied at 0, 1, 2, 4, and 7 days of storage, against the pathogen and background 
microflora were also investigated. 
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MATERIALS AND METHODS 
Preparation of bacterial inoculum. Five food and human-disease originated strains of L. 
monocytogenes, kindly provided by Dr. Martin Wiedmann (Department of Food Science, Cornel 
University, Ithaca, NY), representing diverse ribotypes, PFGE patterns, lineages, and serotypes 
were used in this study (Fugett et al., 2006). These strains were J1-177 (lineage I, Serotype 
1/2b), C1-056 (lineage II, Serotype 1/2a), N3-013 (lineage I, Serotype 4b), R2-499 (lineage II, 
Serotype 1/2a), and N1-227 (lineage I, Serotype 4b), and were kept on PALCAM agar (Difco, 
Becton Dickinson, Franklin Lakes, NJ) at 4°C prior to the study. Strains were activated 
separately from a single colony of the stored stock as described by Yang et al. (2009a).  Each 
strain was then washed and centrifuged at 4,629 g for 15 min with 10 ml sterile saline (0.85% 
NaCl), resuspended in 10 ml of ham homogenate (Yang et al., 2009b), and habituated separately 
for two days at 7°C before inoculation, to allow acclimatization of L. monocytogenes cells to the 
food environment and low-temperature. Before inoculation, the suspensions of the five 
habituated stains were composited and serially, 10-fold diluted, in phosphate-buffered saline 
(PBS, pH 7.4; 0.2 g/liter KH2PO4, 1.5 g/liter Na2HPO4·7H2O, 8.0 g/liter NaCl, and 0.2 g/liter 
KCl) to achieve an initial concentration of 3-4 log CFU per gram of sample. The L. 
monocytogenes counts of the composite inoculum after habituation were 9.2±0.2 CFU/ml.  
Preparation of chicken samples, inoculation, and storage. Fresh boneless skinless chicken 
breast muscles purchased from a local processor were aseptically cut into approximately 100-g 
pieces and stored in sealed plastic bags (approximately 20 samples in each bag) at -20°C for less 
than two weeks prior to use. Chicken samples were thawed at refrigerated temperature (4°C) for 
approximately 48 h and cooked (16-in electrical skillet, National Presto Industries, Inc., Eau 
Claire., WI) to the target internal temperature of 73.8°C.The temperature was recorded every 5 s 
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with k-type thermocouples connected to PicoLog data acquisition software (Pico Technology, 
Ltd., Cambridge, UK). Cooked samples were stored aerobically at 7°C in Pyrex dishes (25 by 35 
cm, 5 cm deep) covered with cling paper for no more than 2 h. The surfaces of the cooked and 
cooled-to-4°C samples were then inoculated with 100 µL per side of the above-mentioned 
diluted habituated composite of L. monocytogenes strains, with a 15 min interval between 
inoculations of each side, to achieve an initial inoculation level of approximately 3-4 log CFU/g. 
The inoculated samples were placed in Pyrex dishes (15 samples in each dish) covered with cling 
paper, and stored aerobically in a 7°C incubator. During storage, samples were reheated and 
analyzed microbiologically and for physiochemical parameters on days 0, 1, 2, 4, and 7. 
Product reheating. Cooked stored inoculated samples were individually placed in a microwave 
safe dish (22 cm dia, 4 cm deep) and subjected to 30, 60 or 90 s of microwave heating at the 
100% power level in  a domestic microwave oven (Amana, Model Radarange AMC5243, 
Newton, IA) with 1100 W power output.  At the end of the  intervention, the surface temperature 
of each sample was measured and recorded manually by a noncontact infrared  thermometer 
(Oaklon TemoTestr IR, Lane Cove, Australia) from a distance of approximately 15 cm (to cover 
a reading area of 2.75 cm
2
, based on manufacturer’s recommendation). Immediately after 
microwaving and recording of surface temperature, each sample was aseptically transferred in a 
sterile filter bag (Whirl-Pak, Modesto, CA), placed into ice-water slush, and prepared for 
microbiological analyses.   
For oven reheating, each sample was placed onto a sterile stainless steel tray with a k-type 
thermocouple, aseptically inserted into its geometrical center. A domestic oven (Magic Chef 
Standard Kitchen Oven, Maytag Group, Newton, IA) was preheated to 148°C (300°F) for 
approximately 30 min and samples were then reheated to internal temperatures of 50, 60 or 70 
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°C. The temperature of the cooking chamber of the oven was also monitored with a k-type 
thermocouple suspended approximately in the center of the oven, without any contact with the 
surroundings.  
For reheating by the stove-top method, each sample with inserted thermocouple in its 
geometrical center was placed onto the sterile surface of a non-stick skillet (diameter 
approximately 30 cm [Farberware Licensing Company, LLC. Berwick PA]) preheated on a 
domestic oven stove top (Magic Chef Standard Kitchen Oven, Maytag Group, Newton, IA). 
Every two min samples were flipped over for exposure of both sides to the skillet surface. The 
samples were reheated to the internal temperatures of 50, 60, or 70 °C, with collection of 
time/temperature profile data every 5 s as described for oven reheating. Surface temperature of 
the skillet was also measured by suspending a thermocouple in approximately 5 ml of vegetable 
oil in a 20 ml glass container placed onto the frying skillet during the reheating procedure.  For 
both stove top and oven, similar to microwave treatment, immediately after reaching the 
designated internal temperature, samples were placed in sterile filter bags (Whirl-Pak, Modesto, 
CA), cooled in ice-water slush, and analyzed microbiologically.  Selection of the internal 
temperatures, reheating methods, and times for microwave intervention was based on a 
preliminary experiment (data not shown). 
Microbiological and physiochemical analyses. As indicated, for microbiological analyses, each 
sample was placed in a sterile filter bag (Whirl-Pak, Modesto, CA), with an equal amount of 
maximum recovery diluent (0.85% NaCl and 0.1% peptone [Difco, Becton Dicknison]),  added 
immediately after reheating and cooling the samples in ice, homogenized (Masticator, IUL 
Instruments, Barcelona, Spain) for 2 min (6 strokes per s), and serially diluted (10-fold) with 
0.1% buffered peptone water (Difco, Becton Dickinson, Franklin Lakes, NJ). Samples were 
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spread-plated onto tryptic soy agar (Acumedia, Lansing, MI) with 0.6%  yeast extract (Difco, 
Becton Dicknison) and PALCAM agar (Difco, Becton, Dicknison), for enumeration of total 
aerobic bacteria and L. monocytogenes counts after incubation at 25 and 30°C for 72 and 48 h, 
respectively. The detection limit for these microbiological analyses was 0.4 CFU log per g of 
sample. Samples with no detected colonies by plating at the detection level were enriched to 
evaluate presence/absence of the pathogen by a procedure modified form the USDA-FSIS (2008) 
method, as described by Rodriguez-Marval et al. (2009). For all the samples with below the 
detection limit pathogen counts, no pathogen was detected after the above-mentioned enrichment 
stage. Water activity (AquaLab Instrument, Decagon Devices, Inc., Pullman, WA) and pH 
(Denver Instrument, Arvada, CO) of samples were measured as described by Byelashov et al. 
(2010).  
Experimental design and statistical analyses. The experiment was repeated twice with 
different ingredients with three replicates within each of these two repetitions. Mean microbial 
counts of each treatment or storage period, after log transformation, as well as cooking time, pH, 
and water activity values, were compared statistically with ANOVA-based procedures followed 
by Tukey-adjusted multiple comparison methods for further mean separation at type one error 
level of 0.05 (α=0.05). The dataset was analyzed as a randomized complete block design, with 
each of the two repetition trials considered as a blocking factor, using Proc GLM and Proc 
Mixed commands of SAS 9.2 (SAS, Inc., Chicago, IL). Additionally, in order to compare the 
inactivation rates of  L. monocytogenes by stove-top and oven reheating methods at three internal 
temperatures of 50, 60, and 70ºC, GInaFiT software, a non-log-linear microbial survivor curve 
were used, comparing counts of days 7, 4, 2, 1, and 0 (after inoculation). This model as described 
by Geeraerd et al. (2005) and reports specific inactivation rates of Kmax and adjusted-R
2
. Kmax is 
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specific inactivation rate for log-linear monophasic curves fitted for each internal temperature 
with unit of 1/time and thus longer time required for microbial cell reductions is associated to 
smaller Kmax values while adjusted-R
2
 values show proportion of the data described by the 
model. Kmax values obtained for each internal temperature of stove-top reheating were compared 
statistically to those obtained from oven reheating using student-best t-test procedure at α=0.05. 
RESULTS AND DISCUSSION 
Water activity, pH and temperature measurements. Water activity and pH of reheated stored 
samples ranged from 0.982± 0.001 to 0.992±0.001, and 6.03±0.13 to 6.12 ±0.12, respectively 
with no difference (P≥0.05) among samples of different days of storage and reheating methods. 
Surface temperatures of the microwave treated samples ranged from 48.8±2.5 to 57.6±4.0, 
64.5±4.0 to 69.5±4.0, and 75.7±4.7 to 82.6±3.1°C, for samples reheated for 30, 60, and 90 s, 
respectively. The values of pH for these samples ranged from 6.05±0.07 to 6.13±0.08, 5.88±0.08 
to 6.14±0.11, and 5.99±0.18 to 6.19±0.16, for samples reheated for 30, 60, and 90 s, respectively, 
with no statistical difference (P≥0.05).  
The temperatures of the oven cooking chamber for samples reheated to target internal 
temperatures of 50, 60 and 70 °C were 145.9 ±11.0, 147.6 ±9.9, and 143.5 ±1.2 °C, respectively.  
Surface temperatures of the cooking area during stove top reheating were 142.7 ±12.4, 140.9 
±9.9, and 148.3 ±11.3°C for samples reheated to internal temperatures of 50, 60, or 70 °C, 
respectively. The values of pH for samples reheated in the oven were in the ranges of 6.05±0.07 
to 6.13±0.10, 6.02±0.09 to 6.13±0.05, and 6.03±0.04 to 6.20±0.10 for samples reheated to 
internal temperatures of 50, 60, and 70 °C, respectively, and 6.07±0.07 to 6.13±0.12, 6.09±0.06 
to 6.16±0.03, and 5.98±0.12 to 6.10±0.06, for samples reheated on stove top to internal 
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temperatures of 50, 60, and 70 °C, respectively, without significant differences (P≥0.05) among 
samples reheated to different internal temperatures. 
Survival and growth during storage. Many previous studies, have isolated L. monocytogenes 
from domestic and industrial refrigerators as well as food preparation and processing 
environments (Sergelidis et al., 1997; Walker et al., 1990), making leftovers potentially 
hazardous foods due to contamination with psychotropic pathogens including L. monocytogenes. 
In the present study, initial counts of L. monocytogenes on the day of inoculation were 3.7±0.1 
log CFU/g and increased to 7.8±0.2 log CFU/g by day-7 of storage at 7°C (Figure 6.1 and 
Appendix Table A23) confirming the concern that if cross-contamination occurs after 
preparation of foods, L. monocytogenes can multiply extensively during the refrigerated storage. 
Similar results were observed for aerobic plate counts with more than a 4-log increase from the 
first day to day-7 (Figure 6.2 and Appendix Table A24). The extensive multiplication of L. 
monocytogenes in this study could be explained by increased hydrolysis of macromolecules and 
bioavailability of nutrients on the surface of chicken samples as a result of cooking (Damodaran 
et al., 2008) that can enhance multiplication of the pathogen as well as the background 
microflora during storage.  
Inactivation by reheating.  Microwave oven reheating showed a high potential for reduction of 
L. monocytogenes counts. On day-0, microwaving for 30, 60, and 90 s was responsible for 
reductions of 0.3, 1.1, and more than 3.4 log CFU/g of L. monocytogenes, respectively. Similar 
trends were observed for samples reheated on days 1, 2, 4, and 7 (Figure 6.1 and Appendix Table 
A23). For example on day-4, counts of the untreated control were 6.2±0.1 and were reduced 
(P<0.05) to 4.8±0.1, 4.2±0.1 and 1.8±0.8 as the result of microwaving treatment for 30, 60, and 
90 s, respectively. As storage days increased, higher number of survivors after reheating was 
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observed. In other words, storage time that affected the initial microbial counts and each day of 
storage had a major impact on subsequent death due to reheating. On day-4, as an example, 
although 90 s of microwaving caused more than a 4-log reduction of the pathogen, the 1.8 log 
CFU/g of survivors could still be of concern from a food safety standpoint but the same (i.e., 
microwaving for 90 s) intervention on day-0 was able to reduce the L. monocytogenes counts to 
undetectable levels. This indicates that intensity of reheating needs to be adjusted based on the 
storage period (that affects the initial bacterial load) of food in order to assure reduction of 
potential pathogen counts to acceptable levels.  In general, the microwave treatment, as 
compared to other reheating methods evaluated in this study, had high potential for reduction of 
microbial loads with 3.4, 3.5, 4.2, 4.4, and 5.2 log CFU/g reductions in 90 s at 0, 1, 2, 4, and 7 
days of storage, respectively (Figures 6.1 and 6.2 and Appendix Tables A23 and A24). 
The effectiveness of microwave treatments against surface inoculated L. monocytogenes is 
in agreement with previous studies. Rodriguez-Marval et al. (2009) demonstrated that L. 
monocytogenes inoculated on surface of frankfurters could be reduced by 3.7 log CFU/g after 75 
s of microwaving. Similarly, Shen et al. (2009) showed that 30 s of microwaving resulted in 0.8 
to 1.3 log CFU/g reduction of inoculated L. monocytogenes. It is noteworthy that although 
microwave treatments showed high pathogen reduction effectiveness, it has been reported that 
their performance can be considerably affected by size and position of the food, and age and 
power output of microwave (Swain et al., 2008) that need to be considered before development 
of recommendations for safe microwave reheating of leftover food by consumers. 
Oven reheating on day-0 reduced the pathogen by 2.9, 2.7, and 1.4 log CFU/g after 
reheating to internal temperatures of 50, 60, and 70 °C, respectively (Figures 6.3 and Appendix 
Table A25). Similar to the microwave treatment, as storage time between inoculation and 
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reheating increased, microbial multiplication increased and more pathogen cells survived on the 
reheated samples (Figures 6.3 and 6.4 and Appendix Table A25 and A26). In other words, 
storage time that affected the initial microbial counts on each day of storage had a major impact 
on subsequent death due to reheating. For stove-top reheating, on days 0 and 1, L. 
monocytogenes loads of samples reheated to the internal temperature of 70 °C were less than one 
log CFU/g but like other treatments more survivors were detected as the time interval between 
inoculation and reheating increased. Similar results were observed by other investigators for 
reduction of inoculated L. monocytogenes on pork Scrapple reheated by pan-frying methods 
during storage (Adenkule et al., 2009). 
Comparing the domestic oven and stove-top reheating, the two methods required 
considerably different lengths of time to reach the same internal temperatures (i.e., 50, 60, and 
70°C) in the geometric center of the samples (Figure 6.7 and Appendix Table A27), and, thus, 
exhibited different pathogen reduction potential. On day-7, as an example, the oven and stove 
top reheating to internal temperatures of 70°C required 24.2 and 17.1 min (Figure 6.7 and 
Appendix Table A27), and were responsible for reductions of 2.0 and 3.0 log CFU/g of the 
inoculated pathogen, respectively (Figures 6.3 and 6.4 and Appendix Tables A25 and A26). 
These differences could be explained by the different heat transfer principles involved in each 
method: oven reheating involves convection heat transfer whereas stove top reheating involves 
conduction as the primary mode of heat transfer (Adler et al., 2009).The other characteristic of 
oven and stove reheating methods investigated in this study was the relatively high standard 
deviation of reheating time to reach designated internal temperatures. The high variation in 
performance of domestic cooking appliances were also reported by other investigators (Gupta et 
96 
 
al., 2010; Shen et al., 2010), and it appears that these variations need to be considered for 
preparation of safe reheating recommendations for consumers. 
Table 6.1 provides inactivation rates of L. monocytogenes throughout days 7, 4, 2, 1, and 0 
by stove-top and oven reheating methods to internal temperatures of 50, 60, and 70ºC.  Based on 
adjusted R
2
 values, 87% to 89% of samples reheated by stove-top, and 92 to 97% of oven-
reheated samples were described by the utilized GInaFiT model, a log-linear monophasic curve 
fitted for each internal temperature. At internal temperatures of 50, 60 ºC, stove-top reheating 
had higher (P<0.05) Kmax values (Kmax parameter±SE), indicating that this method required 
lower time to reach the internal temperature of 50 and 60 ºC compared to oven reheating. For 
internal temperature of 70ºC, Kmax values of stove-top and oven reheating were 2.57±0.18 and 
2.58±0.14, respectively with no statistical difference (P≥0.05). 
In summary, due to different heat transfer mechanisms (i.e., primarily convection-based 
transfer for oven and conduction-based transfer for stove-top reheating) these two methods 
demonstrated different pathogen reduction potentials and times for reaching the same designated 
internal temperature indicating a need for method-specific recommendations for assuring the 
safety of leftover reheated in domestic and foodservice environments by different heating 
methods.  
Along with increasing evidence of L. monocytogenes presence in domestic and food service 
environments in recent years, it appears that safe management of leftover food, especially for 
people at-risk for listeriosis, is of particular importance. In our study, initial counts of L. 
monocytogenes increased (P<0.05) by over 4.0 log CFU/g during 7 days of storage at 7°C, 
confirming the concern that if cross-contamination occurs after preparation of foods, L. 
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monocytogenes can multiply extensively during refrigerated storage. Although the reheating 
methods investigated in this study reduced L. monocytogenes contamination by 2-5 log CFU/g, 
growth of the pathogen during storage allowed high numbers of survivors after reheating, 
especially after two days of storage. In other words, storage time that affected the initial 
microbial counts had a major impact on subsequent death due to reheating. This indicates that 
storage period, and type and intensity of reheating need to be considered for safe consumption of 
leftover food. Regardless of reheating method, high numbers of survivors after reheating, 
especially after two days of storage indicated a need of consideration for utilization of leftover 















Figure 6.1 (Data in Appendix Table A23). Effects of domestic microwave oven reheating against inoculated Listeria monocytogenes (log 
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Figure 6.2 (Data in Appendix Table A24). Effects of domestic microwave oven reheating against aerobic bacterial counts (log CFU/g) of cooked 
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Figure 6.3 (Data in Appendix Table A25). Effects of domestic oven reheating against inoculated Listeria monocytogenes (log CFU/g) of cooked 
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Figure 6.4 (Data in Appendix Table A26). Effects of domestic oven reheating against aerobic (log CFU/g) bacteria of cooked chicken during a 7 
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Figure 6.5 (Data in Appendix Table A25). Effects of domestic stove top reheating against inoculated Listeria monocytogenes (log CFU/g) of 
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Figure 6.6 (Data in Appendix Table A26). Effects of domestic stove top reheating methods against aerobic bacteria (log CFU/g) of cooked 
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Figure 6.7 (Data in Appendix Table A27). Time and temperature profiles of samples reheated by 
domestic oven and stove top methods. (A) samples reheated to internal temperature of 50 °C, (B) 
samples reheated to internal temperature of 60 °C, and (C) samples reheated to internal 











































































Table 6.1. Non-linear microbial survivor analysis for comparing inactivation rates of L. monocytogenes by stove-top and oven 









Kmax values associated to stove-top reheating followed by a * is significantly larger (P<0.05) than values of oven reheating for each 
internal temperature. Kmax values (parameter± standard error) are specific inactivation rates for log-linear monophasic curves fitted for 







    L. monocytogenes inactivation 




 70  2.57±0.18 0.87 
  60  2.65±0.17* 0.89 
  50  3.04±0.20* 0.89 
      
Domestic Oven  70  2.58±0.14 0.92 
  60  2.20±0.11 0.93 




Microwave reheating for reduction of Listeria monocytogenes during 
refrigerated storage of post-cooking inoculated chicken breast meat 
treated with different marinades 
SUMMARY 
Listeria monocytogenes has been isolated from various raw and processed food products, as 
well as domestic and commercial food preparation areas, having the potential to serve as source 
of cross-contamination of ready-to-eat foods. This study evaluated growth of L. monocytogenes 
inoculated on cooked chicken meat with different marinades and survival of the pathogen as 
affected by microwave oven reheating during aerobic storage at 7°C. Raw chicken breast meat 
samples were treated with three commercially-formulated and three domestically-available 
marinades, and then cooked (74.4°C internal temperature), cooled to 4°C, and surface-inoculated 
with L. monocytogenes. During storage at 7°C, on days 0, 1, 2, 4, and 7, samples were reheated 
by microwave oven (1100 W) for 45 or 90 s and analyzed microbiologically. L. monocytogenes 
counts on non-marinated control samples increased (P<0.05) from 2.7±0.1 to 6.9±0.1 log CFU/g 
during storage. At day-7 of storage, pathogen levels on samples marinated with tomato juice 
were not different (P≥0.05; 6.9±0.1 log CFU/g) from those of the control, whereas for samples 
treated with the remaining marinades, pathogen counts were 0.7 to 2.0 log CFU/g lower (P<0.05) 
than those of control samples. Microwave reheating reduced L. monocytogenes by 1.9 to 4.1 (at 
45 s) and 2.1 to 5.0 (at 90 s) log CFU/g. With similar trends across different marinates, the high 
levels of L. monocytogenes survivors found after microwave reheating, especially after two days 
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of storage, indicate that length of storage and reheating time need to be considered for safe 
consumption of leftover cooked chicken. 
INTRODUCTION 
As one of the oldest further processing methods of muscle foods, marinating is a common 
approach for meat preparation in commercial food processing as well as domestic and 
foodservice operations (Maguelonne, 2009). In addition to adding value and improving 
palatability, marinating ingredients may provide improvement in shelf-life through their 
antimicrobial properties.  
As an ubiquitous microorganism, Listeria monocytogenes has been isolated from a variety of 
environments, including the domestic home environment and commercial food preparation areas 
as well as different processed and raw food products, having the potential to serve as source of 
cross-contamination of ready-to-eat foods. (Gandhi and Chikindas, 2007). Presence of L. 
monocytogenes in various environments, its halophilic nature, its capability to form biofilms, and 
its ability to multiply and proliferate at refrigeration temperatures have allowed this pathogen to 
be linked with many foodborne outbreak episodes (Ryser and Marth, 2007).  Listeriosis caused 
by L. monocytogenes is primarily a foodborne severe illness with the very young and infants, the 
elderly, and immunocompromized patients among the most susceptible groups (Ryser and 
Marth, 2007).  Most recent epidemiological investigations of the Centers for Disease Control and 
Prevention show that L. monocytogenes is responsible for 1,662, 1,520, and 266 episodes of 
illness, hospitalization, and death every year in the United States, with over 99% of the cases 
associated to contaminated food products (Scallan et al., 2011a, 2011b, Morris, 2011).  
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Chicken meat accounts for 37% of meat consumption in the United States which is higher 
than the consumption of beef, pork, or lamb (Harley 2000; AMI 2009). White chicken muscle 
tissue (i.e., breast meat) is among the most popular cuts of meat in market, and have been 
associated with many foodborne outbreak episodes (Harley 2000; AMI 2009). A nationwide 
recall of cooked chicken breast in 2007 is an example of survival and multiplication of L. 
monocytogenes during storage of cooked chicken breasts (FDA 2010). 
While some marinating formulations have been shown to have little to no effects in reducing 
microbial load of poultry products during storage (Perko-Makela et al., 2000), some studies 
suggest marinating ingredients can reduce foodborne pathogens after application and during 
storage. Bjorkroth et al. (2000) suggested use of tomato-based marination to inhibit 
multiplication of lactic acid bacteria associated with gaseous spoilage of modified-atmosphere-
packaged raw chicken meat. In two studies, Pathania et al. (2010a, 2010b) also showed that 
teriyaki and lemon pepper marinades could both reduce the Salmonella load on chicken skin and 
red meat during aerobic storage.  
This study evaluated the effect of three commercially formulated (tomato-based, soy sauce-
based, and lemon based), and three domestically available (tomato juice, soy sauce, and lemon 
juice) marinades against post-cooking inoculated L. monocytogenes on chicken breasts, during a 
7-day aerobic storage period at 7°C. Pathogen survival after microwave oven reheating of stored 
marinated chicken was also investigated. 
MATERIALS AND METHODS 
Preparation procedure of strains. A mixture of food and human-disease derived L.  
monocytogenes strains, provided by Dr. Martin Wiedman (Department of Food Science, Cornel 
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University, Ithaca, NY) was used in this study (Fugett et al., 2006). These strains are J1-177 
(lineage I, Serotype 1/2b), C1-056 (lineage II, Serotype 1/2a), N3-013 (lineage I, Serotype 4b), 
R2-499 (lineage II, Serotype 1/2a), and N1-227 (lineage I, Serotype 4b). Each strain was stored 
on PALCAM agar (Difco, Becton Dickinson, Franklin Lakes, NJ) at 4°C prior to the study. 
Individual strains were activated separately from a single colony of the stored stock cultures as 
described by Yang et al. (2009a).  The culture of each strain was then washed and centrifuged at 
4,629 g for 15 min with 10 ml sterile saline (0.85% NaCl), resuspended in 10 ml ham 
homogenate (Yang et al.,2009b), and habituated separately for two days at 7°C product 
inoculation to allow acclimatization of L. monocytogenes cells to the food environment and low-
temperature. Before inoculation, the cell suspension of all five habituated stains were composited 
and 10-fold serially diluted, in phosphate-buffered saline (PBS, pH 7.4; 0.2 g/liter KH2PO4, 1.5 
g/liter Na2HPO4·7H2O, 8.0 g/liter NaCl, and 0.2 g/liter KCl) to achieve an initial concentration 
of 3-4 log CFU of pathogen per gram of sample. 
Sample preparation, inoculation, and storage. Fresh boneless skinless chicken breast meat  
purchased from a local processor was aseptically cut into approximately 100-g pieces and stored 
in sealed plastic bags (approximately 20 samples in each bag) at -20°C for less than two weeks 
prior to use. Chicken samples were thawed at refrigerated temperature (4°C) for approximately 
48 h and marinated with one of the marinades presented in Table 7.1 for 30 minutes (1:1 meat 
and marinade ratio) at refrigerated temperature (4°C). Marinated samples were then cooked (16-
in electrical skillet, National Presto Industries, Inc., Eau Claire., WI) to the internal temperature 
of 74.4±0.4°C. The temperature was recorded every 5 s with k-type thermocouples connected to 
PicoLog data acquisition software (Pico Technology, Ltd., Cambridge, UK). Cooked samples 
were aerobically stored at 7°C in Pyrex dishes (25 by 35 cm, 5 cm deep) covered with cling 
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paper for no more than 2 h. The surfaces of the cooked and cooled samples were then inoculated 
with 100 µL per side of the above-mentioned diluted habituated composite of L. monocytogenes 
strains, with a 15 min interval between inoculations of each side, to achieve an initial inoculation 
level of approximately 2-3 log CFU/g. The inoculated samples were then placed in Pyrex dishes 
(15 samples in each dish) covered with cling paper, and stored in a 7°C incubator for reheating 
interventions and microbiological and physiochemical analyses.  
Reheating of inoculated samples. During storage (i.e., days 0, 1, 2, 4, and 7) samples were 
reheated in a domestic microwave oven (Amana, Model Radarange AMC5243, Newton, IA) 
with 1100 W power output.  Cooked and stored inoculated samples were individually placed in a 
microwave safe dish (22 cm dia, 4 cm deep) and were treated in the microwave oven for 45 or 90 
s at the 100% power level. At the end of the intervention, the surface temperature of each sample 
was recorded by a noncontact infrared  thermometer (Oaklon TemoTestr IR, Lane Cove, 
Australia) from a distance of approximately 15 cm (to cover a reading area of 2.75 cm
2
, based on 
manufacturer’s recommendation). Immediately after microwaving and recording of surface 
temperature, each sample was aseptically transferred in a sterile filter bag (Whirl-Pak, Modesto, 
CA), placed into ice-water slush, and prepared for microbiological analyses.   
Microbiological, pH, and water activity analyses. For microbiological analyses, each sample 
was diluted with an equal weight of maximum recovery diluent (0.85% NaCl and 0.1% peptone 
[Difco, Becton Dicknison]), homogenized (Masticator, IUL Instruments, Barcelona, Spain) for 2 
min (6 strokes per s), and serially diluted (10-fold) with 0.1% buffered peptone water (Difco, 
Becton Dickinson, Franklin Lakes, NJ). Samples were spread-plated onto tryptic soy agar 
(Acumedia, Lansing, MI) with 0.6% yeast extract (Difco, Becton Dicknison) and PALCAM agar 
(Difco, Becton, Dicknison), respectively, for enumeration of aerobic plate counts (APC) and L. 
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monocytogenes counts after incubation at 25°C and 30°C for 72 and 48 h. The detection limit for 
these microbiological analyses was 0.3 log CFU/g. Water activity (AquaLab Instrument, 
Decagon Devices, Inc., Pullman, WA) and pH (Denver Instrument, Arvada, CO) of samples and 
marinades were measured based on procedures described by Byelashov et al. (2010).  
Statistical analyses. The experiment was repeated twice (as biologically independent trials) with 
different ingredients with three replicates within each of the two repetitions. Each repetition 
experiment was considered as a blocking factor and thus the experiment was analyzed as a 
randomized complete blocked design using Proc Mixed command of SAS (SAS, Inc., Chicago, 
IL). Mean microbial counts of each treatment or storage period, after log transformation were 
compared statistically using a ANOVA-based procedures followed by Tukey-adjusted multiple 
comparison methods for further mean separation at type one error level of 0.05 (α=0.05).  
RESULTS AND DISCUSSION 
Physical and chemical analyses of samples and marinades. Water activity of samples were 
ranging from 0.976±0.014 to 0.989±0.027 with no significant difference among non-marinated 
control and marinated samples across the 7-day storage period (P≥0.05). The pH of non-
marinated control and samples marinated with commercial tomato-based, commercial soy-based, 
commercial lemon-based, tomato juice, soy sauce, and lemon juice ranged from (mean±SD) 
6.03±0.14 to 6.11±0.12, 5.19±0.89 to 5.55±0.19, 5.91±0.18 to 6.18±0.39, 5.76±0.18 to 
5.94±0.14, 5.83±0.24 to 5.86±0.14, 5.85±0.16 to 6.00±0.32, and 5.48±0.28 to 5.50±0.22, 
respectively. Surface temperatures (after microwave reheating) of samples for the above-
mentioned order of marinades were 59.7±4.2 to 64.3±4.3, 60.3±3.9 to 62.2±4.0, 60.6±0.4.0 to 
63.2±4.2, 59.0±3.9 to 64.7±4.3, 60.5±1.2 to 63.3±3.4, 59.5±1.2 to 79.1±2.1, and 58.6±1.6 to 
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63.9±2.0°C for samples reheated for 45 seconds and 75.1±5.0 to 77.9±4.2, 76.3±3.5 to 77.0±4.0, 
77.1±4.2 to 77.7±4.5, 73.8±1.3 to 79.5±1.15, 74.8±1.2 to 79.6±2.6, 75.3±2.3 to 79.1±2.4, and 
77.0±2.8 to 78.4±3.2°C for samples reheated for 90 seconds in microwave oven. As presented in 
Table 7.1, pH and water activity of marinades ranged from 2.71±0.42 to 4.59±0.01 and 
0.851±0.001 to 0.989±0.002 respectively.  
Survival and multiplication during storage. On the day of inoculation (day 0) L. 
monocytogenes counts of non-marinated control, and samples marinated with commercial 
tomato-based, commercial soy-based, commercial lemon-based, tomato juice, soy sauce, and 
lemon juice were 2.7±0.1, 2.6±0.2, 2.7±0.1, 2.4±0.3, 2.5±0.1, 2.7±0.1, and 2.6±0.1 log CFU/g, 
respectively, with no statistical differences among the samples (P≥0.05). On day-7 of storage, 
counts were increased to 4.9±0.1 to 6.9±0.1, with pathogen counts of non-marinated control> 
tomato juice> soy sauce> commercial soy-based> commercial tomato-based> commercial 
lemon-based> lemon juice (Figure 7.1 and Appendix Table A32). Similar trends were observed 
for survival and multiplication of aerobic plate counts (Figure 7.2 and Appendix Table A32). 
Extensive multiplication of L. monocytogenes during the 7-day storage at 7°C could be explained 
by increased hydrolysis of macronutrients on the surface of samples due to cooking, resulting in 
increased bioavailability of micro- and macro-nutrients for inoculated pathogen and background 
microflora (Damodaran et al., 2007). 
Microbial reduction by microwaving. On day-0 (<2 h after inoculation), treatment in the 
microwave oven at 100% power level for 45 s reduced L. monocytogenes counts to 0.6 and less 
than 0.7 log CFU/g, respectively for non-marinated control and marinated samples (Figure 7.3 
and Appendix Tables A28). Similarly, treatment on day-0 for 45 s reduced aerobic plate counts 
to 0.7 and 0.9 log CFU/g, respectively, for non-marinated control and marinated samples (Figure 
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7.4 and Appendix Table A29). Microwaving for 90 s on day-0 reduced the L. monocytogenes 
counts to less than 0.3 and 0.4 log CFU/g for non-marinated control and marinated samples, 
respectively (Figure 7.5 and Appendix Table A30) and reduced aerobic plate counts to 0.4 or less 
than 0.4 log CFU/g for non-marinated control and marinated samples, respectively (Figure 7.6 
and Appendix Table A31). As storage days increased, multiplication of L. monocytogenes and 
aerobic plate counts resulted in more survivors after both microwave treatments. As an example, 
on day-4 of storage, 2.3±0.3 and 1.9±0.3 log CFU/g of L. monocytogenes were detected after 
microwaving of non-marinated control for 45 and 90 s (Figures 7.3 and 7.5 and Appendix Tables 
A28 and A30). Marinated samples with lemon juice, commercial lemon-based, and tomato-based 
had consistently lower (P<0.05) counts and survivors after microwave treatments across the 
storage period than non-marinated samples, while marinated samples with tomato juice, soy 
sauce, and commercial soy-based had higher (P<0.05)  or as higher (P≥0.05)  L. monocytogenes 
counts as non-marinated samples (Figures 7.3 and 7.5 and Appendix Tables A28 and A30). 
Similar trends were observed for aerobic plate counts for 45- and 90-second microwave 
treatments (Figures 7.4 and 7.6 and Appendix Tables A29 and A31). The effectiveness of 
microwave treatments against surface inoculated L. monocytogenes has been investigated in 
some recent studies. Rodriguez-Marval et al. (2009) demonstrated that inoculated L. 
monocytogenes on surface of frankfurters could be reduced by 3.7 log CFU/g in 75 s of 
microwaving. Similarly, Shen et al. (2009) showed 30 s of microwaving can result in 0.8-1.3 log 
CFU/g reduction of inoculated L. monocytogenes. 
In Conclusion, although microwave reheating was responsible for 1.9 to 4.1 and 2.1 to 5.0 
log CFU/g reduction of L. monocytogenes counts during storage, for treatments at 45 S and 90 S, 
respectively,  numbers of pathogen survivors after reheating increased as populations on stored 
114 
 
(7°C) product increased. With similar trends across different marinated samples, high levels of L. 
monocytogenes survivors after microwave oven reheating, especially after two days of storage, 
indicates that length of storage and reheating time need to be considered for safe consumption of 

















Table 7.1. Marinating ingredients, and their pH (mean±SD) and water activity (mean±SD).  
  Ingredients  pH  Water activity 
Commercial marinades 
Tomato puree based commercial 
marinade 
 (A1® Classic Marinade) 
  
Tomato Paste, vinegar, corn syrup, high 
fructose corn syrup, salt, raisin juice, dried 
onion, modified food starch, less than 1% of 







Lemon based commercial marinade 
(Lawry’s® Lemon Pepper) 
  
Water, lemon juice, high fructose corn 
syrup, salt, distilled vinegar, soybean oil, 
modified food starch, black pepper, xanthan 
gum, fried minced onion, distilled potassium 
sorbate, sodium benzoate, natural flavors, 






Soy sauce based commercial marinade  
(Kikkoman® Teriyaki marinade) 
  
Soy Sauce (water, wheat, soy bean, salt), 
wine, high fructose corn syrup, water, 
vinegar, salt, spices, onion powder, succinic 





Domestic  marinades       
Lemon Juice (100%) 
(Kroger® company) 
 Lemon juice (water, lemon juice 
concentrate) sodium bisulfate, lemon oil, 
sodium benzoate. 












Tomato Juice (100%) 
(Campbell’s® company) 
  
Tomato juice (water, tomato concentrate), 














Figure 7.1 (Data in Appendix Table A32). Survival and multiplication of L. monocytogenes on marinated cooked chicken stored 













































Figure 7.2 (Data in Appendix Table A32). Survival and multiplication of aerobic plate counts on marinated cooked chicken stored 
















































Figure 7.3 (Data in Appendix Table A28). Effects of microwave reheating for 45 seconds on reduction of inoculated Listeria monocytogenes 




































Figure 7.4 (Data in Appendix Table A29). Effects of microwave reheating at 45 seconds on reduction of inoculated aerobic plate counts during a 






































Figure 7.5 (Data in Appendix Table A30). Effects of microwave reheating for 90 seconds on reduction of inoculated Listeria monocytogenes 









































Figure 7.6 (Data in Appendix Table A31). Effects of microwave reheating at 90 seconds on reduction of inoculated aerobic plate counts during a 





































Formation and decontamination of biofilms of foodborne pathogenic E. coli and Salmonella 
serovars. In this study, at vast majority of time intervals, temperatures and sanitation treatments, 
MDR and MDR-AmpC phenotypes of Salmonella were equally or less resistant to interventions 
than susceptible Salmonella serovars, indicating that validating a cleaning and sanitation 
procedure against susceptible Salmonella serovars will most probably be equally effective 
against the control of drug-resistant phenotypes as well. This study also indicated control of non-
O157 STEC serogroups on stainless steel material can be achieved with similar interventions 
validated against E. coli O157:H7.  
Under the conditions of this study, it was observed that efficacy of the tested sanitizers was 
reduced as a result of higher temperatures used in biofilm formations. Treatments with a 
quaternary ammonium compound-based sanitizer, were able to reduce biofilm mass of one-week 
mature biofilms to less than the detection limit for most pathogen groups when tested at 4°C, 
while the same treatments at 25°C, allowed survival of over 100 pathogenic cell/cm
2
 on the 
surface of stainless steel.  
In this study, it was observed that sanitizer efficacy against one-week mature biofilms at three 
tested temperatures was low. Nearly for all the seven tested pathogen groups stored at 4, 15, and 
25°C, it was observed that efficacy of the peroxyacetic-based sanitizer for inactivation of one-
week mature biofilm, at the highest manufacturers recommended concentration for inactivation 
of food contact surfaces, was low. The quaternary ammonium compound-based sanitizer tested 
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in this study, especially at higher temperatures of biofilm formation, was not capable of complete 
sanitation of the surfaces as well, when tested at the maximum recommended concentration for 
general disinfection. This confirms and reinforces the importance and need for incorporating 
proper cleaning including physical scrubbing before applying sanitizers for effective removal of 
biofilms in processing areas.  
This study was designed to compare serogroups of pathogens for ability to survive and form 
biofilm and for their sensitivity AB and QAC sanitizers. Overall, for decontamination of 
stainless steel coupons from biofilm of foodborne pathogenic bacteria, we observed low efficacy 
of quaternary ammonium compound-based and peroxyacetic-based chemical decontamination 
which were previously validated to be effective in removal of planktonic cells. This decrease in 
efficacy was more notable as a result of increase in temperature of biofilm environment. Seven 
tested pathogen groups in this study had similar biofilm formation and susceptibility to chemical 
decontamination indicating that a successful cleaning and sanitation program validated against E. 
coli O157:H7 will most probably be effective against the other tested non-O157 E. coli and 
Salmonella serovars as well.  
Lactic acid resistance of shiga toxin-producing E. coli and multidrug-resistant and 
susceptible Salmonella serovars in meat homogenate. Results showed that in most cases, 
individual strains of non-O157 STEC (wild-type and rifampicin-resistant) were less acid tolerant 
than the E. coli O157:H7 5-strain mixture (wild-type and rifampicin-resistant). This indicates 
that currently in-place lactic acid interventions in processing of red meat, validated to be efficient 
against E. coli O157:H7 are most probably efficient against the six tested serogroups of non-
O157 STEC as well. Similarly, the present study showed the low acid tolerance of nearly all 
tested Salmonella strains as compared to E. coli O157:H7. In addition, for the majority of time 
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intervals of strains, MDR and MDR-AmpC phenotypes of Salmonella were equally or less 
resistant to interventions than susceptible Salmonella serovars. 
All tested serogroups of E. coli (i.e., O26, O45, O103, O111, O121, and O145) showed 
higher Kmax1 values relative than those obtained for the five-strain mixtures of wild-type cells 
and rifampicin-resistant variants of E. coli O157:H7. This indicates that the six tested serogroups 
required shorter time for 4D reductions compared to E. coli O157:H7. Thus it can be concluded 
that these six serogroups were less lactic acid tolerant than E. coli O157:H7. For the six non-
O157 serogroups as well as the five-strain mixture of E. coli O157:H7, there were no differences 
between Kmax1 values of wild-type and rifampicin-resistant variants. This indicates that under the 
conditions tested in this study, lactic acid resistance of wild-type and rifampicin-resistant 
variants were not statistically different, showing that wild-type and rifampicin resistant cells of 
foodborne pathogens behave similarly in response to antimicrobials and therefore can be used 
interchangeably in food microbiology laboratory challenge research.  
Overall, the results of this acid intervention conducted in a beef homogenate acidified with 
5% lactic acid, indicated that nearly all individual strains of antibiotic resistant and susceptible S. 
Newport and S. Typhimurium and non-O157 E. coli were less acid tolerant than both the wild-
type and the rifampicin-resistant E. coli O157:H7 5-strain mixtures.  
Decontamination of beef trimmings inoculated with shiga toxin-producing E. coli and 
multidrug-resistant and susceptible Salmonella serovars by lactic acid. Six serotypes of non-
O157 STEC and E. coli O157:H7 strain mixture tested in this experiment showed similar 
resistance to lactic acid during the intervention at 25°C; microbial counts after treatment of non-
O157 STEC were less than 0.3 log different than E. coli O157:H7 counts with no statistical 
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difference. As expected, lactic acid treatments at 55°C were more effective (P<0.05) for 
decontamination of meat samples with no appreciable differences among the seven STEC 
serotypes. Overall, irrespective of lactic acid treatment (i.e., 25 or 55°C), there were no 
appreciable differences in surviving counts of all six non-O157 STEC serotypes on treated 
samples compared to surviving counts of E. coli O157:H7 indicating that the six non-O157 
STEC can be controlled as effectively as E. coli O157:H7 by lactic acid interventions. 
Salmonella serovars, including MDR S. Typhimurium, MDR-AmpC S. Typhimurium and 
Newport, and susceptible S. Typhimurium and Newport, when exposed to lactic acid treatment at 
25°C showed lower surviving counts than E. coli O157:H7 with similar trends for treatments at 
55°C. Salmonella counts, irrespective of serotype or antibiotic resistance profile, were similar or 
lower than counts of E. coli O157:H7 following decontamination of samples with 25 or 55°C 
lactic acid solutions.  
Results of this study showed that the above-mentioned emerging pathogens are less or as 
acid tolerant as E. coli O157:H7 indicating that currently in-place lactic acid interventions in 
primary processing of red meat are most probably efficient against these emerging pathogens as 
well. 
Reheating against Listeria monocytogenes inoculated on cooked chicken. In summary, due to 
different heat transfer mechanisms (i.e., primarily convection-based transfer for oven and 
conduction-based transfer for stove-top reheating) different investigated reheating methods 
demonstrated different pathogen reduction potentials and times for reaching the same designated 
internal temperature. This indicates a need for method-specific recommendations for assuring the 
safety of leftovers reheated in domestic and foodservice environments by different heating 
methods. Along with increasing evidence of L. monocytogenes presence in domestic and food 
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service environments in recent years, it appears that safe management of leftover food, especially 
for people at-risk for listeriosis, is of particular importance. In this study, initial counts of L. 
monocytogenes increased by over 4.0 log CFU/g during 7 days of storage at 7°C, confirming the 
concern that if cross-contamination occurs after preparation of foods, L. monocytogenes can 
multiply extensively during refrigerated storage. Although the reheating methods investigated in 
this study reduced L. monocytogenes contamination by 2-5 log CFU/g, growth of the pathogen 
during storage allowed high numbers of survivors after reheating, especially after two days of 
storage. In other words, storage time affected the initial microbial counts and had a major impact 
on subsequent death due to reheating. This indicates that storage period, and type and intensity of 
reheating need to be considered for safe consumption of leftover food. Regardless of reheating 
method, high numbers of survivors after reheating, especially after two days of storage indicated 
a need of consideration for utilization of leftover food, especially by at-risk populations.  
Microwave reheating and marinating for reduction of Listeria monocytogenes. Although 
microwave reheating was responsible for 1.9 to 4.1 and 2.1 to 5.0 log CFU/g reduction of L. 
monocytogenes counts during storage, for treatments at 45 seconds and 90 seconds, respectively,  
numbers of pathogen survivors after reheating increased as populations on stored (7°C) product 
increased. With similar trends across different marinated samples, high levels of L. 
monocytogenes survivors after microwave oven reheating, especially after two days of storage, 
indicates that length of storage and reheating time need to be considered for safe consumption of 
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Table A1 (Data for Figure 3.1). Biofilm formation at 4°C for the seven pathogen groups (selective media counts).  
  Days  
  0  1  4  7  
Escherichia coli O157:H7*  1.6±0.4 aA  1.7±0.3 abA  1.9±0.3 aA  1.2±0.8 aA  
Non-O157 Escherichia coli serovars  1.7±0.4 aA  2.1±0.5 abA  2.2±0.5 aA  1.4±0.3 aA  
Susceptible Salmonella Typhimurium  1.5±0.6 aB  1.7±0.5 bB  2.5±0.3 aA  1.9±0.4 aAB  
MDR Salmonella Typhimurium    2.0±0.4 aA  1.7±0.7 bA  2.4±0.1 aA  1.7±1.0 aA  
MDR-AmpC Salmonella Typhimurium  2.0±0.5 aA  1.9±1.0 abA  2.2±0.3 aA  1.5±0.3 aA  
Susceptible Salmonella Newport  2.1±0.8 aA  1.8±0.6 abA  2.3±0.5 aA  1.4±0.6 aA  
MDR-AmpC Salmonella Newport  2.4±0.6 aAB  2.8±0.2 aA  2.5±0.1 aAB  1.9±0.8 aB  













Table A2 (Data for Figure 3.1). Biofilm formation at 15°C for the seven pathogen groups (selective media counts). 
  Days 
  0  1  4  7 
Escherichia coli O157:H7  1.4±0.6 aC  2.3±0.4 aBC  3.0±0.9 aB  4.8±0.6 abA 
Non-O157 Escherichia coli serovars  1.7±0.8 aC  2.4±0.3 aBC  3.3±1.2 aB  4.9±0.6 aA 
Susceptible Salmonella Typhimurium  1.3±0.8 aB  2.7±0.8 aA  3.3±0.6 aA  3.8±0.5 bA 
MDR Salmonella Typhimurium    2.3±0.4 aC  2.8±0.3 aBC  3.3±0.7 aAB  4.2±0.6 abA 
MDR-AmpC Salmonella Typhimurium  1.9±0.3 aC  2.3±0.3 aC  3.3±0.5 aB  4.7±0.6 abA 
Susceptible Salmonella Newport  2.1±0.4 aC  2.8±0.5 aBC  3.1±0.5 aB  4.5±0.4 abA 
MDR-AmpC Salmonella Newport  2.0±0.2 aC  2.5±0.3 aBC  2.9±0.5 a B  4.5±0.8 abA 















Table A3 (Data for Figure 3.1). Biofilm formation at 25°C for the seven pathogen groups (selective media counts). 
  Days  
  0  1  4  7  
Escherichia coli O157:H7  2.0±0.3 aB  2.1±0.8 aB  3.5±0.4 aA  3.3±0.7 bcA  
Non-O157 Escherichia coli serovars  2.0±0.8 aB  2.6±1.3 aB  4.1±0.2 aA  2.9±0.5 cAB  
Susceptible Salmonella Typhimurium  1.5±0.8 aB  3.5±0.9 aA  3.7±0.8 aA  4.2±0.4 abA  
MDR Salmonella Typhimurium    1.7±0.7 aB  3.2±1.0 aA  4.0±0.7 aA  4.3±0.4 aA  
MDR-AmpC Salmonella Typhimurium  1.6±0.9 aB  2.7±1.1 aB  4.3±0.4 aA  4.1±1.0 abA  
Susceptible Salmonella Newport  1.6±0.9 aB  3.3±0.9 aA  4.2±0.8 aA  4.3±0.4 abA  
MDR-AmpC Salmonella Newport  1.7±1.0 aB  3.6±0.7 aA  4.3±0.4 aA  4.3±0.5 abA  















Table A4 (Data for Figure 3.2). Biofilm formation at 4°C for the seven pathogen groups and background microflora (non-selective media 
counts). 
  Days 
  0  1  4  7 
Escherichia coli O157:H7*  2.2±0.4 aD  2.6±0.1 bC   4.1±0.2 aB  5.5±0.2 aA 
Non-O157 Escherichia coli serovars  2.2±0.4 aC  2.6±0.2 bC  3.9±0.2 aB  5.5±0.2 aA 
Susceptible Salmonella Typhimurium  2.2±0.3 aC  2.8±0.2 bC  3.9±0.7 aB  5.7±0.2 aA 
MDR Salmonella Typhimurium    2.5±0.3 aC  2.8±0.3 bC  4.3±0.2 aB  5.4±0.2 aA 
MDR-AmpC Salmonella Typhimurium  2.4±0.4 aC  2.9±0.4 bC  4.2±0.5 aB  5.7±0.4 aA 
Susceptible Salmonella Newport  2.6±0.4 aC  3.0±0.2 abC  4.4±0.1 aB  5.5±0.1 aA 
MDR-AmpC Salmonella Newport  2.8±0.6 aC  3.3±0.1 aC  4.4±0.6 aB  5.6±0.4 aA 














Table A5 (Data for Figure 3.2). Biofilm formation at 15°C for the seven pathogen groups and background microflora (non-selective media 
counts). 
  Days 
  0  1  4  7 
Escherichia coli O157:H7  2.3±0.3 aD  4.6±0.1 bC  5.9±0.3 aB  6.5±0.2 aA 
Non-O157 Escherichia coli serovars  2.5±0.4 aD  4.6±0.2 bC  6.0±0.2 aB  6.4±0.3 aA 
Susceptible Salmonella Typhimurium  2.2±0.2 aD  4.6±0.1 bC  5.8±0.3 aB  6.4±0.3 aA 
MDR Salmonella Typhimurium    2.6±0.4 aD  4.6±0.0 abC  5.8±0.3 aB  6.4±0.3 aA 
MDR-AmpC Salmonella Typhimurium  2.2±0.2 aD  4.8±0.2 abC  5.9±0.2 aB  6.6±0.2 aA 
Susceptible Salmonella Newport  2.4±0.2 aD  5.0±0.3 aC  5.9±0.2 aB  6.5±0.3 aA 
MDR-AmpC Salmonella Newport  2.4±0.1 aD   4.6±0.2 bC  5.9±0.3 aB  6.3±0.2 aA 














Table A6 (Data for Figure 3.2). Biofilm formation at 25°C for the seven pathogen groups and background microflora (non-selective media 
counts). 
  Days  
  0  1  4  7  
Escherichia coli O157:H7  2.3±0.4 aC  5.2±0.1 aB  6.8±0.3 aA  6.4±0.6 aA  
Non-O157 Escherichia coli serovars  2.1±0.5 aC  5.1±0.1 aB  6.7±0.4 aA  6.5±0.6 aA  
Susceptible Salmonella Typhimurium  2.0±0.5 aC  5.2±0.3 aB  6.4±0.6 aA  7.0±0.2 aA  
MDR Salmonella Typhimurium    2.3±0.4 aD  5.2±0.2 aC  6.5±0.3 aB  7.1±0.4 aA  
MDR-AmpC Salmonella Typhimurium  2.3±0.5 aC  5.2±0.3 aB  6.3±0.4 aA  6.5±0.5 aA  
Susceptible Salmonella Newport  2.2±0.4 aC  5.1±0.1 aB  6.6±0.5 aA  7.1±0.4 aA  
MDR-AmpC Salmonella Newport  2.3±0.4 aC  5.2±0.2 aB  6.7±0.5 aA  7.0±0.1 aA  
* Within a column, means with different lowercase letter(s) and within a row, means with different upper case letter(s) are significantly different (P<0.05). 
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Table A7 (Data for Figures 4.1 and 4.2). Survival of parents and rifampicin-resistant E. coli O26 strains (log CFU/ ml) during exposure to 5% 
lactic acid in 10% (W/W) beef homogenate at 25°C. 
    Time (minutes) 
Strain Serotype Media Control 0 2 4 6 8 
5-strain mix O157: H7 TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
5-strain mix 
R 
O157: H7 TSA+Rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0  E <1.0 E 
O26 (1) O26 TSA 6.1±0.0 A 5.3±0.0 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O26 (1) R
*
 O26 TSA+Rif 6.2±0.1 A 5.0±0.2 B 2.3±0.3 C ** 1.2±0.4 D ** 1.1±0.2 D ** <1.0 E 
          
O26(2) O26 TSA 5.8±0.4 A * <1.0 B * <1.0 B * <1.0 B * <1.0 B * <1.0 B * 
O26(2) R O26 TSA+Rif 6.3±0.1 A 2.0±0.1 B** <1.0 C ** <1.0 C ** <1.0 C <1.0 C 
         
A1-006 O26 TSA 6.2±0.1 A  4.4±0.3 B * 1.7±0.1 C * <1.0 D * <1.0 D * <1.0 D * 
A1-006 R O26 TSA+Rif 6.3±0.1 A** 4.6±0.9 B 2.4±0.1 C** <1.0 D ** <1.0 D <1.0 D 
         
A1-007 O26 TSA 6.1±0.2 A 2.4±0.3 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
A1-007 R O26 TSA+Rif 6.5±0.1 A** 2.3±0.3 B** <1.0 C ** <1.0 C ** <1.0 C <1.0 C 
         
A1-008 O26 TSA 6.4±0.2 A * 5.2±0.1 B 3.0±0.0 C * 2.8±0.1 D * 2.6±0.1 D  2.4±0.1 E * 
A1-008 R O26 TSA+Rif 6.5±0.1 A** 5.2±0.2 B 2.7±0.4 C 2.1±0.1 D ** <1.0 E <1.0 E 
         
A1-009 O26 TSA 6.3±0.2 A  5.6±0.2 B * 2.8±0.5 C * <1.0 D * <1.0 D * <1.0 D * 
A1-009 R O26 TSA+Rif 6.4±0.1 A** 5.0±0.0 B <1.0 C ** <1.0 C ** <1.0 C <1.0 C 
         
A1-010 O26 TSA 6.2±0.1 A  3.5±0.7 B 2.6±0.1 C * 1.5±0.1 D * <1.0 E * <1.0 E * 
A1-010 R O26 TSA+Rif 6.5±0.3 A** 3.6±0.2 B** 2.7±0.2 C ** 1.4±0.7 D  <1.0 E <1.0 E 
R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. TSA values within each 
column followed by * are significantly (P<0.05) different with TSA values of the control mixture of Escherichia coli O157:H7. TSA+rif values within each 





Table A8 (Data for Figures 4.1 and 4.2). Survival of parents and rifampicin-resistant E. coli O111 strains (log CFU/ ml) during exposure to 5% 
lactic acid in 10% (W/W) beef homogenate at 25°C. 
    Time (min) 
Strain Serotype Media Control 0 2 4 6 8 
5-strain mix O157:H7 TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
5-strain mix R O157:H7 TSA+Rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0  E <1.0 E 
A1-001 O111 TSA 6.1±0.1 A 4.5±0.1 B * 2.5±0.8 C * <1.0 D * <1.0 D * <1.0 D * 
A1-001 R O111 TSA+Rif 6.4±0.1 A** 5.2±0.2 B 1.7±0.2 C** <1.0 D** <1.0 D <1.0 D 
A1-002 O111 TSA 6.4±0.1 A * 5.2±0.1 B 3.2±0.2 C * 1.7±0.5 D * <1.0 E * <1.0 E * 
A1-002 R O111 TSA+Rif 6.2±0.3 A 5.5±0.1 B 2.9±0.4 C** 1.7±0.1 D <1.0  E                   <1.0 E 
A1-003 O111 TSA 6.1±0.1 A 5.7±0.0 B 3.3±0.4 * 3.4±0.3  2.3±0.8 1.7±0.1 * 
A1-003 R O111 TSA+Rif 6.3±0.1 A** 5.9±0.1 B** 3.6±0.2 E 3.1±0.1 D** 2.2±0.1 E ** 1.9±0.2 F ** 
A1-004 O111 TSA 6.5±0.1 A * 2.8±0.1 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
A1-004 R O111 TSA+Rif 6.5±0.1 A** 3.8±0.3 B** 1.6±0.1 C** 1.05±0.1 D** <1.0 D <1.0 D 
A1-005 O111 TSA 6.2±0.1 A 4.7±0.4 B 2.3±0.4 C * <1.0 ±0.0 D * <1.0 D * <1.0 D * 
A1-005 R O111 TSA+Rif 6.4±0.0 A** 4.1±0.32 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
O111(1) O111 TSA 6.2±0.1 A <1.0 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O111(1) R O111 TSA+Rif 6.1±0.3 A 3.4±0.4 B** 1.8±0.1 C** <1.0 D** <1.0 D <1.0 D 
O111(2) O111 TSA 5.7±0.1 A * 2.1±0.6 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
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O111(2) R O111 TSA+Rif 6.2±0.1 A 2.1±0.1 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. TSA values within each 
column followed by * are significantly (P<0.05) different with TSA values of the control mixture of Escherichia coli O157:H7. TSA+rif values within each 

















Table A9 (Data for Figures 4.1 and 4.2). Survival of parents and rifampicin-resistant E. coli O103 strains (log CFU/ ml) during exposure to 5% 
lactic acid in 10% (W/W) beef homogenate at 25°C. 
    Time (min) 
Strain Serotype Media Control 0 2 4 6 8 
5-strain mix O157:H7 TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
5-strain mix R O157:H7 TSA+Rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0  E <1.0 E 
O103(1) O103 TSA 6.1±0.1 A 4.3±0.4 B * 1.3±0.4 C * <1.0 D * <1.0 D * <1.0 D * 
O103(1) R O103 TSA+Rif 6.0±0.2 A 1.6±0.2 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
         
A1-0103 (2) O103 TSA 6.2±0.1 A * 4.6±0.6 B * 2.4±0.6 C * <1.5±0.0 D * <1.0 E * <1.0 E * 
A1-0103 (2) R O103 TSA+Rif 6.4±0.1 A** 5.2±0.0 B 3.1±0.1 C** 3.0±0.1 C** 1.6±0.3 D <1.0 E 
         
A1-011 O103 TSA 6.1±0.1 A 4.9±0.1 B * 2.4±0.5 C * 1.3±0.3 C * <1.0 D * <1.0 D * 
A1-011 R O103 TSA+Rif 6.1±0.2 A 5.3±0.2 B 3.7±0.2 C 2.3±0.1 D** 1.7±0.1 E** <1.0 F 
         
A1-012 O103 TSA 6.5±0.1 A * 3.4±0.3 B * 2.1±0.1 C * 1.7±0.1 D * <1.0 E * <1.0 E * 
A1-012 R O103 TSA+Rif 6.5±0.1 A** 1.9±0.3 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
         
A1-013 O103 TSA 5.9±0.1 A * 4.9±0.1 B * 2.4±0.5 C * <1.0 D * <1.0 D * <1.0 D * 
A1-013 R O103 TSA+Rif 6.2±0.4 A 3.9±0.6 B** 1.8±0.1 C** <1.0 D** <1.0 D <1.0 D 
         
A1-014 O103 TSA 6.2±0.3 A 3.8±0.1 B * 3.4±0.1 C * 2.6±0.1 D * 2.5±0.1 D 2.5±0.1 D * 
A1-014 R O103 TSA+Rif 6.4±0.1 A** 6.0±0.1 B** 3.6±0.1 C** 2.6±0.3 D** <1.0 E <1.0 E 
         
A1-015 O103 TSA 6.3±0.1 A * 2.2±0.0 B * 1.4±0.1 C * 1.0±0.0 D * <1.0 D * <1.0 D * 
A1-015 R O103 TSA+Rif 6.4±0.1 A ** 3.5±0.1 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. TSA values within each 
column followed by * are significantly (P<0.05) different with TSA values of the control mixture of Escherichia coli O157:H7. TSA+rif values within each 





Table A10 (Data for Figures 4.1 and 4.2). Survival of parents and rifampicin-resistant E. coli O45 strains (log CFU/ ml) during exposure to 5% 
lactic acid in 10% (W/W) beef homogenate at 25°C. 
R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. TSA values within each 
column followed by * are significantly (P<0.05) different with TSA values of the control mixture of Escherichia coli O157:H7. TSA+rif values within each 
column followed by ** are significantly (P<0.05) different with TSA+rif values of the control mixture of Escherichia coli O157:H7. 
 
 
    Time (min) 
Strain Serotype Media Control 0 2 4 6 8 
5-strain mix O157 TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
5-strain mix R O157 TSA+Rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0  E <1.0 E 
O45(1) O45 TSA 5.9±0.2 A <1.0 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O45(1) R O45 TSA+Rif 6.2±0.2 A 2.1±0.9 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
O45(2) O45 TSA 6.1±0.1 A 5.2±0.4 B <2.1±0.9 C * <1.0 D * <1.0 D * <1.0 D * 
O45(2) R O45 TSA+Rif 6.4±0.1 A** 4.1±0.5 B 1.2±0.4 C** <1.0 D** <1.0 D <1.0 D 
O45: H2 05-6545 O45 TSA 5.9±0.1 A 5.4±0.3 B 4.9±0.1 C  3.6±0.3 D  3.7±0.0 D * 2.6±0.0 E * 
O45: H2 R 05-6545 O45 TSA+Rif 5.7±0.1 A 5.2±0.3 B 4.1±0.2 C** 2.8±0.4 D** <1.0 E <1.0 E 
O45: H2(2) 96-3285 O45 TSA 6.0±0.0 A 5.5±0.1 B <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O45: H2(2) R 96-3285 O45 TSA+Rif 6.0±0.2 A 2.1±0.4 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
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Table A11 (Data for Figures 4.1 and 4.2). Survival of parents and rifampicin-resistant E. coli O121 strains (log CFU/ ml) during exposure to 5% 
lactic acid in 10% (W/W) beef homogenate at 25°C. 
R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. TSA values within each 
column followed by * are significantly (P<0.05) different with TSA values of the control mixture of Escherichia coli O157:H7. TSA+rif values within each 
column followed by ** are significantly (P<0.05) different with TSA+rif values of the control mixture of Escherichia coli O157:H7. 
    Time (min) 
Strain Serotype Media Control 0 2 4 6 8 
5-strain mix O157:H7 TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
5-strain mix R O157:H7 TSA+Rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0  E <1.0 E 
O121(1) O121 TSA 5.8±0.2 A * 1.0±0.0 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O121(1) R O121 TSA+Rif 6.2±0.4 A 2.3±0.0 B** 2.2±0.0 C** 1.8±0.2 D 1.1±0.1 E <1.0 E 
O121(2) O121 TSA 6.0±0.1 A 3.0±0.3 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O121(2) R O121 TSA+Rif 6.4±0.1 A** 3.5±0.5 B** 1.1±0.2 C** <1.0 D** <1.0 D <1.0 D 
O121:H19 97-3068 O121 TSA 5.7±0.0 A * 5.4±0.1 B 4.9±0.1 C * 2.9±0.1 D * 1.6±0.1 E * <1.0 F * 
O121:H19 R 97-
3068 
O121 TSA+Rif 6.1±0.4 A 4.5±0.1 B 2.0±0.9 C** <1.0 D** <1.0 D <1.0 D 
O121:NM  03-4064 O121 TSA 5.8±0.1 A * 5.0±0.2 B 2.7±0.7 C * <1.0 D * <1.0 D * <1.0 D * 
O121:NM R 03-
4064 
O121 TSA+Rif 6.2±0.1 A** 3.3±0.1 B** 3.2±0.1  B** 2.4±0.7  C** 1.8±0.5 D ** <1.0 E 
O121:H19 08023 O121 TSA 5.7±0.1 A * <1.0 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O121:H19 R 08023 O121 TSA+Rif 5.9±0.33 A 4.4±0.3 B <1.0 C** <1.0 C** <1.0 C <1.0 C 
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Table A12 (Data for Figures 4.1 and 4.2). Survival of parents and rifampicin-resistant E. coli O145 strains (log CFU/ ml) during exposure to 5% 
lactic acid in 10% (W/W) beef homogenate at 25°C. 
    Time (min) 
Strain Serotype Media Control 0 2 4 6 8 
5-strain mix O157:H7 TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
5-strain mix R O157:H7 TSA+Rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0  E <1.0 E 
O145(1) O145 TSA 6.2±0.1 A 1.3±0.4 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O145(1)R
 
O145 TSA+Rif 6.5±0.1 A** 4.0±0.1 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
O145(2) O145 TSA 6.3±0.1 A 4.2±0.1 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O145(2)R
 
O145 TSA+Rif 6.3±0.1 A 4.9±0.3 B 1.5±0.4 C** <1.0 D**  <1.0 D <1.0 D 
O145:NM 03-499 O145 TSA 5.9±0.1 A 5.4±0.3 B 4.9±0.0 C * 4.1±0.1  D <1.0 E * <1.0 E * 
O145:NM R 03-499 O145 TSA+Rif 6.0±0.3 A 5.1±0.3 B 3.1±0.8 C** <1.0 D** <1.0 D <1.0 D 
O145:NM 83-75 O145 TSA 6.1±0.2 A 4.7±0.3 B * <1.0 C * <1.0 C * <1.0 C * <1.0 C * 
O145:NM R 83-75 O145 TSA+Rif 5.9±0.4 A 1.7±0.3 B** <1.0 C** <1.0 C** <1.0 C  <1.0 C 
O145:H18 07865 O145 TSA 5.4±0.1 A* <1.0 B * <1.0  B * <1.0  B * <1.0  B * <1.0 B * 
O145:H18 R 07865 O145 TSA+Rif 5.8±0.4 A 2.4±1.3 B** <1.0 C** <1.0 C** <1.0 C <1.0 C 
R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. TSA values within each 
column followed by * are significantly (P<0.05) different with TSA values of the control mixture of Escherichia coli O157:H7. TSA+rif values within each 




Table A13 (Data for Figure 4.3 and 4.4). Survival of antibiotic (drug) susceptible Salmonella Newport (log CFU/ ml) during exposure to 5% 
lactic acid in 10% (W/W) beef homogenate at 25°C. 
R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. XLD (xylose lysine 
deoxycholate) values within each column followed by * are significantly (P<0.05) different with TSA+rif (tryptic soy agar+ rifampicin) values of the control 
mixture of Escherichia coli O157:H7.  TSA (tryptic soy agar) values within each column followed by ** are significantly (P<0.05) different with TSA values of 




   Time (min) 
Strain Media Control 0 2 4 6 8 
O157:H7 mix R TSA+rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0 E <1.0 E 
O157:H7 mix TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
CVM N4505 XLD 5.8±0.1 A * <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.8±0.1 A 1.3±0.4 B ** <1.0 B ** <1.0 B** <1.0 B ** <1.0 B** 
CVM N18445 XLD 5.9±0.1 A <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.8±0.2 A** 3.2±0.1 B** <1.0 B** <1.0 B** <1.0 B** <1.0 B** 
CVM N1509 XLD 6.1±0.1 A <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.9±0.1A 1.3±0.3 B** 1.1±0.2 B** <1.0 B** <1.0 B** <1.0 B** 
FSL S5-639 XLD 5.8±0.3 A <1.8±0.1 B * <1.0 ±0.1 C * <1.2±0.1 C * <1.0 C <1.0 C 
 TSA 5.9±0.2 A 3.5±0.1 B** <1.9±0.1 C** <1.1±0.2  D** <1.0 D** <1.0 D** 
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Table A14 (Data for Figure 4.3 and 4.4). Survival of MDR-AmpC Salmonella Newport (log CFU/ ml) during exposure to 5% lactic acid in 10% 
(W/W) beef homogenate at 25°C. 
   Time (min) 
Strain Media Control 0 2 4 6 8 
O157:H7 mix R TSA+rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0 E <1.0 E 
O157:H7 mix TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
FSL R6-531 XLD 6.0±0.1 A 2.9±0.1 B <1.2±0.3 C * 1.1±0.1 C * <1.0 C <1.0 C 
 TSA 6.1±0.1 A 4.3±0.1 B** 2.0±0.1 C ** 2.0±0.1 C 1.3±0.1 D ** 1.2±0.3 D 
FSL R8-0104 XLD 5.7±0.1 A * <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0  B 
 TSA 5.7±0.2 A** <1.0 ±0.1 B** <1.0±0.1 B ** <1.0 B ** <1.0 B ** <1.0 B ** 
FSL S5-413 XLD 5.6±0.1 A * <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.4±0.2 A** <1.0 ±0.1 B** <1.0 B** <1.0 B ** <1.0 B ** <1.0 B ** 
FSL S5-436 XLD 6.0±0.1 A <2.4±0.2 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 6.0±0.1 A 3.9±0.1 B** 1.5±0.1  C ** <1.0  C ** <1.0  C ** <1.0  C ** 
FSL S5-577 XLD 5.8±0.1 A  <1.0 B * <1.0 B * <1.0 0B * <1.0 B <1.0 B 
 TSA 5.7±0.1 A** 2.0±0.1 B** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
FSL S5-920 XLD 5.8±0.1 A 1.2±0.1 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 5.7±0.1 A** 3.8±0.1 B** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
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R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. XLD (xylose lysine 
deoxycholate) values within each column followed by * are significantly (P<0.05) different with TSA+rif (tryptic soy agar+ rifampicin) values of the control 
mixture of Escherichia coli O157:H7.  TSA (tryptic soy agar) values within each column followed by ** are significantly (P<0.05) different with TSA values of 
the control mixture of Escherichia coli O157:H7. 
 
 
FSL R8-2926 XLD 5.9±0.1 A 1.6±0.1 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.0±0.1 A 3.8±0.2 B** <1.0±0.1 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
FSL R8-2350 XLD 5.9±0.1 A 1.7±0.1 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.0±0.1 A 2.7±0.1 B** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM N635 XLD 6.0±0.1 A 1.3±0.1 B * <1.0 C * <1.0 C * <1.0 C  <1.0 C  
 TSA 5.9±0.2 A 2.0±0.2 B** <1.0 C** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM 22698 XLD 6.1±0.1 A 1.1±0.2 B * <1.0  C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.0±0.1 A 3.0±0.1 B** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C **  
CVM 29461 XLD 5.9±0.1 A <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.9±0.2 A 2.1±0.1 B** <1.0 B ** <1.0 B ** <1.0 B ** <1.0 B ** 
CVM 22707 XLD 5.8±0.1 A <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.7±0.1 A** 2.3±0.2 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM N19852 XLD 6.0±0.1 A 1.9±0.2 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.0±0.1 A 3.3±0.1 B** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
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Table A15 (Data for Figure 4.3 and 4.4). Survival of antibiotic (drug) susceptible Salmonella Typhimurium (log CFU/ ml) during exposure to 















R=Rifampicin resistant. Values  (mean±SD) within each row, followed by different uppercase letters are significantly (P<0.05) different. XLD (xylose lysine 
deoxycholate) values within each column followed by * are significantly (P<0.05) different with TSA+rif (tryptic soy agar+ rifampicin) values of the control 
mixture of Escherichia coli O157:H7.  TSA (tryptic soy agar) values within each column followed by ** are significantly (P<0.05) different with TSA values of 
the control mixture of Escherichia coli O157:H7. 
 
 
   Time (min) 
Strain Media Control 0 2 4 6 8 
O157:H7 mix R TSA+rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0 E <1.0 E 
O157:H7 mix TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
CVM N7300 XLD 6.4±0.1 A * 2.0±0.1 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.4±0.1 A ** 3.3±0.1 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM N15788 XLD 6.0±0.3 A 1.6±0.2 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.1±0.2 A 3.4±0.2 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM N18534 XLD 6.0±0.1 A 3.1±0.1 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 5.9±0.1 A 3.3±0.1 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
FSL S5-536 XLD 6.1±0.2 A <1.3±0.1 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.0±0.1 A 3.7±0.1  B ** <1.0±0.1 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
161 
 
Table A16 (Data for Figure 4.3 and 4.4). Survival of MDR Salmonella Typhimurium (log CFU/ ml during exposure to 5% lactic acid in 10% 





















   Time (min) 
Strain Media Control 0 2 4 6 8 
O157:H7 mix R TSA+rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0 E <1.0 E 
O157:H7 mix TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
FSL R6-215 XLD 6.0±0.1 A 2.0±0.2 B * 1.4±0.1 C * <1.0 D * <1.0 D <1.0 D 
 TSA 6.0±0.1 A 4.0±0.1 B ** 2.1±0.1  C ** 2.0±0.1 C ** 1.6±0.1 D ** <1.0  E ** 
FSL S9-165 XLD 5.9±0.1 A 1.4±0.3 B * <1.1±0.1 C * <1.0  C * <1.0  C <1.0  C 
 TSA 6.0±0.1 A 2.7±0.1 B ** 1.9±0.1 C ** <1.0 D ** <1.0 D ** <1.0 D ** 
FSL R8-2540 XLD 5.9±0.1 A <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.7±0.1 A** <1.0 B ** <1.0 B ** <1.0 B ** <1.0 B ** <1.0 B ** 
CVM N6431 XLD 5.9±0.2 A 3.0±0.1 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.0±0.1A  3.6±0.1 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM 30662 XLD 5.9±0.2 A  <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.7±0.1 A ** 1.1±.2 B ** <1.0 B ** <1.0 B ** <1.0 B ** <1.0 B ** 
CVM N497 XLD 6.1±0.2 A * <1.0 B * <1.0 B * <1.0 B * <1.0 B <1.0 B 
 TSA 5.4±0.2 A ** 2.4±0.1 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
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Table A17  (Data for Figure 4.3 and 4.4). Survival of MDR-Ampc Salmonella Typhimurium (log CFU/ ml) during exposure to 5% lactic acid in 




















   Time (min) 
Strain Media Control 0 2 4 6 8 
O157:H7 mix R TSA+rif 5.9±0.2 A 5.0±0.6 B 3.9±0.3 C 1.7±0.5 D <1.0 E <1.0 E 
O157:H7 mix TSA 6.1±0.1 A 5.4±0.1 B 4.6±0.1 C 3.8±0.2 D 2.5±0.9 E 1.1±0.2 F 
FSL S5-786 XLD 6.2±0.1 A * 3.0±0.1 B * <1.0  C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.1±0.1 A 4.1±0.1 B ** 2.5±0.2 C ** 1.9±0.1 D ** 1.1±0.1 E ** <1.0 E ** 
FSL S5-916 XLD 5.8±0.1 A 2.5±0.2 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 5.9±0.1 A 4.4±0.1 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
FSL S5-385 XLD 6.0±0.1 A  1.4±0.2 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 6.0±0.1 A 4.3±0.1 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM N176 XLD 5.8±0.1 A * 2.0±.2 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 5.7±0.1 A** 2.7±0.1 B ** 1.7±0.1 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM 33831 XLD 5.6±0.1 A * 1.7±0.1 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 5.7±0.1 A** 2.2±0.1 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
CVM 30034 XLD 5.8±0.1 A 1.9±0.2 B * <1.0 C * <1.0 C * <1.0 C <1.0 C 
 TSA 5.8±0.1 A** 1.8±0.1 B ** <1.0 C ** <1.0 C ** <1.0 C ** <1.0 C ** 
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Table A18 (Data for Figure 5.1). Effects of lactic acid immersion interventions at 25 and 55°C against 7 inoculated serotypes of shiga toxin 










Values (mean ± standard deviation) within each row, followed by different uppercase letter are significantly (P<0.05) different. 













Lactic Acid at 25°C 
  
 
Lactic Acid at 55°C 
O26 
 
3.2 ± 0.1 Aa 
 
2.4 ± 0.1 Bb 
 
2.1 ± 0.3 Ca 
O45 
 
3.2 ± 0.1  Aa 
 
2.5 ± 0.2  Bab 
 
1.8 ± 0.5 Ca 
O103 
 
3.2 ± 0.1  Aa 
 
2.7 ± 0.2 Ba 
 
2.1 ± 0.3  Ca 
O145 
 
3.3 ± 0.4  Aa 
 
2.4 ± 0.3  Bb 
 
2.2 ± 0.3 Ba 
O111 
 
3.2 ± 0.1  Aa 
 
2.5 ± 0.1  Bab 
 
2.2 ± 0.3 Ba 
O121 
 
3.1 ± 0.1  Aa 
 
2.4 ± 0.2  Bb 
 
2.0 ± 0.2 Ca 
O157:H7 
 
3.2 ± 0.1 Aa 
 
2.5 ± 0.2  Bab 
 
1.8 ± 0.4 Ca 
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Table A19 (Data for Figure 5.2). Effects of lactic acid immersion interventions at 25 and 55°C against background microflora (TSA counts) on 










Values (mean ± standard deviation) within each row, followed by different uppercase letter are significantly (P<0.05) different. 













Lactic Acid at 25°C 
  
 
Lactic Acid at 55°C 
O26 
 
3.5 ± 0.2 Aa 
 
2.8 ± 0.3 Ba 
 
2.4 ± 0.6 Ba 
O45 
 
3.6 ± 0.2 Aa 
 
2.8 ± 0.4 Ba 
 
2.2 ± 0.5 Ca 
O103 
 
3.5 ± 0.1 Aa 
 
2.8 ± 0.2 Ba 
 
2.4 ± 0.3 Ca 
O145 
 
3.6 ± 0.2 Aa 
 
2.7 ± 0.5 Ba 
 
2.6 ± 0.6 Ba 
O111 
 
3.6 ± 0.5 Aa 
 
2.5 ± 0.6 Ba 
 
2.3 ± 0.5 Ba 
O121 
 
3.6 ± 0.4 Aa 
 
2.9 ± 0.4 Ba 
 
2.5 ± 0.5 Ba 
O157:H7 
 
3.6 ± 0.4 Aa 
 
2.8 ± 0.3 Ba 
 
2.3 ± 0.5 Ba 
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Table A20  (Data for Figure 5.3). Effects of lactic acid immersion interventions at 25 and 55°C against inoculated serotypes of Escherichia coli 










Values (mean ± standard deviation) within each row, followed by different uppercase letter are significantly (P<0.05) different. 













Lactic Acid at 25°C 
  
Lactic Acid at 
55°C 




3.2 ± 0.1 Aa 
 
1.9 ± 0.2 Bb 
 
1.6 ± 0.4 Bab 
         
S. Typhimurium, MDR  XLD  3.3 ± 0.0 Aa  2.0 ± 0.2 Bb  1.4 ± 0.5 Cab 




3.0 ± 0.1 Aa 
 
1.7 ± 0.2 Bbc 
 
1.3 ± 0.4 Bb 
         
S. Newport,  Antibiotic susceptible  XLD  3.1 ± 0.0 Aa  1.8 ± 0.1 Bbc  1.5 ± 0.4 Bab 
         
S. Newport,  MDR, AmpC  XLD  3.1 ± 0.1 Aa  1.6 ± 0.2 Bc  1.2 ± 0.3 Cb 
         
E. coli O157:H7  TSA+Rif  3.2 ± 0.1 Aa  2.7 ± 0.1 Ba  2.0± 0.4 Ca 
166 
 
Table A21  (Data for Figure 5.4). Effects of lactic acid immersion interventions at 25 and 55°C against inoculated serotypes of Escherichia coli 










Values (mean ± standard deviation) within each row, followed by different uppercase letter are significantly (P<0.05) different. 













Lactic Acid at 25°C 
  
Lactic Acid at 55°C 




3.2 ± 0.1 Aa 
 
1.9 ± 0.2 Bb 
 
1.6 ± 0.4 Ba 
         
S. Typhimurium, MDR  XLD  3.3 ± 0.0 Aa  2.0 ± 0.2 Bab  1.4 ± 0.5 Ca 




3.0 ± 0.1 Aa 
 
1.7 ± 0.2 Bbc 
 
1.3 ± 0.4 Ba 
         
S. Newport,  Antibiotic susceptible  XLD  3.1 ± 0.0 Aa  1.8 ± 0.1 Bbc  1.5 ± 0.4 Ba 
         
S. Newport,  MDR, AmpC  XLD  3.1 ± 0.1 Aa  1.6 ± 0.2 Bc  1.2 ± 0.3 Ca 
         
E. coli O157:H7  mSMAC  3.0 ± 0.1 Aa  2.2 ± 0.0 Ba  1.5 ± 0.5 Ca 
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Table A22 (Data for Figure 5.5). Effects of lactic acid immersion interventions at 25 and 55°C against background microflora (TSA counts) on 









Values (mean ± standard deviation) within each row, followed by different uppercase letter are significantly (P<0.05) different. 








   
No Treatment 
  
Lactic Acid at 25°C 
  
Lactic Acid at 55°C 
 S. Typhimurium,  Antibiotic susceptible   4.2 ± 0.5 Aa  3.1 ± 0.4 Ba  2.5 ± 0.4 Ca 
        
S. Typhimurium, MDR   3.9 ± 0.1 Aa  3.0 ± 0.2 Ba  2.5 ± 0.4 Ca 
        
S. Typhimurium,  MDR, AmpC   3.9 ± 0.3 Aa  3.1 ± 0.4 Ba  2.7 ± 0.4  Ba 
        
S. Newport,  Antibiotic susceptible   3.9 ± 0.4 Aa  3.0 ± 0.2 Ba  2.7 ± 0.4 Ba 
        
S. Newport,  MDR, AmpC   4.1 ± 0.3 Aa  2.8 ± 0.3 Ba  2.6 ± 0.3 Ba  
        
E. coli O157:H7   4.0 ± 0.3 Aa  3.2 ± 0.2 Ba  3.0 ± 0.3 Ba 
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Table A23 (Data for Figure 6.1). Listeria monocytogenes counts (mean ± standard deviation) of cooked chicken during a 7 day aerobic storage at 
7°C before (control) and after 30, 60, and 90 seconds of domestic microwave oven reheating (1100 W). 
Storage (Day)  Listeria monocytogenes counts (log CFU/g)  
  Control 30 s 60 s 90 s  
0  3.7±0.1 D a
 
3.4±0.1 D b 2.7±0.1 D c <0.4±0.1 C d  
1  3.8±0.1 D a 3.6±0.1 D b 2.8±0.1 D c 0.4±0.1 C d  
2  4.6±0.1 C a 4.3±0.1 C b 3.5±0.1 C c 0.4±0.1 C d  
4  6.2±0.1 B a 4.8±0.1 B b 4.2±0.1 B c 1.8±0.1 B d  
7  7.8±0.2 A a 7.3±0.3 A b 5.6±0.1 A c 2.6±0.2 A d  









Table A24 (Data for Figure 6.2). Effects of domestic microwave reheating against aerobic plate counts (log CFU/g) of cooked chicken during a 7 
day aerobic storage at 7°C (mean ± standard deviation). 
Storage (Day)  Microwave Reheating Times  
  Control  30 s  60 s  90 s  
0  3.3±0.5 E a  3.0±0.3 D a  2.3±0.1 D b  0.8±0.4 C c  
1  4.0±0.2 D a  3.8±0.4 C a  2.6±0.1 D c  1.3±0.1 B c  
2  4.7±0.3 C a  4.7±0.0 B a  2.5±0.1 B b  1.1±0.4 BC c  
4  6.0±0.1 B a  4.9±0.1 B b  2.6±0.0 B c  0.8±0.3 C d  
7  7.8±0.7 A a  7.0±0.4 A b  3.9±0.1 A c  2.6±0.2 A d  









Table A25 (Data for Figures 6.3 and 6.4). Listeria monocytogenes counts (mean ± standard deviation) of cooked chicken during a 7 day aerobic storage at 7°C 
before (control) and after reheating to internal temperatures of 50, 60, and 70°C using domestic oven and stove-top methods. 
Storage (Day)  Listeria monocytogenes counts (log CFU/g) 
  Control 50°C 60°C 70°C 
Domestic Oven      
0  3.7±0.1 D a
b
 2.9±0.1 E b 2.7±0.1 E b 1.4±0.3 E c 
1  3.8±0.1 D a 3.7±0.1 D b 3.1±0.0 D c 1.8±0.2 D d 
2  4.6±0.1 C a 4.5±0.4 C a 4.0±0.1 C b 2.6±0.2 C c 
4  6.2±0.1 B a 5.7±0.3 B b 4.9±0.1 B c 4.0±0.1 B d 
7  7.8±0.2 A a 6.7±0.1 A b 6.6±0.4 A b 5.9±0.1 A c 
Stove-top Reheating      
 0  3.7±0.1 D a 1.7±0.1 E b 1.1±0.4 D c <0.5±0.4 D d 
1  3.8±0.1 D a 1.8±0.1 D b 1.3±0.2 D c <0.4±0.1 D d 
  2  4.6±0.1 C a 2.6±0.1 C b 2.1±0.1 C c 1.5±0.1 C d 
4  6.2±0.1 B a 4.6±0.1B b 3.8±0.1B c 3.0±0.1 B d 
  7  7.8±0.2 A a 6.8±0.0 A b 5.6±0.1 A c 4.8±0.0 A d 
Values within a column (for domestic oven and stove-top methods separately) followed by different uppercase letters, and values within a row 
followed by different lowercase letters are significantly (P<0.05) different. 
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Table A26 (Data for Figures 6.5 and 6.6). Effects of domestic oven reheating against aerobic plate counts (log CFU/g) of cooked chicken during 
a 7 day aerobic storage at 7°C (mean ± standard deviation). 
    Samples Internal Temperatures  
Storage (Day)  Control  50°C  60°C  70 °C  
Domestic Oven          
0  3.3±0.5 E a
 
  2.9±0.0 E b  2.7±0.1 D b  2.1±0.1 D c  
1  4.0±0.2 D a  3.9±0.1 D a  3.6±0.1 C b  2.2±0.3 D c  
2  4.7±0.3 C a  4.4±0.2 C b  3.8±0.1 C c  3.3±0.2 C d  
4  6.0±0.1 B a  5.3±0.1 B b  4.8±0.1 B c  4.7±0.1 B d  
7  7.8±0.7 A a  6.9±0.1 A b  5.7±0.2 A c  6.7±0.1 A b  
Stove Top          
0  3.3±0.5 E a
 
  2.7±0.1 E b  2.5±0.1 D b  1.9±0.1 E c  
1  4.0±0.2 D a  3.8±0.2 D a  2.8±0.1 D b  <0.4±0.0 D c  
2  4.7±0.3 C a  4.1±0.5 C b  3.0±0.4 C c  2.2±0.2 C d  
4  6.0±0.1 B a  4.8±0.1 B b  4.5±0.3 B b  4.1±0.4 B c  
7  7.8±0.7 A a  7.0±0.2 A b  6.7±0.1 A b  5.9±0.1A c  
Internal temperature of cooked chicken samples. For each reheating methods, values with a column followed by different uppercase letters, and 
values within a row followed by different lowercase letters are significantly (P<0.05) different. 
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 Oven  Stove-top 
 Internal Temperatures  Internal Temperatures 
Time (min) 50°C 60°C 70°C  50°C 60°C 70°C 
0   9.22±0.10   9.12±0.10   9.07±0.10   9.00±0.10   9.10±0.10   7.03±0.10 
1 10.47±0.10 10.47±0.10 10.47±0.10  10.97±0.10 11.33±0.10 10.97±0.10 
2 12.89±0.10 11.28±0.10 10.95±0.10  11.27±0.10 12.33±0.10 11.27±0.10 
3 16.28±0.10 12.89±0.10 11.36±0.10  12.28±0.10 13.06±0.10 12.28±0.10 
4 18.65±0.10 13.54±0.10 12.89±0.10  14.23±0.10 14.65±0.10 13.65±0.10 
5 20.92±0.10 14.29±0.10 13.06±0.10  16.87±0.10 16.67±0.10 14.23±0.10 
6 23.65±0.10 16.28±0.10 14.36±0.10  20.69±0.10 17.65±0.10 15.36±0.10 
7 26.40±0.10 17.63±0.10 15.63±0.10  26.24±0.10 19.38±0.10 16.87±0.10 
8 31.73±0.10 18.39±0.10 16.28±0.10  42.82±0.10 23.63±0.10 19.65±0.10 
9 36.84±0.10 20.92±0.10 18.63±0.10  49.65±0.10 26.68±0.10 23.64±0.10 
10 41.48±0.10 21.36±0.10 20.92±0.10  50.09±0.10 30.15±0.10 26.24±0.10 
11 45.64±0.10 22.63±0.10 26.40±0.10   33.25±0.10 42.82±0.10 
12 49.40±0.10 25.63±0.10 27.65±0.10   41.32±0.10 50.51±0.10 
13 50.12±0.10 27.36±0.10 28.63±0.10   47.50±0.10 51.73±0.10 
14  31.73±0.10 29.45±0.10   57.12±0.10 51.53±0.10 
15  34.61±0.10 30.60±0.10   60.11±0.10 57.03±0.10 
16  38.26±0.10 31.73±0.10    63.94±0.10 
17  41.48±0.10 36.84±0.10    68.47±0.10 
18  49.40±0.10 45.64±0.10    70.05±0.10 
19  60.07±0.10 53.31±0.10     
20   60.98±0.10     
21   61.63±0.10     
22   64.12±0.10     
23   66.29±0.10     
24   68.17±0.10     
25   70.03±0.10     
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Table A28 (Data for Figure 7.3). Effects of microwave reheating for 45 seconds on reduction of inoculated Listeria monocytogenes (log CFU/g) 











































  Storage days at 7°C 
  0*  1  2  4  7 
Non-marinated control Log reduction 2.1 ± 0.3 A Z  2.6 ± 0.3 A Y  2.6 ± 0.2 A X  3.4 ± 0.1 AB W  4.1 ± 0.5  A V 
 Survivors 0.6 ± 0.2 a z  0.7 ± 0.2 a y  1.8 ± 0.1 a x  2.3 ± 0.3 b w  3.4 ± 0.0 b v 
           
Commercial Tomato-based Log reduction 2.0 ± 0.2 A Z  2.2 ± 0.1 B Y  2.1 ± 0.2 BC X  3.7 ± 0.2 A W  4.1 ± 0.4 A V 
 Survivors 0.6 ± 0.2 a w  0.6 ± 0.2 abc w  0.7 ± 0.2 b w  1.0 ± 0.3 de w  1.8 ± 0.2 f v 
           
Commercial Soy-based Log reduction 2.2 ± 0.2 A X  2.2 ± 0.1 AB X  2.5 ± 0.2 AB W  2.7 ± 0.1 D W  3.8 ± 0.1 AB V 
 Survivors 0.5 ± 0.2 a x  0.3 ± 0.1 bc x  0.7 ± 0.3 b wx  0.9 ± 0.2 e w  3.1 ± 0.1 c v 
           
Commercial Lemon-based Log reduction 1.9 ± 0.2 A X  1.9 ± 0.2 B X  1.8 ± 0.2 C X  3.2 ± 0.2 BC W  3.5 ± 0.1 B V 
 Survivors 0.6 ± 0.3 a y  0.7 ± 0.2 ab xy  0.9 ± 0.2 b x  1.5 ± 0.1 c w  2.1 ± 0.1 e v 
           
Tomato-based Log reduction 2.0 ± 0.3 A W  2.2 ± 0.3 B VW  2.5 ± 0.4 AB V  3.0 ± 0.3  CD V  2.9 ± 0.1 CD V 
 Survivors 0.5 ± 0.2 a y  0.8 ± 0.2 a y  1.6 ± 0.4 a x  3.3 ± 0.1 a w  4.0 ± 0.3 a v 
           
Soy-based Log reduction 2.0 ± 0.2 A X  2.2 ± 0.4 AB X  2.3 ± 0.1 AB X  3.0 ± 0.1  CD W  3.4 ± 0.1 BC V 
 Survivors 0.7 ± 0.2 a y  0.7 ± 0.3 ab y  1.0 ± 0.1 b x  2.3 ± 0.1 b w  3.1 ± 0.0 c v 
           
Lemon-based Log reduction 2.1 ± 0.2 A X  2.2 ± 0.1 AB X  2.1 ± 0.3 BC X  2.4 ± 0.2 E W  2.7 ± 0.5 D V 
 Survivors 0.5 ± 0.2 a xy  0.3 ± 0.0 bc y  0.7 ± 0.3 b x  1.4 ± 0.4 c w  2.6 ± 0.2 d v 
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Table A29 (Data for Figure 7.4). Effects of microwave reheating at 45 seconds on reduction of inoculated aerobic plate 
counts during a 7 day aerobic storage at 7°C. 
*Values are mean ± standard deviation of two repetitions with three samples per treatment.  Log reduction values followed by different 
uppercase letters of A, B, C, D, E, F, or G within each column, and followed by different uppercase letters of  V, W, X, Y, or Z within 
each row, are statistically (P<0.05) different. Survivor values followed by different lowercase letters of a, b, c, d, e, f, or g within each 





  Storage days at 7°C 
  0  1  2  4  7 
Non-marinated control Log reduction 2.5 ± 0.1 A X  2.4 ± 0.3 AB X  2.7 ± 0.2 A X  3.5 ± 0.2  A W  4.0 ± 0.2  A V 
 Survivors 0.7 ± 0.2 a z  1.1 ± 0.2 a y  1.8 ± 0.1 a x  2.5 ± 0.2 b w  3.8 ± 0.1 b v 
           
Commercial Tomato-based Log reduction 2.3 ± 0.2 AB X  2.6 ± 0.2 A X  2.0 ± 0.2 CD Y  2.9 ± 0.2 BC W  4.2 ± 0.5 A V 
 Survivors 0.6 ± 0.2 a x  0.5 ± 0.2 c x  1.1 ± 0.2 b w  1.2 ± 0.3 cd w  2.7 ± 0.3 d v 
           
Commercial Soy-based Log reduction 2.0 ± 0.1 B X  2.1 ± 0.3 B X  2.6 ± 0.2  AB W  2.4 ± 0.1 D W  4.1 ± 0.4  A V 
 Survivors 0.7 ± 0.1 a x  0.7 ± 0.2 bc x  0.6 ± 0.2 c x  1.0 ± 0.2 d w  3.3 ± 0.1 c v 
           
Commercial Lemon-based Log reduction 2.1 ± 0.3 AB W  2.2 ± 0.2 AB W  1.9 ± 0.2 D W  2.1 ± 0.1 D W  3.7 ± 0.5  AB V 
 Survivors 0.7 ± 0.3 a y  0.7 ± 0.1 bc y  1.0 ± 0.1 b x  1.5 ± 0.2 c w  3.5 ± 0.1 c v 
           
Tomato-based Log reduction 2.1 ± 0.4 AB X  2.2 ± 0.3 AB X  2.2 ± 0.4  BCD X  2.8 ± 0.1 C W  3.0 ± 0.1 C V 
 Survivors 0.7 ± 0.3 a y  0.9 ± 0.2 ab y  2.0 ± 0.2 a x  3.5 ± 0.1 a w  4.3 ± 0.1  a v 
           
Soy-based Log reduction 2.0 ± 0.1 B Y  2.0 ± 0.1 B Y  2.4 ± 0.1  ABC X  3.2 ± 0.2  AB W  3.3 ± 0.2 BC V 
 Survivors 0.9 ± 0.1 a x  1.0 ± 0.0 ab x  1.0 ± 0.1 b x   2.4 ± 0.1 b w  2.9 ± 0.2 d v 
           
Lemon-based Log reduction 2.1 ± 0.2 AB W  <2.2 ± 0.2 AB W  2.0 ± 0.2 CD W  2.1 ± 0.4  D W  2.3 ± 0.3 D V 
 Survivors 0.8 ± 0.2 a x  <0.5 ± 0.1 c y  0.9 ± 0.2 bc x  2.1 ± 0.2 b y   2.8 ± 0.2 d v  
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Table A30 (Data for Figure 7.). Effects of microwave reheating for 90 seconds on reduction of inoculated Listeria monocytogenes 
during a 7 day aerobic storage. 
*Values are mean ± standard deviation of two repetitions with three samples per treatment.  Log reduction values followed by different uppercase letters of A, B, C, D, 
E, F, or G within each column, and followed by different uppercase letters of  V, W, X, Y, or Z within each row, are statistically (P<0.05) different. Survivor values 
followed by different lowercase letters of a, b, c, d, e, f, or g within each column, and followed by lowercase letters of w, z, y, or z within each row are statistically 
(P<0.05) different. 
   Storage days at 7°C 
   0  1  2  4  7 
Non-marinated control Log reduction  <2.4 ± 0.1 A X  <3.0 ± 0.2 A X  3.5 ± 0.2 A W  4.3 ± 0.3 AB V  4.4 ± 0.4 AB V 
 Survivors  <0.3 ± 0.0 a y  <0.3 ± 0.1 a y  0.9 ± 0.1 a x  1.9 ± 0.3 a w  2.6 ± 0.2 a v 
            
Commercial Tomato-based Log reduction  <2.3 ± 0.2 A X  <2.5 ± 0.1 BC X  <2.5 ± 0.1 B W  4.3 ± 0.2 AB V  4.6 ± 0.4 AB V 
 Survivors  <0.3 ± 0.0 a w  <0.3 ± 0.0 a w  <0.3 ± 0.1 b w  0.5 ± 0.2 c w  1.3 ± 0.2 cd v 
            
Commercial Soy-based Log reduction  <2.4 ± 0.0 A X  2.2 ± 0.2 BCD X  <2.8 ± 0.1 B W  4.3 ± 0.3 AB V  4.1 ± 0.3 BC V 
 Survivors  <0.3 ± 0.0 a x  0.4 ± 0.1 a x  <0.3 ± 0.1 b x  0.6 ± 0.2 c w  1.5 ± 0.3 bc v 
            
Commercial Lemon-based Log reduction  <2.1 ± 0.3 A X  2.0 ± 0.3 D X  2.3 ± 0.3 C X  4.3 ± 0.2 BC V  3.5 ± 0.3 C W 
 Survivors  <0.3 ± 0.0 a x  0.5 ± 0.3 a xw  0.5 ± 0.2 b x  0.7 ± 0.2 c w  1.8 ± 0.2 b v 
            
Tomato-based Log reduction  <2.2 ± 0.1 A Z  <2.6 ± 0.2 ABY  3.7 ± 0.2 A X  4.3 ± 0.1 AB W  5.0 ± 0.5 A V 
 Survivors  <0.3 ± 0.0 a x  <0.4 ± 0.3 a x  0.5 ± 0.2 b x  1.3 ± 0.6 b w  2.6 ± 0.2 a v 
            
Soy-based Log reduction  <2.3 ± 0.3 A Y  <2.5 ± 0.2 BC X  2.9 ± 0.3 B X  4.6 ± 0.4 A W  5.0 ± 0.2 A V 
 Survivors  <0.4 ± 0.3 a x  <0.3 ± 0.1 a x  0.4 ± 0.2 b x  0.8 ± 0.2 bc w  1.6 ± 0.4 bc v 
            
Lemon-based Log reduction  <2.3 ± 0.1 A X  <2.2 ± 0.1 CD X  2.4 ± 0.3 C X  4.0 ± 0.3 B V  3.8 ± 0.1 C W 
 Survivors  <0.3 ± 0.0 a w  <0.3 ± 0.0 a w  0.4 ± 0.1 b w  0.3 ± 0.0 c w  0.9 ± 0.3 d v 
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Table A31 (Data for Figure 7.6). Effects of microwave reheating at 90 seconds on reduction of inoculated aerobic plate counts 
during a 7 day aerobic storage. 
*Values are mean ± standard deviation of two repetitions with three samples per treatment.  Log reduction values followed by different uppercase letters 
of A, B, C, D, E, F, or G within each column, and followed by different uppercase letters of  V, W, X, Y, or Z within each row, are statistically (P<0.05) 
different. Survivor values followed by different lowercase letters of a, b, c, d, e, f, or g within each column, and followed by lowercase letters of w, z, y, 
or z within each row are statistically (P<0.05) different. 
   Storage days at 7°C 
   Day 0  Day 1  Day 2  Day 4  Day 7 
Non-marinated control Log reduction  2.8 ± 0.3 A Y  <2.6 ± 0.3 A Y  3.4 ± 0.3 A X  4.0 ± 0.1 ABC W  4.4 ± 0.2 BC V 
 Survivors  0.4 ± 0.2 a y  <0.9 ± 0.3 a x  1.0 ± 0.2 a x  2.1 ± 0.1 a w  3.2 ± 0.1 a v 
            
Commercial Tomato-based Log reduction  2.5 ± 0.2 AB W  2.6 ± 0.2 A W  2.6 ± 0.2 BCD W  4.1 ± 0.2 AB V  4.5 ± 0.5 B V 
 Survivors  0.4 ± 0.2 a x  0.4 ± 0.3 b x  0.5 ± 0.2  b x  0.8 ± 0.2 cd w  1.5 ± 0.2 c v 
            
Commercial Soy-based Log reduction  2.3 ± 0.3 B Y  2.5 ± 0.1 A Y  2.8 ± 0.3 B X  3.8 ± 0.2 C W  4.5 ± 0.4 B V 
 Survivors  0.4 ± 0.1 a x  0.3 ± 0.0 b wx  0.4 ± 0.2 b w  0.5 ± 0.2 d w  1.9 ± 0.2 bc v 
            
Commercial Lemon-based Log reduction  <2.6 ± 0.1 AB X  <2.5 ± 0.1 A X  2.4 ± 0.2 CD X  3.4 ± 0.1 D W  4.2 ± 0.4 BC V 
 Survivors  <0.3 ± 0.0 a y  <0.4 ± 0.1 b xy  0.6 ± 0.2 b x  1.0 ± 0.3 bc w  2.2 ± 0.2 b v 
            
Tomato-based Log reduction  2.5 ± 0.2 AB Y  2.5 ± 0.2 A Y  3.5 ± 0.3 A X  3.9 ± 0.1 BC W  5.4 ± 0.1 A V 
 Survivors  0.3 ± 0.1 a y  0.5 ± 0.3 b xy  0.7 ± 0.2 ab x  1.2 ± 0.1 b w  3.2 ± 0.1 a v 
            
Soy-based Log reduction  <2.6 ± 0.1 AB X  <2.6 ± 0.2 A X  2.7 ± 0.3 BC X  4.3 ± 0.1 A W  4.7 ± 0.2 B V 
 Survivors  <0.3 ± 0.1 a y  <0.4 ± 0.2 b xy  0.6 ± 0.3 ab x  1.1 ± 0.1 bc w  1.9 ± 0.1 b v 
            
Lemon-based Log reduction  <2.6 ± 0.1 AB W  <2.4 ± 0.1 A W  2.2 ± 0.1 CD W  3.9 ± 0.3 BC V  3.8 ± 0.4 C V 
 Survivors  <0.3 ± 0.0 a x  <0.3 ± 0.1 b x  0.6 ± 0.1 b w  0.7 ± 0.2 d w  1.1 ± 0.4 d v 
 Storage (days) 
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Table A32 (Data for Figures 7.1 and 7.2). Survival and multiplication of L. monocytogenes 






 Storage (days) 
(Selective Counts) 0 1 2 4 7 
Non-marinated control 2.7±0.1 3.3±0.1 4.4±0.2 6.3±0.2 6.9±0.3 
Commercial Tomato-based 2.6±0.1 2.8±0.1 2.9±0.1 5.0±0.2 5.5±0.3 
Commercial Soy-based 2.7±0.1 2.6±0.1 3.1±0.1 4.7±0.2 5.8±0.3 
Commercial Lemon-based 2.4±0.2 2.5±0.1 2.7±0.1 5.0±0.3 5.3±0.2 
Domestic Tomato-based 2.5±0.1 2.9±0.1 4.2±0.1 6.2±0.2 6.9±0.3 
Domestic Soy-based 2.7±0.1 2.9±0.1 3.3±0.1 5.7±0.2 6.1±0.3 
Domestic Lemon-based 2.6±0.2 2.5±0.1 2.8±0.1 4.1±0.3 4.9±0.2 
      
(Non-selective Counts)      
Non-marinated control 3.2±0.1 3.5±0.1 4.4±0.1 6.5±0.2 7.3±0.3 
Commercial Tomato-based 2.9±0.2 3.0±0.2 3.1±0.2 5.3±0.2 5.7±0.3 
Commercial Soy-based 2.7±0.2 2.8±0.2 3.2±0.1 5.0±0.3 5.7±0.3 
Commercial Lemon-based 2.9±0.1 2.8±0.2 2.9±0.2 5.2±0.3 5.6±0.3 
Domestic Tomato-based 2.8±0.1 3.1±0.1 4.2±0.2 6.5±0.3 7.1±0.2 
Domestic Soy-based 2.9±0.1 3.0±0.1 3.4±0.1 5.7±0.3 6.2±0.3 
Domestic Lemon-based 2.9±0.1 2.7±0.1 2.8±0.1 4.5±0.3 5.0±0.1 
